S8293506B2	NNP	O
-	:	O
L-cysteine-producing	JJ	O
bacterium	NN	O
and	CC	O
a	DT	O
method	NN	O
for	IN	O
producing	VBG	O
L-cysteine	NNP	O
-	:	O
Google	NN	O
Patents	NNS	O
Info	NNP	O
Links	NNP	O
Images	NNP	O
Classifications	NNP	O
Abstract	NNP	O
Description	NNP	O
This	DT	O
application	NN	O
claims	VBZ	O
priority	NN	O
under	IN	O
35	CD	O
U.S.C.	.	O
§119	NN	O
to	TO	O
Japanese	JJ	O
Patent	NNP	O
Application	NNP	O
No.	.	O
2009-042561,	,	O
filed	VBN	O
on	IN	O
Feb.	NNP	O
25,	,	O
2009,	,	O
and	CC	O
U.S.	.	O
Provisional	JJ	O
Patent	NNP	O
Application	NNP	O
No.	.	O
61/155,513,	,	O
filed	VBN	O
on	IN	O
Feb.	NNP	O
25,	,	O
2009,	,	O
both	DT	O
of	IN	O
which	WDT	O
are	VBP	O
incorporated	VBN	O
in	IN	O
their	PRP$	O
entireties	NNS	O
by	IN	O
reference.	.	O
The	DT	O
Sequence	NNP	O
Listing	NNP	O
in	IN	O
electronic	JJ	O
format	NN	O
filed	VBN	O
herewith	NN	O
is	VBZ	O
also	RB	O
hereby	RB	O
incorporated	VBN	O
by	IN	O
reference	NN	O
in	IN	O
its	PRP$	O
entirety	NN	O
(File	NNP	O
Name:	:	O
US-388_Seq_List;	:	O
File	NNP	O
Size:	:	O
30	CD	O
KB;	:	O
Date	NNP	O
Created:	:	O
Feb.	NNP	O
23,	,	O
2010).	.	O
BACKGROUND	NNP	O
OF	IN	O
THE	NNP	O
INVENTION	NNP	O
1.	.	O
Field	NN	O
of	IN	O
the	DT	O
Invention	NNP	O
The	DT	O
present	JJ	O
invention	NN	O
relates	VBZ	O
to	TO	O
a	DT	O
method	NN	O
for	IN	O
producing	VBG	O
L-cysteine	NNP	O
or	CC	O
related	VBN	O
substances.	.	O
Specifically,	,	O
the	DT	O
present	JJ	O
invention	NN	O
relates	VBZ	O
to	TO	O
a	DT	O
bacterium	NN	O
suitable	NN	O
for	IN	O
the	DT	O
production	NN	O
of	IN	O
L-cysteine	NNP	O
or	CC	O
related	VBN	O
substances	NNS	O
and	CC	O
a	DT	O
method	NN	O
for	IN	O
producing	VBG	O
L-cysteine	NNP	O
or	CC	O
related	VBN	O
substances	NNS	O
utilizing	VBG	O
such	JJ	O
a	DT	O
bacterium.	.	O
L-cysteine	JJ	O
and	CC	O
L-cysteine	JJ	O
related	JJ	O
substances	NNS	O
are	VBP	O
useful	JJ	O
in	IN	O
the	DT	O
fields	NNS	O
of	IN	O
drugs,	,	O
cosmetics,	,	O
and	CC	O
foods.	.	O
2.	.	O
Brief	JJ	O
Description	NNP	O
of	IN	O
the	DT	O
Related	JJ	O
Art	NNP	O
L-cysteine	NNP	O
is	VBZ	O
conventionally	RB	O
obtained	VBN	O
by	IN	O
extraction	NN	O
from	IN	O
keratin-containing	JJ	O
substances	NNS	O
such	JJ	O
as	IN	O
hair,	,	O
horns,	,	O
and	CC	O
feathers,	,	O
or	CC	O
by	IN	O
the	DT	O
conversion	NN	O
of	IN	O
DL-2-aminothiazoline-4-carboxylic	NNP	O
acid	NN	O
using	VBG	O
a	DT	O
microbial	JJ	O
enzyme.	.	O
L-cysteine	NN	O
has	VBZ	O
also	RB	O
been	VBN	O
produced	VBN	O
on	IN	O
a	DT	O
large	JJ	O
scale	NN	O
by	IN	O
using	VBG	O
an	DT	O
immobilized	JJ	O
enzyme	NN	O
method	NN	O
and	CC	O
a	DT	O
novel	JJ	O
enzyme.	.	O
Furthermore,	,	O
it	PRP	O
has	VBZ	O
also	RB	O
been	VBN	O
attempted	VBN	O
to	TO	O
produce	VB	O
L-cysteine	JJ	O
by	IN	O
fermentation	NN	O
utilizing	VBG	O
a	DT	O
microorganism.	.	O
Microorganisms	NNP	O
which	WDT	O
are	VBP	O
able	JJ	O
to	TO	O
produce	VB	O
L-cysteine	NNP	O
are	VBP	O
known.	.	O
For	IN	O
example,	,	O
a	DT	O
coryneform	NN	O
bacterium	NN	O
with	IN	O
increased	JJ	O
intracellular	JJ	O
serine	NN	O
acetyltransferase	NN	O
activity	NN	O
produces	VBZ	O
cysteine	NN	O
(Japanese	JJ	O
Patent	NNP	O
Laid-open	NNP	O
(Kokai)	)	O
No.	.	O
2002-233384).	.	O
The	DT	O
ability	NN	O
to	TO	O
produce	VB	O
L-cysteine	NNP	O
can	MD	O
also	RB	O
be	VB	O
increased	VBN	O
by	IN	O
incorporating	VBG	O
serine	NN	O
acetyltransferase	NN	O
which	WDT	O
has	VBZ	O
been	VBN	O
mutated	VBN	O
to	TO	O
attenuate	VB	O
feedback	NN	O
inhibition	NN	O
by	IN	O
L-cysteine	NNP	O
(Japanese	JJ	O
Patent	NNP	O
Laid-open	NNP	O
No.	.	O
11-155571,	,	O
U.S.	NNP	O
Patent	NNP	O
Published	NNP	O
Application	NNP	O
No.	.	O
20050112731,	,	O
U.S.	NNP	O
Pat.	.	O
No.	.	O
6,218,168).	.	O
Furthermore,	,	O
the	DT	O
ability	NN	O
to	TO	O
produce	VB	O
L-cysteine	NNP	O
in	IN	O
a	DT	O
microorganism	NN	O
can	MD	O
be	VB	O
enhanced	VBN	O
by	IN	O
suppressing	VBG	O
the	DT	O
L-cysteine	NNP	O
decomposition	NN	O
system.	.	O
Examples	NNS	O
of	IN	O
such	JJ	O
microorganisms	NNS	O
include	VBP	O
coryneform	JJ	O
bacteria	NNS	O
or	CC	O
Escherichia	NNP	O
bacteria	NNS	O
in	IN	O
which	WDT	O
the	DT	O
activity	NN	O
of	IN	O
cystathionine-β-lyase	NN	O
(Japanese	JJ	O
Patent	NNP	O
Laid-open	NNP	O
No.	.	O
11-155571),	,	O
tryptophanase	NN	O
(Japanese	JJ	O
Patent	NNP	O
Laid-open	NNP	O
No.	.	O
2003-169668),	,	O
or	CC	O
O-acetylserine	JJ	O
sulfhydrylase	NN	O
B	NNP	O
(Japanese	JJ	O
Patent	NNP	O
Laid-open	NNP	O
No.	.	O
2005-245311)	)	O
is	VBZ	O
attenuated	VBN	O
or	CC	O
deleted.	.	O
Furthermore,	,	O
it	PRP	O
is	VBZ	O
known	VBN	O
that	IN	O
the	DT	O
ydeD	NN	O
gene	NN	O
which	WDT	O
encodes	VBZ	O
the	DT	O
YdeD	NNP	O
protein	NN	O
participates	VBZ	O
in	IN	O
secretion	NN	O
of	IN	O
the	DT	O
metabolic	JJ	O
products	NNS	O
of	IN	O
the	DT	O
cysteine	NN	O
pathway	NN	O
Dabler	NNP	B
et	RB	I
al.,	,	I
Mol.	.	I
Microbiol.,	,	I
36,	,	I
1101-1112	CD	I
(2000)).(	.	O
Furthermore,	,	O
techniques	NNS	O
for	IN	O
enhancing	VBG	O
the	DT	O
ability	NN	O
to	TO	O
produce	VB	O
L-cysteine	JJ	O
by	IN	O
increasing	VBG	O
expression	NN	O
of	IN	O
the	DT	O
mar-locus,	,	O
emr-locus,	,	O
acr-locus,	,	O
cmr-locus,	,	O
mex-gene,	,	O
bmr-gene	JJ	O
or	CC	O
qacA-gene	NN	O
are	VBP	O
also	RB	O
known.	.	O
These	DT	O
loci	JJ	O
and/or	NN	O
genes	NNS	O
encode	VBP	O
proteins	NNS	O
which	WDT	O
cause	VBP	O
secretion	NN	O
of	IN	O
toxic	JJ	O
substances	NNS	O
from	IN	O
cells	NNS	O
(U.S.	NNP	O
Pat.	.	O
No.	.	O
5,972,663).	.	O
emrAB,	,	O
emrKY,	,	O
yojIH,	,	O
acrEF,	,	O
bcr,	,	O
and	CC	O
cusA	NNS	O
are	VBP	O
further	JJ	O
examples	NNS	O
(Japanese	JJ	O
Patent	NNP	O
Laid-open	NNP	O
No.	.	O
2005-287333).	.	O
An	DT	O
Escherichia	NNP	O
coli	NN	O
has	VBZ	O
been	VBN	O
reported	VBN	O
which	WDT	O
produces	VBZ	O
L-cysteine,	,	O
and	CC	O
which	WDT	O
has	VBZ	O
increased	VBN	O
activity	NN	O
of	IN	O
the	DT	O
positive	JJ	O
transcriptional	JJ	O
control	NN	O
factor	NN	O
of	IN	O
the	DT	O
cysteine	NN	O
regulon	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
cysB	NN	O
gene	NN	O
(International	NNP	O
Patent	NNP	O
Publication	NNP	O
WO01/27307).	.	O
It	PRP	O
is	VBZ	O
known	VBN	O
that	IN	O
dsbA	NN	O
Shevchik	NNP	B
V.	NNP	I
E.,	,	I
et	FW	I
al.,	,	I
EMBO	NNP	I
J.,	,	I
1994	CD	I
Apr.	.	I
15;	:	I
13(8):2007-12)	)	I
(participates	VBZ	O
in	IN	O
the	DT	O
formation	NN	O
of	IN	O
disulfide	JJ	O
bonds	NNS	O
(S—S)	)	O
of	IN	O
proteins	NNS	O
as	IN	O
described	VBN	O
below,	,	O
but	CC	O
the	DT	O
relation	NN	O
thereof	NN	O
with	IN	O
L-cysteine	JJ	O
production	NN	O
is	VBZ	O
not	RB	O
known.	.	O
In	IN	O
general,	,	O
many	JJ	O
proteins	NNS	O
with	IN	O
a	DT	O
disulfide	JJ	O
bond	NN	O
(S—S)	)	O
are	VBP	O
among	IN	O
proteins	NNS	O
that	WDT	O
are	VBP	O
secreted	VBN	O
into	IN	O
cell	NN	O
membrane	NN	O
surface	NN	O
layers	NNS	O
or	CC	O
out	IN	O
of	IN	O
cells.	.	O
The	DT	O
interior	NN	O
of	IN	O
cells	NNS	O
enclosed	VBN	O
by	IN	O
the	DT	O
cell	NN	O
membranes	NNS	O
is	VBZ	O
under	IN	O
relatively	RB	O
mild	JJ	O
conditions	NNS	O
both	DT	O
physically	RB	O
and	CC	O
chemically.	.	O
However,	,	O
since	IN	O
the	DT	O
exterior	NN	O
of	IN	O
cells	NNS	O
is	VBZ	O
a	DT	O
more	RBR	O
severe	JJ	O
environment,	,	O
the	DT	O
structures	NNS	O
of	IN	O
proteins	NNS	O
need	VBP	O
to	TO	O
be	VB	O
more	JJR	O
rigid.	.	O
The	DT	O
presence	NN	O
of	IN	O
S—S	NNP	O
bonds	NNS	O
in	IN	O
proteins	NNS	O
is	VBZ	O
one	CD	O
of	IN	O
the	DT	O
strategies.	.	O
Anfinsen	NNP	O
et	CC	O
al.	.	O
demonstrated	VBN	O
that	IN	O
oxidative	JJ	O
folding	NN	O
of	IN	O
proteins	NNS	O
accompanied	VBN	O
by	IN	O
the	DT	O
formation	NN	O
of	IN	O
S—S	NNP	O
bonds	NNS	O
spontaneously	RB	O
advanced	VBD	O
under	IN	O
moderate	JJ	O
oxidative	JJ	O
conditions	NNS	O
Givol	NNP	B
D.	NNP	I
et	FW	I
al.,	,	I
J.	NNP	I
Biol.	.	I
Chem.,	,	I
1964,	,	I
Sep.;	:	I
239:PC3114-16).(	.	O
However,	,	O
it	PRP	O
has	VBZ	O
been	VBN	O
elucidated	VBN	O
that,	,	O
in	IN	O
a	DT	O
cell,	,	O
there	EX	O
is	VBZ	O
a	DT	O
delicate	JJ	O
system	NN	O
for	IN	O
the	DT	O
formation	NN	O
of	IN	O
S—S	NNP	O
bond,	,	O
so	IN	O
that	IN	O
it	PRP	O
can	MD	O
advance	VB	O
more	RBR	O
quickly	RB	O
and	CC	O
correctly	RB	O
as	IN	O
compared	VBN	O
with	IN	O
the	DT	O
aforementioned	JJ	O
formation	NN	O
of	IN	O
S—S	NNP	O
bonds	NNS	O
Bardwell	NNP	B
J.	NNP	I
C.,	,	I
et	FW	I
al.,	,	I
Cell,	,	I
1991	CD	I
Nov.	NNP	I
1;	:	I
67(3):581-9.)(.	.	O
For	IN	O
example,	,	O
in	IN	O
the	DT	O
periplasm	NN	O
of	IN	O
Escherichia	NNP	O
coli,	,	O
a	DT	O
series	NN	O
of	IN	O
proteins	NNS	O
called	VBN	O
Dsb	NNP	O
factors	NNS	O
(disulfide	JJ	O
bond,	,	O
DsbA,	,	O
DsbB,	,	O
DsbC	NNP	O
Shevchik	NNP	B
V.	NNP	I
E.,	,	I
et	FW	I
al.,	,	I
EMBO	NNP	I
J.,	,	I
1994	CD	I
Apr.	.	I
15;	:	I
13(8):2007-12),(	,	O
DsbD	NNP	O
Missiakas	NNP	B
D.,	,	I
et	FW	I
al.,	,	I
EMBO	NNP	I
J.,	,	I
1995	CD	I
Jul.	.	I
17;	:	I
14(14):3415-24),(	,	O
and	CC	O
DsbG	NNP	O
Andersen	NNP	B
C.	NNP	I
L.,	,	I
et	FW	I
al.,	,	I
Mol.	.	I
Microbiol.,	,	I
1997,	,	I
Oct.;	:	I
26(1):121-32))	)	I
(form	NN	O
disulfide	JJ	O
bonds	NNS	O
and	CC	O
introduce	VB	O
them	PRP	O
into	IN	O
many	JJ	O
proteins.	.	O
In	IN	O
the	DT	O
periplasm,	,	O
DsbA	NNP	O
(disulfide	JJ	O
oxidoreductase)	)	O
oxidizes	VBZ	O
a	DT	O
substrate	NN	O
protein	NN	O
(AmpC,	,	O
DsbB,	,	O
LivK,	,	O
OstA,	,	O
RcsF	NNP	O
Kadokura	NNP	B
H.,	,	I
et	FW	I
al.,	,	I
Science,	,	I
2004,	,	I
Jan.	NNP	I
23;	:	I
303(5657):534-7)),(	,	O
and	CC	O
the	DT	O
cysteine	NN	O
pair	NN	O
of	IN	O
DsbA	NNP	O
converted	VBD	O
into	IN	O
the	DT	O
reduced	JJ	O
type	NN	O
is	VBZ	O
re-oxidized	JJ	O
with	IN	O
the	DT	O
intracellular	JJ	O
membrane	NN	O
protein	NN	O
DsbB.	.	O
It	PRP	O
has	VBZ	O
been	VBN	O
elucidated	VBN	O
that	IN	O
electrons	NNS	O
received	VBN	O
by	IN	O
DsbB	NNP	O
are	VBP	O
transferred	VBN	O
to	TO	O
ubiquinone	VB	O
(UQ),	,	O
which	WDT	O
is	VBZ	O
a	DT	O
respiratory	NN	O
chain	NN	O
component,	,	O
and	CC	O
oxygen	NN	O
eventually	RB	O
serves	VBZ	O
as	IN	O
an	DT	O
electron	NN	O
acceptor	NN	O
with	IN	O
the	DT	O
aid	NN	O
of	IN	O
cytochrome	JJ	O
oxidase	NN	O
Inaba	NNP	B
K.,	,	I
et	FW	I
al.,	,	I
J.	NNP	I
Biol.	.	I
Chem.,	,	I
279,	,	I
6761-6768	CD	I
(2004)).(	.	O
Although	IN	O
DsbA	NNP	O
has	VBZ	O
superior	JJ	O
characteristics	NNS	O
as	IN	O
an	DT	O
S—S	NNP	O
bond-introducing	NN	O
enzyme,	,	O
the	DT	O
ability	NN	O
thereof	NN	O
to	TO	O
select	VB	O
a	DT	O
cysteine	NN	O
pair	NN	O
into	IN	O
which	WDT	O
the	DT	O
bond	NN	O
is	VBZ	O
introduced	VBN	O
is	VBZ	O
not	RB	O
sufficient.	.	O
It	PRP	O
has	VBZ	O
also	RB	O
been	VBN	O
found	VBN	O
that	IN	O
the	DT	O
enzyme	NN	O
DsbC	NNP	O
(disulfide	JJ	O
isomerase)	)	O
which	WDT	O
recombines	VBP	O
incorrect	JJ	O
S—S	NNP	O
bonds	NNS	O
is	VBZ	O
present	JJ	O
in	IN	O
the	DT	O
periplasm	NN	O
of	IN	O
Escherichia	NNP	O
coli.	.	O
In	IN	O
order	NN	O
for	IN	O
DsbC	NNP	O
to	TO	O
function	VB	O
as	IN	O
an	DT	O
isomerase,	,	O
the	DT	O
active	JJ	O
site	NN	O
thereof	NN	O
must	MD	O
be	VB	O
maintained	VBN	O
as	IN	O
a	DT	O
reduced	JJ	O
type,	,	O
contrary	JJ	O
to	TO	O
DsbA,	,	O
which	WDT	O
is	VBZ	O
an	DT	O
oxidase.	.	O
It	PRP	O
is	VBZ	O
considered	VBN	O
that	IN	O
the	DT	O
source	NN	O
of	IN	O
the	DT	O
reducing	VBG	O
power	NN	O
originates	NNS	O
in	IN	O
the	DT	O
thioredoxin	NN	O
system	NN	O
existing	VBG	O
in	IN	O
the	DT	O
cytoplasm,	,	O
and	CC	O
the	DT	O
reducing	VBG	O
power	NN	O
from	IN	O
thioredoxin	NN	O
is	VBZ	O
transferred	VBN	O
to	TO	O
DsbC	NNP	O
via	IN	O
an	DT	O
intracellular	JJ	O
membrane	NN	O
protein	NN	O
DsbD	NNP	O
Rietsch	NNP	B
A.,	,	I
et	FW	I
al.,	,	I
J.	.	I
Bacteriol.,	,	I
1997	CD	I
November;	:	I
179(21):6602-8).(	.	O
Moreover,	,	O
it	PRP	O
is	VBZ	O
also	RB	O
considered	VBN	O
that	IN	O
a	DT	O
protein	NN	O
called	VBN	O
DsbG	NNP	O
which	WDT	O
shows	VBZ	O
narrower	JJR	O
substrate	JJ	O
specificity	NN	O
is	VBZ	O
also	RB	O
present	JJ	O
in	IN	O
Escherichia	NNP	O
coli,	,	O
and	CC	O
it	PRP	O
has	VBZ	O
activities	NNS	O
of	IN	O
both	DT	O
disulfide	JJ	O
oxidoreductase	NN	O
and	CC	O
disulfide	JJ	O
isomerase	NN	O
Andersen	NNP	B
C.	NNP	I
L.,	,	I
et	FW	I
al.,	,	I
Mol.	.	I
Microbiol.,	,	I
1997,	,	I
Oct.;	:	I
26(1):121-32).(	.	O
As	IN	O
for	IN	O
the	DT	O
use	NN	O
of	IN	O
the	DT	O
aforementioned	JJ	O
Dsb	NNP	O
family,	,	O
there	EX	O
are	VBP	O
such	JJ	O
findings	NNS	O
as	IN	O
mentioned	VBN	O
below,	,	O
with	IN	O
expecting	VBG	O
the	DT	O
effect	NN	O
of	IN	O
correctly	RB	O
forming	VBG	O
S—S	NNP	O
bonds	NNS	O
of	IN	O
proteins.	.	O
Many	JJ	O
proteins	NNS	O
derived	VBN	O
from	IN	O
eukaryotic	JJ	O
organisms	NNS	O
have	VBP	O
a	DT	O
disulfide	JJ	O
bond,	,	O
and	CC	O
they	PRP	O
cannot	RB	O
be	VB	O
expected	VBN	O
to	TO	O
have	VB	O
their	PRP$	O
original	JJ	O
structures	NNS	O
when	WRB	O
they	PRP	O
are	VBP	O
expressed	VBN	O
in	IN	O
the	DT	O
cytoplasm	NN	O
of	IN	O
Escherichia	NNP	O
coli,	,	O
which	WDT	O
is	VBZ	O
under	IN	O
severe	JJ	O
reducing	VBG	O
conditions.	.	O
Therefore,	,	O
it	PRP	O
is	VBZ	O
considered	VBN	O
that,	,	O
for	IN	O
production	NN	O
of	IN	O
such	JJ	O
proteins	NNS	O
derived	VBN	O
from	IN	O
eukaryotic	JJ	O
organisms,	,	O
expression	NN	O
in	IN	O
the	DT	O
form	NN	O
of	IN	O
secretion	NN	O
into	IN	O
the	DT	O
periplasm	NN	O
is	VBZ	O
effective,	,	O
which	WDT	O
is	VBZ	O
under	IN	O
an	DT	O
oxidative	JJ	O
environment	NN	O
preferred	VBN	O
for	IN	O
formation	NN	O
of	IN	O
disulfide	JJ	O
bond.	.	O
However,	,	O
although	IN	O
many	JJ	O
attempts	NNS	O
of	IN	O
expressing	VBG	O
heterogenous	JJ	O
proteins	NNS	O
by	IN	O
secretion	NN	O
into	IN	O
Escherichia	NNP	O
coli	VBP	O
periplasm	NNS	O
have	VBP	O
been	VBN	O
reported,	,	O
any	DT	O
heterogenous	JJ	O
protein	NNS	O
cannot	RB	O
necessarily	RB	O
be	VB	O
expressed	VBN	O
as	IN	O
active	JJ	O
proteins.	.	O
This	DT	O
poses	VBZ	O
a	DT	O
problem	NN	O
especially	RB	O
for	IN	O
proteins	NNS	O
having	VBG	O
many	JJ	O
disulfide	JJ	O
bonds.	.	O
Meanwhile,	,	O
in	IN	O
Escherichia	NNP	O
coli,	,	O
the	DT	O
roles	NNS	O
of	IN	O
DsbA,	,	O
DsbB,	,	O
DsbC,	,	O
and	CC	O
DsbD,	,	O
which	WDT	O
are	VBP	O
the	DT	O
Dsb	NNP	O
family	NN	O
proteins	VBZ	O
involved	VBN	O
in	IN	O
the	DT	O
formation	NN	O
of	IN	O
disulfide	JJ	O
bond,	,	O
were	VBD	O
deduced	VBN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
biochemical	JJ	O
tests	NNS	O
and	CC	O
complementation	NN	O
tests	NNS	O
using	VBG	O
strains	NNS	O
deficient	NN	O
in	IN	O
each	DT	O
of	IN	O
the	DT	O
genes	NNS	O
Bardwell,	,	B
J.	NNP	I
C.,	,	I
Mol.	.	I
Microbiol.,	,	I
14,	,	I
199-205	CD	I
(1994),	,	I
Sone,	,	B
M.,	,	I
et	FW	I
al.,	,	I
J.	NNP	I
Biol.	.	I
Chem.,	,	I
272,	,	I
10349-10352	CD	I
(1997),	,	I
Rietsch,	,	B
A.,	,	I
et	FW	I
al.,	,	I
Proc.	.	I
Natl.	.	I
Acad.	.	I
Sci.	.	I
USA,	,	I
93,	,	I
13048-13053	CD	I
(1996)).(	.	O
Therefore,	,	O
there	EX	O
have	VBP	O
been	VBN	O
made	VBN	O
several	JJ	O
attempts	NNS	O
of	IN	O
overexpressing	VBG	O
DsbA	NNP	O
or	CC	O
DsbC	NNP	O
together	RB	O
with	IN	O
an	DT	O
objective	JJ	O
protein	NN	O
with	IN	O
the	DT	O
goal	NN	O
of	IN	O
improving	VBG	O
the	DT	O
secretion	NN	O
expression	NN	O
of	IN	O
the	DT	O
objective	JJ	O
protein	NN	O
into	IN	O
the	DT	O
periplasm	NN	O
(Japanese	JJ	O
Patent	NNP	O
Laid-open	NNP	O
No.	.	O
2000-83670).	.	O
Furthermore,	,	O
it	PRP	O
is	VBZ	O
also	RB	O
already	RB	O
known	VBN	O
that	IN	O
DsbA	NNP	O
works	VBZ	O
as	IN	O
a	DT	O
re-activating	JJ	O
agent	NN	O
for	IN	O
proteins	NNS	O
that	WDT	O
do	VBP	O
not	RB	O
have	VB	O
physiological	JJ	O
activity	NN	O
Akiyama	NNP	B
Y.,	,	I
et	FW	I
al.,	,	I
J.	NNP	I
Biol.	.	I
Chem.,	,	I
1992	CD	I
Nov.	NNP	I
5;	:	I
(267(31):22440-5,	,	O
Japanese	JJ	O
Patent	NNP	O
Laid-open	NNP	O
No.	.	O
5-336986).	.	O
However,	,	O
only	RB	O
the	DT	O
oxidation	NN	O
of	IN	O
proteins	NNS	O
has	VBZ	O
been	VBN	O
described	VBN	O
in	IN	O
the	DT	O
reports	NNS	O
to	TO	O
date,	,	O
and	CC	O
there	EX	O
is	VBZ	O
no	DT	O
example	NN	O
of	IN	O
reporting	VBG	O
involvement	NN	O
of	IN	O
the	DT	O
Dsb	NNP	O
factors	NNS	O
in	IN	O
oxidation	NN	O
of	IN	O
low	JJ	O
molecules	NNS	O
such	JJ	O
as	IN	O
amino	JJ	O
acids.	.	O
Therefore,	,	O
it	PRP	O
has	VBZ	O
been	VBN	O
completely	RB	O
unknown	JJ	O
whether	IN	O
the	DT	O
Dsb	NNP	O
factors	NNS	O
oxidize	VBP	O
low	JJ	O
molecular	JJ	O
weight	NN	O
molecules	NNS	O
such	JJ	O
as	IN	O
cysteine	NN	O
to	TO	O
form	VB	O
cystine.	.	O
SUMMARY	NN	O
OF	IN	O
THE	NNP	O
INVENTION	NNP	O
The	DT	O
present	JJ	O
invention	NN	O
provides	VBZ	O
a	DT	O
novel	NN	O
technique	NN	O
for	IN	O
improving	VBG	O
bacterial	JJ	O
production	NN	O
of	IN	O
L-cysteine,	,	O
and	CC	O
thereby	RB	O
provides	VBZ	O
an	DT	O
L-cysteine-producing	JJ	O
bacterium,	,	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
method	NN	O
for	IN	O
producing	VBG	O
L-cysteine,	,	O
L-cystine,	,	O
their	PRP$	O
derivatives	NNS	O
or	CC	O
precursors,	,	O
or	CC	O
a	DT	O
mixture	NN	O
of	IN	O
these	DT	O
by	IN	O
using	VBG	O
such	JJ	O
a	DT	O
bacterium.	.	O
L-cysteine-producing	JJ	O
ability	NN	O
of	IN	O
a	DT	O
bacterium	NN	O
is	VBZ	O
enhanced	VBN	O
by	IN	O
modifying	VBG	O
the	DT	O
bacterium	NN	O
so	RB	O
that	IN	O
the	DT	O
activity	NN	O
of	IN	O
the	DT	O
protein	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
dsbA	NN	O
gene	NN	O
is	VBZ	O
increased.	.	O
It	PRP	O
is	VBZ	O
an	DT	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
a	DT	O
bacterium	NN	O
belonging	NN	O
to	TO	O
the	DT	O
family	NN	O
Enterobacteriaceae,	,	O
which	WDT	O
is	VBZ	O
able	JJ	O
to	TO	O
produce	VB	O
L-cysteine	NNP	O
and	CC	O
has	VBZ	O
been	VBN	O
modified	VBN	O
to	TO	O
increase	VB	O
the	DT	O
activity	NN	O
of	IN	O
the	DT	O
protein	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
dsbA	JJ	O
gene	NN	O
as	IN	O
compared	VBN	O
to	TO	O
a	DT	O
non-modified	JJ	O
bacterium.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
further	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
the	DT	O
bacterium	NN	O
as	IN	O
described	VBN	O
above,	,	O
wherein	VBD	O
the	DT	O
activity	NN	O
of	IN	O
the	DT	O
protein	NN	O
is	VBZ	O
increased	VBN	O
by	IN	O
a	DT	O
method	NN	O
selected	VBN	O
from	IN	O
the	DT	O
group	NN	O
consisting	VBG	O
of	IN	O
1)	)	O
increasing	VBG	O
expression	NN	O
of	IN	O
the	DT	O
dsbA	NN	O
gene,	,	O
2)	)	O
increasing	VBG	O
translation	NN	O
of	IN	O
the	DT	O
dsbA	NN	O
gene,	,	O
and	CC	O
3)	)	O
combination	NN	O
thereof.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
further	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
the	DT	O
bacterium	NN	O
as	IN	O
described	VBN	O
above,	,	O
wherein	JJ	O
expression	NN	O
of	IN	O
the	DT	O
dsbA	JJ	O
gene	NN	O
is	VBZ	O
increased	VBN	O
by	IN	O
increasing	VBG	O
the	DT	O
copy	NN	O
number	NN	O
of	IN	O
the	DT	O
dsbA	JJ	O
gene	NN	O
or	CC	O
by	IN	O
modifying	VBG	O
an	DT	O
expression	NN	O
control	NN	O
sequence	NN	O
of	IN	O
the	DT	O
gene.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
further	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
the	DT	O
bacterium	NN	O
as	IN	O
described	VBN	O
above,	,	O
wherein	VBD	O
the	DT	O
protein	NN	O
is	VBZ	O
selected	VBN	O
from	IN	O
the	DT	O
group	NN	O
consisting	VBG	O
of:	:	O
(A)	)	O
a	DT	O
protein	NN	O
comprising	VBG	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:	:	O
2,	,	O
4,	,	O
6,	,	O
8,	,	O
10	CD	O
or	CC	O
12,	,	O
(B)	)	O
a	DT	O
protein	NN	O
comprising	VBG	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:	:	O
2,	,	O
4,	,	O
6,	,	O
8,	,	O
10	CD	O
or	CC	O
12,	,	O
but	CC	O
which	WDT	O
includes	VBZ	O
substitutions,	,	O
deletions,	,	O
insertions	NNS	O
or	CC	O
additions	NNS	O
of	IN	O
one	CD	O
or	CC	O
several	JJ	O
amino	NN	O
acid	NN	O
residues,	,	O
and	CC	O
wherein	VBZ	O
the	DT	O
increase	NN	O
of	IN	O
the	DT	O
protein's	POS	O
activity	NN	O
in	IN	O
the	DT	O
bacterium	NN	O
improves	VBZ	O
the	DT	O
ability	NN	O
of	IN	O
the	DT	O
bacterium	NN	O
to	TO	O
produce	VB	O
L-cysteine.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
further	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
the	DT	O
bacterium	NN	O
as	IN	O
described	VBN	O
above,	,	O
wherein	VBD	O
the	DT	O
dsbA	NN	O
gene	NN	O
is	VBZ	O
selected	VBN	O
from	IN	O
the	DT	O
group	NN	O
consisting	VBG	O
of:	:	O
(a)	)	O
a	DT	O
DNA	NN	O
comprising	VBG	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:	:	O
1,	,	O
3,	,	O
5,	,	O
7,	,	O
9	CD	O
or	CC	O
11,	,	O
(b)	)	O
a	DT	O
DNA	NN	O
which	WDT	O
hybridizes	VBZ	O
with	IN	O
a	DT	O
sequence	NN	O
complementary	NN	O
to	TO	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:	:	O
1,	,	O
3,	,	O
5,	,	O
7,	,	O
9	CD	O
or	CC	O
11,	,	O
or	CC	O
a	DT	O
probe	NN	O
which	WDT	O
is	VBZ	O
prepared	VBN	O
from	IN	O
the	DT	O
nucleotide	JJ	O
sequence,	,	O
under	IN	O
stringent	JJ	O
conditions,	,	O
and	CC	O
codes	NNS	O
for	IN	O
a	DT	O
protein	NN	O
wherein	VBZ	O
the	DT	O
increase	NN	O
of	IN	O
the	DT	O
protein's	POS	O
activity	NN	O
in	IN	O
the	DT	O
bacterium	NN	O
improves	VBZ	O
the	DT	O
ability	NN	O
of	IN	O
the	DT	O
protein	NN	O
to	TO	O
produce	VB	O
L-cysteine.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
further	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
the	DT	O
bacterium	NN	O
as	IN	O
described	VBN	O
above,	,	O
which	WDT	O
contains	VBZ	O
a	DT	O
serine	NN	O
acetyltransferase	NN	O
which	WDT	O
has	VBZ	O
been	VBN	O
mutated	VBN	O
to	TO	O
attenuate	VB	O
feedback	NN	O
inhibition	NN	O
by	IN	O
L-cysteine.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
further	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
the	DT	O
bacterium	NN	O
as	IN	O
described	VBN	O
above,	,	O
wherein	VBD	O
the	DT	O
bacterium	NN	O
has	VBZ	O
been	VBN	O
modified	VBN	O
so	IN	O
that	IN	O
the	DT	O
activity	NN	O
of	IN	O
the	DT	O
protein	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
ydeD	NN	O
gene	NN	O
is	VBZ	O
increased.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
further	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
the	DT	O
bacterium	NN	O
as	IN	O
described	VBN	O
above,	,	O
wherein	VBD	O
3-phosphoglycerate	JJ	O
dehydrogenase	NN	O
has	VBZ	O
been	VBN	O
desensitized	VBN	O
to	TO	O
feedback	VB	O
inhibition	NN	O
by	IN	O
serine.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
further	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
the	DT	O
bacterium	NN	O
as	IN	O
described	VBN	O
above,	,	O
wherein	NN	O
bacterium	NN	O
has	VBZ	O
been	VBN	O
modified	VBN	O
so	IN	O
that	IN	O
the	DT	O
activity	NN	O
of	IN	O
the	DT	O
protein	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
ydeD	NN	O
gene	NN	O
is	VBZ	O
increased.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
further	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
the	DT	O
bacterium	NN	O
as	IN	O
described	VBN	O
above,	,	O
which	WDT	O
is	VBZ	O
an	DT	O
Escherichia	NNP	O
bacterium.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
further	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
the	DT	O
bacterium	NN	O
as	IN	O
described	VBN	O
above,	,	O
which	WDT	O
is	VBZ	O
Escherichia	NNP	O
coli.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
further	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
a	DT	O
method	NN	O
for	IN	O
producing	VBG	O
a	DT	O
compound	NN	O
selected	VBN	O
from	IN	O
the	DT	O
group	NN	O
consisting	VBG	O
of	IN	O
L-cysteine,	,	O
L-cystine,	,	O
and	CC	O
derivatives	NNS	O
or	CC	O
precursors	NNS	O
thereof,	,	O
which	WDT	O
comprises	VBZ	O
culturing	VBG	O
the	DT	O
bacterium	NN	O
as	IN	O
described	VBN	O
above	IN	O
in	IN	O
a	DT	O
medium	NN	O
and	CC	O
collecting	VBG	O
the	DT	O
compound	NN	O
from	IN	O
the	DT	O
medium.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
further	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
the	DT	O
method	NN	O
as	IN	O
described	VBN	O
above,	,	O
wherein	VBD	O
the	DT	O
derivative	NN	O
of	IN	O
L-cysteine	NNP	O
is	VBZ	O
a	DT	O
thiazolidine	JJ	O
derivative.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
further	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
the	DT	O
method	NN	O
as	IN	O
described	VBN	O
above,	,	O
wherein	VBD	O
the	DT	O
precursor	NN	O
of	IN	O
L-cysteine	NNP	O
is	VBZ	O
O-acetylserine	JJ	O
or	CC	O
N-acetylserine.	.	O
According	VBG	O
to	TO	O
the	DT	O
present	JJ	O
invention,	,	O
L-cysteine-producing	JJ	O
ability	NN	O
of	IN	O
bacteria	NNS	O
can	MD	O
be	VB	O
improved.	.	O
Furthermore,	,	O
according	VBG	O
to	TO	O
the	DT	O
present	JJ	O
invention,	,	O
L-cysteine,	,	O
L-cystine,	,	O
their	PRP$	O
derivatives	NNS	O
or	CC	O
precursors,	,	O
or	CC	O
combinations	NNS	O
thereof	NNS	O
can	MD	O
be	VB	O
efficiently	RB	O
produced.	.	O
Still	RB	O
other	JJ	O
aspects,	,	O
features,	,	O
and	CC	O
attendant	JJ	O
advantages	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
will	MD	O
become	VB	O
apparent	JJ	O
to	TO	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
from	IN	O
a	DT	O
reading	NN	O
of	IN	O
the	DT	O
following	VBG	O
detailed	JJ	O
description	NN	O
of	IN	O
embodiments	NNS	O
constructed	VBN	O
in	IN	O
accordance	NN	O
therewith,	,	O
taken	VBN	O
in	IN	O
conjunction	NN	O
with	IN	O
the	DT	O
accompanying	VBG	O
drawings.	.	O
BRIEF	JJ	O
DESCRIPTION	NNP	O
OF	IN	O
THE	NNP	O
DRAWINGS	NNP	O
FIG.	.	O
1	CD	O
shows	NNS	O
cysteine	VBP	O
sensitivity	NN	O
of	IN	O
a	DT	O
dsbA-deficient	JJ	O
strain	NN	O
and	CC	O
complementation	NN	O
(recovery	NN	O
of	IN	O
growth)	)	O
with	IN	O
a	DT	O
dsbA	NN	O
plasmid	NN	O
(photograph).	.	O
FIG.	.	O
2	CD	O
shows	NNS	O
oxidized	VBN	O
and	CC	O
reduced	VBN	O
states	NNS	O
of	IN	O
the	DT	O
DsbA	NNP	O
protein	NN	O
provided	VBN	O
by	IN	O
cysteine	NN	O
(electrophoresis	JJ	O
photograph).	.	O
FIG.	.	O
3	CD	O
shows	NNS	O
oxidized	VBN	O
and	CC	O
reduced	VBN	O
states	NNS	O
of	IN	O
the	DT	O
OstA	NNP	O
protein	NN	O
provided	VBN	O
by	IN	O
cysteine	NN	O
(electrophoresis	JJ	O
photograph).	.	O
FIG.	.	O
4	CD	O
shows	NNS	O
cysteine	JJ	O
production	NN	O
by	IN	O
a	DT	O
DsbA-enhanced	JJ	O
cysteine-producing	JJ	O
bacterium.	.	O
DETAILED	JJ	O
DESCRIPTION	NNP	O
OF	NNP	O
EXEMPLARY	NNP	O
EMBODIMENTS	NNP	O
<1>	NN	O
Bacterium	NNP	O
The	DT	O
bacterium	NN	O
belongs	VBZ	O
to	TO	O
the	DT	O
family	NN	O
Enterobacteriaceae,	,	O
and	CC	O
is	VBZ	O
able	JJ	O
to	TO	O
produce	VB	O
L-cysteine.	.	O
Furthermore,	,	O
the	DT	O
bacterium	NN	O
has	VBZ	O
been	VBN	O
modified	VBN	O
to	TO	O
increase	VB	O
the	DT	O
activity	NN	O
of	IN	O
the	DT	O
protein	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
dsbA	JJ	O
gene.	.	O
The	DT	O
“ability	NN	O
to	TO	O
produce	VB	O
L-cysteine”	NNP	O
or	CC	O
the	DT	O
“L-cysteine-producing	JJ	O
ability”	NN	O
means	VBZ	O
an	DT	O
ability	NN	O
of	IN	O
the	DT	O
bacterium	NN	O
to	TO	O
produce	VB	O
L-cysteine	NNP	O
and	CC	O
cause	VB	O
accumulation	NN	O
of	IN	O
L-cysteine	NNP	O
in	IN	O
a	DT	O
medium	NN	O
or	CC	O
the	DT	O
bacterial	JJ	O
cells	NNS	O
in	IN	O
such	PDT	O
an	DT	O
amount	NN	O
that	IN	O
the	DT	O
L-cysteine	NNP	O
can	MD	O
be	VB	O
collected	VBN	O
from	IN	O
the	DT	O
medium	NN	O
or	CC	O
cells	NNS	O
when	WRB	O
the	DT	O
bacterium	NN	O
is	VBZ	O
cultured	VBN	O
in	IN	O
the	DT	O
medium.	.	O
A	DT	O
bacterium	NN	O
having	VBG	O
L-cysteine-producing	NNP	O
ability	NN	O
means	VBZ	O
a	DT	O
bacterium	NN	O
which	WDT	O
can	MD	O
produce	VB	O
and	CC	O
cause	VB	O
accumulation	NN	O
of	IN	O
a	DT	O
larger	JJR	O
amount	NN	O
of	IN	O
L-cysteine	NNP	O
as	IN	O
compared	VBN	O
with	IN	O
a	DT	O
wild-type,	,	O
parent,	,	O
or	CC	O
unmodified	JJ	O
strain,	,	O
for	IN	O
example,	,	O
a	DT	O
bacterium	NN	O
which	WDT	O
can	MD	O
produce	VB	O
and	CC	O
cause	VB	O
accumulation	NN	O
of	IN	O
L-cysteine	NNP	O
in	IN	O
a	DT	O
medium	NN	O
in	IN	O
an	DT	O
amount	NN	O
of	IN	O
0.05	CD	O
g/L	NN	O
or	CC	O
more,	,	O
0.1	CD	O
g/L	NN	O
or	CC	O
more,	,	O
or	CC	O
even	RB	O
0.2	CD	O
g/L	NN	O
or	CC	O
more.	.	O
The	DT	O
L-cysteine	NNP	O
produced	VBN	O
by	IN	O
the	DT	O
bacterium	NN	O
can	MD	O
change	VB	O
into	IN	O
L-cystine	NNP	O
in	IN	O
the	DT	O
medium	NN	O
by	IN	O
the	DT	O
formation	NN	O
of	IN	O
a	DT	O
disulfide	JJ	O
bond.	.	O
Especially,	,	O
as	IN	O
described	VBN	O
later,	,	O
it	PRP	O
is	VBZ	O
considered	VBN	O
that	IN	O
if	IN	O
L-cysteine	NNP	O
is	VBZ	O
produced	VBN	O
in	IN	O
a	DT	O
large	JJ	O
amount	NN	O
by	IN	O
enhancing	VBG	O
the	DT	O
DsbA	NNP	O
activity,	,	O
formation	NN	O
of	IN	O
L-cystine	NNP	O
from	IN	O
L-cysteine	NNP	O
by	IN	O
the	DT	O
DsbA-DsbB-UQ	NNP	O
oxidation	NN	O
system	NN	O
is	VBZ	O
promoted.	.	O
Furthermore,	,	O
S-sulfocysteine	NNP	O
can	MD	O
be	VB	O
generated	VBN	O
by	IN	O
the	DT	O
reaction	NN	O
of	IN	O
L-cysteine	NNP	O
and	CC	O
thiosulfuric	JJ	O
acid	NN	O
in	IN	O
the	DT	O
medium	NN	O
Szczepkowski	NNP	B
T.	NNP	I
W.,	,	I
Nature,	,	I
vol.	.	I
182	CD	I
(1958)).(	.	O
Furthermore,	,	O
the	DT	O
L-cysteine	NNP	O
generated	VBD	O
in	IN	O
bacterial	JJ	O
cells	NNS	O
can	MD	O
be	VB	O
condensed	VBN	O
with	IN	O
a	DT	O
ketone,	,	O
aldehyde,	,	O
or,	,	O
for	IN	O
example,	,	O
pyruvic	JJ	O
acid,	,	O
which	WDT	O
is	VBZ	O
present	JJ	O
in	IN	O
the	DT	O
cells,	,	O
to	TO	O
produce	VB	O
a	DT	O
thiazolidine	JJ	O
derivative	JJ	O
via	IN	O
a	DT	O
hemithioketal	JJ	O
intermediate	NN	O
(refer	VBP	O
to	TO	O
Japanese	JJ	O
Patent	NNP	O
No.	.	O
2992010).	.	O
This	DT	O
thiazolidine	NN	O
derivative	NN	O
and	CC	O
hemithioketal	NN	O
can	MD	O
be	VB	O
present	JJ	O
as	IN	O
an	DT	O
equilibrated	JJ	O
mixture.	.	O
Therefore,	,	O
the	DT	O
L-cysteine-producing	JJ	O
ability	NN	O
is	VBZ	O
not	RB	O
limited	VBN	O
to	TO	O
the	DT	O
ability	NN	O
to	TO	O
accumulate	VB	O
only	RB	O
L-cysteine	NNP	O
in	IN	O
the	DT	O
medium	NN	O
or	CC	O
cells,	,	O
but	CC	O
also	RB	O
includes	VBZ	O
the	DT	O
ability	NN	O
to	TO	O
accumulate	VB	O
L-cystine	NNP	O
or	CC	O
its	PRP$	O
derivatives	NNS	O
or	CC	O
precursors,	,	O
or	CC	O
a	DT	O
mixture	NN	O
thereof	NN	O
in	IN	O
the	DT	O
medium.	.	O
Examples	NNS	O
of	IN	O
the	DT	O
aforementioned	JJ	O
derivative	NN	O
of	IN	O
L-cysteine	NNP	O
or	CC	O
L-cystine	NNP	O
include,	,	O
for	IN	O
example,	,	O
S-sulfocysteine,	,	O
thiazolidine	NN	O
derivatives,	,	O
hemithioketal,	,	O
and	CC	O
so	RB	O
forth.	.	O
Examples	NNS	O
of	IN	O
the	DT	O
precursor	NN	O
of	IN	O
L-cysteine	NNP	O
or	CC	O
L-cystine	NNP	O
include,	,	O
for	IN	O
example,	,	O
O-acetylserine,	,	O
which	WDT	O
is	VBZ	O
a	DT	O
precursor	NN	O
of	IN	O
L-cysteine.	.	O
The	DT	O
precursors	NNS	O
of	IN	O
L-cysteine	NNP	O
or	CC	O
L-cystine	NNP	O
also	RB	O
include	VBP	O
derivatives	NNS	O
of	IN	O
the	DT	O
precursors,	,	O
and	CC	O
examples	NNS	O
include,	,	O
for	IN	O
example,	,	O
N-acetylserine,	,	O
which	WDT	O
is	VBZ	O
a	DT	O
derivative	JJ	O
of	IN	O
O-acetylserine,	,	O
and	CC	O
so	RB	O
forth.	.	O
O-Acetylserine	NNP	O
(OAS)	)	O
is	VBZ	O
a	DT	O
precursor	NN	O
of	IN	O
L-cysteine	JJ	O
biosynthesis.	.	O
OAS	NNP	O
is	VBZ	O
a	DT	O
metabolite	NN	O
of	IN	O
bacteria	NNS	O
and	CC	O
plants,	,	O
and	CC	O
is	VBZ	O
produced	VBN	O
by	IN	O
acetylation	NN	O
of	IN	O
L-serine	NNP	O
by	IN	O
an	DT	O
enzymatic	JJ	O
reaction	NN	O
catalyzed	VBN	O
by	IN	O
serine	JJ	O
acetyltransferase	NN	O
(SAT).	.	O
OAS	NNP	O
is	VBZ	O
further	RB	O
converted	VBN	O
into	IN	O
L-cysteine	NNP	O
in	IN	O
cells.	.	O
The	DT	O
bacterium	NN	O
having	VBG	O
L-cysteine-producing	JJ	O
ability	NN	O
can	MD	O
inherently	RB	O
have	VB	O
the	DT	O
ability	NN	O
to	TO	O
produce	VB	O
L-cysteine,	,	O
or	CC	O
it	PRP	O
can	MD	O
be	VB	O
imparted	VBN	O
by	IN	O
modifying	VBG	O
a	DT	O
microorganism	NN	O
such	JJ	O
as	IN	O
those	DT	O
described	VBN	O
below	IN	O
by	IN	O
mutagenesis	NN	O
or	CC	O
a	DT	O
recombinant	JJ	O
DNA	NN	O
technique.	.	O
Unless	IN	O
specially	RB	O
mentioned,	,	O
the	DT	O
term	NN	O
L-cysteine	JJ	O
refers	NNS	O
to	TO	O
the	DT	O
reduced-type	JJ	O
L-cysteine,	,	O
L-cystine,	,	O
a	DT	O
derivative	JJ	O
or	CC	O
precursor	NN	O
such	JJ	O
as	IN	O
those	DT	O
mentioned	VBN	O
above,	,	O
or	CC	O
a	DT	O
mixture	NN	O
thereof.	.	O
The	DT	O
bacterium	NN	O
is	VBZ	O
not	RB	O
particularly	RB	O
limited	VBN	O
so	RB	O
long	RB	O
as	IN	O
the	DT	O
bacterium	NN	O
belongs	VBZ	O
to	TO	O
the	DT	O
family	NN	O
Enterobacteriaceae	NNP	O
and	CC	O
has	VBZ	O
L-cysteine-producing	JJ	O
ability.	.	O
Such	JJ	O
bacteria	NNS	O
include	VBP	O
those	DT	O
of	IN	O
the	DT	O
genera	NN	O
Escherichia,	,	O
Enterobacter,	,	O
Pantoea,	,	O
Klebsiella,	,	O
Serratia,	,	O
Erwinia,	,	O
Salmonella	NNP	O
and	CC	O
Morganella.	.	O
Specifically,	,	O
those	DT	O
classified	VBN	O
into	IN	O
the	DT	O
family	NN	O
Enterobacteriaceae	NNP	O
according	VBG	O
to	TO	O
the	DT	O
taxonomy	NN	O
used	VBN	O
in	IN	O
the	DT	O
NCBI	NNP	O
(National	NNP	O
Center	NNP	O
for	IN	O
Biotechnology	NNP	O
Information)	)	O
database	NN	O
(http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=91347)	)	O
can	MD	O
be	VB	O
used.	.	O
As	IN	O
the	DT	O
parent	NN	O
strain	NN	O
of	IN	O
the	DT	O
family	NN	O
Enterobacteriaceae	NNP	O
which	WDT	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
perform	VB	O
modification,	,	O
it	PRP	O
is	VBZ	O
desirable	JJ	O
to	TO	O
use,	,	O
especially,	,	O
a	DT	O
bacterium	NN	O
of	IN	O
the	DT	O
genus	NN	O
Escherichia,	,	O
Enterobacter,	,	O
Pantoea,	,	O
Erwinia,	,	O
or	CC	O
Klebsiella.	.	O
Although	IN	O
the	DT	O
Escherichia	NNP	O
bacteria	NNS	O
are	VBP	O
not	RB	O
particularly	RB	O
limited,	,	O
specifically,	,	O
those	DT	O
described	VBN	O
in	IN	O
the	DT	O
work	NN	O
of	IN	O
Neidhardt	NNP	B
et	FW	I
al.	.	I
(Backmann	NNP	I
B.	NNP	I
J.,	,	I
1996,	,	I
Derivations	NNP	I
and	CC	I
Genotypes	NNP	I
of	IN	I
some	DT	I
mutant	JJ	I
derivatives	NNS	I
of	IN	I
Escherichia	NNP	I
coli	JJ	I
K-12,	,	I
p.	JJ	I
2460-2488,	,	I
Table	JJ	O
1,	,	O
In	IN	O
F.	NNP	O
D.	NNP	O
Neidhardt	NNP	O
(ed.),	,	O
Escherichia	NNP	O
coli	NN	O
and	CC	O
Salmonella	NNP	O
Cellular	NNP	O
and	CC	O
Molecular	NNP	O
Biology/Second	NNP	O
Edition,	,	O
American	NNP	O
Society	NNP	O
for	IN	O
Microbiology	NNP	O
Press,	,	O
Washington,	,	O
D.C.)	)	O
can	MD	O
be	VB	O
used.	.	O
An	DT	O
example	NN	O
of	IN	O
Escherichia	NNP	O
bacterium	NN	O
includes	VBZ	O
Escherichia	NNP	O
coli.	.	O
Examples	NNS	O
of	IN	O
Escherichia	NNP	O
coli	NNS	O
include	VBP	O
Escherichia	NNP	O
coli	NNS	O
W3110	NNP	O
(ATCC	NNP	O
27325),	,	O
Escherichia	NNP	O
coli	VBZ	O
MG1655	NNP	O
(ATCC	NNP	O
47076),	,	O
and	CC	O
so	RB	O
forth,	,	O
and	CC	O
include	VBP	O
those	DT	O
derived	VBN	O
from	IN	O
the	DT	O
prototype	NN	O
wild-type	NN	O
strain,	,	O
K12	NNP	O
strain.	.	O
These	DT	O
strains	NNS	O
are	VBP	O
available	JJ	O
from,	,	O
for	IN	O
example,	,	O
the	DT	O
American	JJ	O
Type	NNP	O
Culture	NNP	O
Collection	NNP	O
(Address:	:	O
12301	CD	O
Parklawn	NNP	O
Drive,	,	O
Rockville,	,	O
Md.	.	O
20852,	,	O
P.O.	.	O
Box	NN	O
1549,	,	O
Manassas,	,	O
Va.	NNP	O
20108,	,	O
United	NNP	O
States	NNPS	O
of	IN	O
America).	.	O
That	DT	O
is,	,	O
registration	NN	O
numbers	NNS	O
are	VBP	O
given	VBN	O
to	TO	O
each	DT	O
of	IN	O
the	DT	O
strains,	,	O
and	CC	O
the	DT	O
strains	NNS	O
can	MD	O
be	VB	O
ordered	VBN	O
by	IN	O
using	VBG	O
these	DT	O
registration	NN	O
numbers	NNS	O
(refer	VBP	O
to	TO	O
http://www.atcc.org/).	.	O
The	DT	O
registration	NN	O
numbers	NNS	O
of	IN	O
the	DT	O
strains	NNS	O
are	VBP	O
listed	VBN	O
in	IN	O
the	DT	O
catalogue	NN	O
of	IN	O
the	DT	O
American	NNP	O
Type	NNP	O
Culture	NNP	O
Collection.	.	O
Examples	NNS	O
of	IN	O
the	DT	O
Enterobacter	NNP	O
bacteria	NNS	O
include	VBP	O
Enterobacter	NNP	O
agglomerans,	,	O
Enterobacter	NNP	O
aerogenes	NNS	O
and	CC	O
so	RB	O
forth,	,	O
and	CC	O
examples	NNS	O
of	IN	O
the	DT	O
Pantoea	NNP	O
bacteria	NNS	O
include	VBP	O
Pantoea	NNP	O
ananatis.	.	O
Some	DT	O
strains	NNS	O
of	IN	O
Enterobacter	NNP	O
agglomerans	NNS	O
were	VBD	O
recently	RB	O
reclassified	VBN	O
into	IN	O
Pantoea	NNP	O
agglomerans,	,	O
Pantoea	NNP	O
ananatis,	,	O
or	CC	O
Pantoea	NNP	O
stewartii	NN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
nucleotide	JJ	O
sequence	NN	O
analysis	NN	O
of	IN	O
16S	CD	O
rRNA	NN	O
etc.	.	O
A	DT	O
bacterium	NN	O
belonging	NN	O
to	TO	O
either	DT	O
Enterobacter	NNP	O
or	CC	O
Pantoea	NNP	O
can	MD	O
be	VB	O
used	VBN	O
so	RB	O
long	RB	O
as	IN	O
it	PRP	O
is	VBZ	O
classified	VBN	O
as	IN	O
the	DT	O
family	NN	O
Enterobacteriaceae.	.	O
In	IN	O
particular,	,	O
Pantoea	NNP	O
bacteria,	,	O
Erwinia	NNP	O
bacteria,	,	O
and	CC	O
Enterobacter	NNP	O
bacteria	NNS	O
are	VBP	O
classified	VBN	O
as	IN	O
γ-proteobacteria,	,	O
and	CC	O
they	PRP	O
are	VBP	O
taxonomically	RB	O
very	RB	O
close	RB	O
to	TO	O
one	CD	O
another	DT	O
J.	NNP	B
Gen.	NNP	I
Appl.	.	I
Microbiol.,	,	I
1997,	,	I
43,	,	I
355-361;	:	I
International	NNP	B
Journal	NNP	I
of	IN	I
Systematic	NNP	I
Bacteriology,	,	I
October	NNP	I
1997,	,	I
pp.	.	I
1061-1067).(	.	O
In	IN	O
recent	JJ	O
years,	,	O
some	DT	O
bacteria	NNS	O
belonging	VBG	O
to	TO	O
the	DT	O
genus	NN	O
Enterobacter	NNP	O
were	VBD	O
reclassified	VBN	O
as	IN	O
Pantoea	NNP	O
agglomerans,	,	O
Pantoea	NNP	O
dispersa,	,	O
or	CC	O
the	DT	O
like,	,	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
DNA-DNA	NNP	O
hybridization	NN	O
experiments	NNS	O
etc.	.	O
International	NNP	B
Journal	NNP	I
of	IN	I
Systematic	NNP	I
Bacteriology,	,	I
July	NNP	I
1989,	,	I
39(3),	,	I
pp.	.	I
337-345).(	.	O
Furthermore,	,	O
some	DT	O
bacteria	NNS	O
belonging	VBG	O
to	TO	O
the	DT	O
genus	NN	O
Erwinia	NNP	O
were	VBD	O
reclassified	VBN	O
as	IN	O
Pantoea	NNP	O
ananas	VBD	O
or	CC	O
Pantoea	NNP	O
stewartii	NN	O
(refer	NN	O
to	TO	O
International	NNP	B
Journal	NNP	I
of	IN	I
Systematic	NNP	I
Bacteriology,	,	I
January	NNP	I
1993;	:	I
43(1),	,	I
pp.	.	I
162-1′73).Examples	.	O
of	NNS	O
the	IN	O
Enterobacter	DT	O
bacteria	NNP	O
include,	NNS	O
but	,	O
are	CC	O
not	VBP	O
limited	RB	O
to,	VBN	O
Enterobacter	,	O
agglomerans,	NNP	O
Enterobacter	,	O
aerogenes,	NNP	O
and	,	O
so	CC	O
forth.	RB	O
Specifically,	.	O
the	,	O
strains	DT	O
exemplified	NNS	O
in	VBN	O
European	IN	O
Patent	JJ	O
Publication	NNP	O
No.	NNP	O
952221	.	O
can	CD	O
be	MD	O
used.	VB	O
A	.	O
typical	DT	O
strain	JJ	O
of	NN	O
the	IN	O
genus	DT	O
Enterobacter	NN	O
is	NNP	O
the	VBZ	O
Enterobacter	DT	O
agglomeranses	NNP	O
ATCC	VBZ	O
12287	NNP	O
strain.	CD	O
Typical	.	O
strains	JJ	O
of	NNS	O
the	IN	O
Pantoea	DT	O
bacteria	NNP	O
include,	NNS	O
but	,	O
are	CC	O
not	VBP	O
limited	RB	O
to,	VBN	O
Pantoea	,	O
ananatis,	NNP	O
Pantoea	,	O
stewartii,	NNP	O
Pantoea	,	O
agglomerans,	NNP	O
and	,	O
Pantoea	CC	O
citrea.	NNP	O
Specific	.	O
examples	JJ	O
of	NNS	O
Pantoea	IN	O
ananatis	NNP	O
include	NN	O
the	VBP	O
Pantoea	DT	O
ananatis	NNP	O
AJ13355	NN	O
strain	NNP	O
and	NN	O
SC17	CC	O
strain.	NNP	O
The	.	O
SC17	DT	O
strain	NNP	O
was	NN	O
selected	VBD	O
as	VBN	O
a	IN	O
low	DT	O
phlegm-producing	JJ	O
mutant	NN	O
strain	NN	O
from	NN	O
the	IN	O
AJ13355	DT	O
strain	NNP	O
(FERM	NN	O
BP-6614),	NNP	O
which	,	O
was	WDT	O
isolated	VBD	O
from	VBN	O
soil	IN	O
in	NN	O
Iwata-shi,	IN	O
Shizuoka-ken,	,	O
Japan	,	O
for	NNP	O
its	IN	O
ability	PRP$	O
to	NN	O
proliferate	TO	O
in	VB	O
a	IN	O
low	DT	O
pH	JJ	O
medium	NN	O
containing	NN	O
L-glutamic	VBG	O
acid	JJ	O
and	NN	O
a	CC	O
carbon	DT	O
source	NN	O
(U.S.	NN	O
Pat.	NNP	O
No.	.	O
6,596,517).	.	O
The	.	O
Pantoea	DT	O
ananatis	NNP	O
AJ13355	NN	O
strain	NNP	O
was	NN	O
deposited	VBD	O
at	VBN	O
the	IN	O
National	DT	O
Institute	NNP	O
of	NNP	O
Bioscience	IN	O
and	NNP	O
Human-Technology,	CC	O
Agency	,	O
of	NNP	O
Industrial	IN	O
Science	NNP	O
and	NNP	O
Technology,	CC	O
Ministry	,	O
of	NNP	O
International	IN	O
Trade	NNP	O
and	NNP	O
Industry	CC	O
(currently,	NNP	O
the	,	O
National	DT	O
Institute	NNP	O
of	NNP	O
Advanced	IN	O
Industrial	NNP	O
Science	NNP	O
and	NNP	O
Technology,	CC	O
International	,	O
Patent	NNP	O
Organism	NNP	O
Depositary,	NNP	O
Address:	,	O
Tsukuba	:	O
Central	JJ	O
6,	NNP	O
1-1,	,	O
Higashi	,	O
1-Chome,	NNP	O
Tsukuba-shi,	,	O
Ibaraki-ken,	,	O
305-8566,	,	O
Japan)	,	O
on	)	O
Feb.	IN	O
19,	NNP	O
1998	,	O
and	CD	O
assigned	CC	O
an	VBD	O
accession	DT	O
number	NN	O
of	NN	O
FERM	IN	O
P-16644.	NNP	O
It	.	O
was	PRP	O
then	VBD	O
converted	RB	O
to	VBN	O
an	TO	O
international	DT	O
deposit	JJ	O
under	NN	O
the	IN	O
provisions	DT	O
of	NNS	O
Budapest	IN	O
Treaty	NNP	O
on	NNP	O
Jan.	IN	O
11,	NNP	O
1999	,	O
and	CD	O
assigned	CC	O
an	VBD	O
accession	DT	O
number	NN	O
of	NN	O
FERM	IN	O
BP-6614.	NNP	O
This	.	O
strain	DT	O
was	NN	O
identified	VBD	O
as	VBN	O
Enterobacter	IN	O
agglomerans	NNP	O
when	VBZ	O
it	WRB	O
was	PRP	O
isolated	VBD	O
and	VBN	O
deposited	CC	O
as	VBN	O
the	IN	O
Enterobacter	DT	O
agglomerans	NNP	O
AJ13355	NNS	O
strain.	NNP	O
However,	.	O
it	,	O
was	PRP	O
recently	VBD	O
reclassified	RB	O
as	VBN	O
Pantoea	IN	O
ananatis	NNP	O
on	NN	O
the	IN	O
basis	DT	O
of	NN	O
nucleotide	IN	O
sequencing	JJ	O
of	NN	O
16S	IN	O
rRNA	CD	O
and	NN	O
so	CC	O
forth.	RB	O
Examples	.	O
of	NNS	O
the	IN	O
Erwinia	DT	O
bacteria	NNP	O
include,	NNS	O
but	,	O
are	CC	O
not	VBP	O
limited	RB	O
to,	VBN	O
Erwinia	,	O
amylovora	NNP	O
and	NN	O
Erwinia	CC	O
carotovora,	NNP	O
and	,	O
examples	CC	O
of	NNS	O
the	IN	O
Klebsiella	DT	O
bacteria	NNP	O
include	NNS	O
Klebsiella	VBP	O
planticola.	NNP	O
Hereinafter,	.	O
methods	,	O
for	NNS	O
imparting	IN	O
L-cysteine-producing	VBG	O
ability	JJ	O
to	NN	O
bacteria	TO	O
belonging	VB	O
to	VBG	O
Enterobacteriaceae,	TO	O
or	,	O
methods	CC	O
for	NNS	O
enhancing	IN	O
L-cysteine-producing	VBG	O
ability	JJ	O
of	NN	O
such	IN	O
bacteria,	JJ	O
are	,	O
described.	VBP	O
To	.	O
impart	TO	O
the	VB	O
ability	DT	O
to	NN	O
produce	TO	O
L-cysteine,	VB	O
methods	,	O
conventionally	NNS	O
employed	RB	O
in	VBN	O
the	IN	O
breeding	DT	O
of	NN	O
coryneform	IN	O
bacteria	NN	O
or	NNS	O
bacteria	CC	O
of	NNS	O
the	IN	O
genus	DT	O
Escherichia	NN	O
(see	NNP	O
“Amino	VB	B
Acid	NNP	I
Fermentation”,	NNP	I
Gakkai	,	I
Shuppan	NNP	I
Center	NNP	I
(Ltd.),	NNP	I
1st	,	I
Edition,	CD	I
published	,	I
May	VBN	I
30,	NNP	I
1986,	,	I
pp.	,	I
77-100)	.	I
can	)	O
be	MD	O
used.	VB	O
Such	.	O
methods	JJ	O
include	NNS	O
by	VBP	O
acquiring	IN	O
the	VBG	O
properties	DT	O
of	NNS	O
an	IN	O
auxotrophic	DT	O
mutant,	JJ	O
an	,	O
analogue-resistant	DT	O
strain,	JJ	O
or	,	O
a	CC	O
metabolic	DT	O
regulation	JJ	O
mutant,	NN	O
or	,	O
by	CC	O
constructing	IN	O
a	VBG	O
recombinant	DT	O
strain	JJ	O
so	NN	O
that	IN	O
it	IN	O
overexpresses	PRP	O
an	VBZ	O
L-cysteine	DT	O
biosynthesis	JJ	O
enzyme.	NN	O
Here,	.	O
in	,	O
the	IN	O
breeding	DT	O
of	NN	O
a	IN	O
bacteria	DT	O
able	NN	O
to	JJ	O
produce	TO	O
L-cysteine,	VB	O
one	,	O
or	CD	O
more	CC	O
of	JJR	O
the	IN	O
above	DT	O
described	JJ	O
properties	NN	O
such	NNS	O
as	JJ	O
auxotrophy,	IN	O
analogue	,	O
resistance,	NN	O
and	,	O
metabolic	CC	O
regulation	JJ	O
mutation	NN	O
can	NN	O
be	MD	O
imparted.	VB	O
The	.	O
expression	DT	O
of	NN	O
L-cysteine	IN	O
biosynthesis	JJ	O
enzyme(s)	NN	O
can	)	O
be	MD	O
enhanced	VB	O
alone	VBN	O
or	RB	O
in	CC	O
combinations	IN	O
of	NNS	O
two	IN	O
or	CD	O
more.	CC	O
Furthermore,	.	O
imparting	,	O
properties	VBG	O
such	NNS	O
as	JJ	O
an	IN	O
auxotrophy,	DT	O
analogue	,	O
resistance,	NN	O
or	,	O
metabolic	CC	O
regulation	JJ	O
mutation	NN	O
can	NN	O
be	MD	O
combined	VB	O
with	VBN	O
enhancement	IN	O
of	NN	O
the	IN	O
biosynthesis	DT	O
enzymes.	NN	O
An	.	O
auxotrophic	DT	O
mutant	JJ	O
strain,	NN	O
L-cysteine	,	O
analogue-resistant	JJ	O
strain,	JJ	O
or	,	O
metabolic	CC	O
regulation	JJ	O
mutant	NN	O
strain	NN	O
with	NN	O
the	IN	O
ability	DT	O
to	NN	O
produce	TO	O
L-cysteine	VB	O
can	NNP	O
be	MD	O
obtained	VB	O
by	VBN	O
subjecting	IN	O
a	VBG	O
parent,	DT	O
wild-type,	,	O
or	,	O
unmodified	CC	O
strain	JJ	O
to	NN	O
conventional	TO	O
mutatagenesis,	JJ	O
such	,	O
as	JJ	O
exposure	IN	O
to	NN	O
X-rays	TO	O
or	NNS	O
UV	CC	O
irradiation,	NNP	O
or	,	O
by	CC	O
treating	IN	O
with	VBG	O
a	IN	O
mutagen	DT	O
such	NN	O
as	JJ	O
N-methyl-N′-nitro-N-nitrosoguanidine,	IN	O
ethyl	,	O
methanesulfonate	NN	O
(EMS)	NN	O
etc.,	)	O
and	,	O
then	CC	O
selecting	RB	O
those	VBG	O
which	DT	O
exhibit	WDT	O
autotrophy,	VBP	O
analogue	,	O
resistance,	NN	O
or	,	O
a	CC	O
metabolic	DT	O
regulation	JJ	O
mutation	NN	O
and	NN	O
which	CC	O
also	WDT	O
have	RB	O
the	VBP	O
ability	DT	O
to	NN	O
produce	TO	O
L-cysteine	VB	O
from	NNP	O
the	IN	O
obtained	DT	O
transformants.	JJ	O
Specific	.	O
examples	JJ	O
of	NNS	O
L-cysteine-producing	IN	O
bacteria	NNP	O
include,	NNS	O
but	,	O
are	CC	O
not	VBP	O
limited	RB	O
to,	VBN	O
E.	,	O
coli	NNP	O
JM15	VBZ	O
transformed	NNP	O
with	VBD	O
multiple	IN	O
kinds	JJ	O
of	NNS	O
cysE	IN	O
gene	JJ	O
alleles	NN	O
encoding	NNS	O
serine	VBG	O
acetyltransferase	JJ	O
(SAT)	NN	O
resistant	)	O
to	VBP	O
feedback	TO	O
inhibition	VB	O
(U.S.	NN	O
Pat.	NNP	O
No.	.	O
6,218,168),	.	O
E.	,	O
coli	NNP	O
W3110	VBP	O
in	NNP	O
which	IN	O
a	WDT	O
gene	DT	O
encoding	NN	O
a	VBG	O
protein	DT	O
responsible	NN	O
for	JJ	O
excretion	IN	O
of	NN	O
cytotoxic	IN	O
substances	NN	O
is	NNS	O
overexpressed	VBZ	O
(U.S.	VBN	O
Pat.	NNP	O
No.	.	O
5,972,663),	.	O
an	,	O
E.	DT	O
coli	NNP	O
strain	NNS	O
having	VBP	O
decreased	VBG	O
cysteine	VBN	O
desulfhydrase	JJ	O
activity	NN	O
(Japanese	NN	O
Patent	JJ	O
Laid-open	NNP	O
No.	NNP	O
11-155571),	.	O
and	,	O
E.	CC	O
coli	NNP	O
W3110	NNS	O
with	NNP	O
decreased	IN	O
activity	JJ	O
of	NN	O
the	IN	O
positive	DT	O
transcriptional	JJ	O
control	JJ	O
factor	NN	O
of	NN	O
the	IN	O
cysteine	DT	O
regulon	NN	O
encoded	NN	O
by	VBN	O
the	IN	O
cysB	DT	O
gene	NN	O
(WO01/27307).	NN	O
The	.	O
following	DT	O
proteins	JJ	O
are	NNS	O
known	VBP	O
to	VBN	O
have	TO	O
the	VB	O
cysteine	DT	O
desulfhydrase	JJ	O
activity	NN	O
of	NN	O
E.	IN	O
coli:	NNP	O
cystathionine-β-lyase	:	O
(metC	NN	O
product,	JJ	O
Japanese	,	O
Patent	JJ	O
Laid-open	NNP	O
No.	NNP	O
11-155571,	.	O
Chandra	,	O
et	NNP	O
al.,	FW	O
Biochemistry,	,	O
21	,	O
(1982)	CD	O
3064-3069),	)	O
tryptophanase	,	O
(tnaA	NN	O
product,	JJ	O
Japanese	,	O
Patent	JJ	O
Laid-open	NNP	O
No.	NNP	O
2003-169668,	.	O
Austin	,	O
Newton	NNP	O
et	NNP	O
al.,	FW	O
J.	,	O
Biol.	NNP	O
Chem.,	.	O
240	,	O
(1965)	CD	O
1211-1218)),	)	O
O-acetylserine	,	O
sulfhydrylase	JJ	O
B	NN	O
(cysM	NNP	O
gene	JJ	O
product,	NN	O
Japanese	,	O
Patent	JJ	O
Laid-open	NNP	O
No.	NNP	O
2005-245311)	.	O
and	)	O
the	CC	O
malY	DT	O
gene	JJ	O
product	NN	O
(Japanese	NN	O
Patent	JJ	O
Laid-open	NNP	O
No.	NNP	O
2005-245311).	.	O
By	.	O
decreasing	IN	O
the	VBG	O
activities	DT	O
of	NNS	O
these	IN	O
proteins,	DT	O
L-cysteine-producing	,	O
ability	JJ	O
is	NN	O
improved.	VBZ	O
The	.	O
phrase	DT	O
“decreasing	NN	O
activity	VBG	O
of	NN	O
a	IN	O
protein”	DT	O
can	NN	O
mean	MD	O
that	VB	O
activity	DT	O
of	NN	O
the	IN	O
protein	DT	O
is	NN	O
decreased	VBZ	O
as	VBN	O
compared	IN	O
with	VBN	O
a	IN	O
non-modified	DT	O
strain	JJ	O
such	NN	O
as	JJ	O
a	IN	O
wild-type	DT	O
or	NN	O
parent	CC	O
strain,	NN	O
and	,	O
also	CC	O
can	RB	O
mean	MD	O
the	VB	O
complete	DT	O
disappearance	JJ	O
of	NN	O
the	IN	O
activity.	DT	O
Decreasing	.	O
the	VBG	O
activity	DT	O
of	NN	O
a	IN	O
protein	DT	O
having	NN	O
the	VBG	O
cysteine	DT	O
desulfhydrase	JJ	O
activity	NN	O
can	NN	O
be	MD	O
attained	VB	O
by,	VBN	O
for	,	O
example,	IN	O
reducing	,	O
expression	VBG	O
of	NN	O
a	IN	O
gene	DT	O
coding	NN	O
for	VBG	O
the	IN	O
protein.	DT	O
Specifically,	.	O
for	,	O
example,	IN	O
intracellular	,	O
activity	JJ	O
of	NN	O
the	IN	O
protein	DT	O
can	NN	O
be	MD	O
reduced	VB	O
by	VBN	O
deleting	IN	O
a	VBG	O
part	DT	O
of	NN	O
or	IN	O
the	CC	O
entire	DT	O
coding	JJ	O
region	NN	O
of	NN	O
the	IN	O
target	DT	O
gene	NN	O
on	NN	O
the	IN	O
chromosome.	DT	O
Expression	.	O
of	NN	O
a	IN	O
target	DT	O
gene	NN	O
can	NN	O
also	MD	O
be	RB	O
decreased	VB	O
by	VBN	O
modifying	IN	O
an	VBG	O
expression	DT	O
control	NN	O
sequence	NN	O
of	NN	O
the	IN	O
gene	DT	O
such	NN	O
as	JJ	O
promoter	IN	O
and	NN	O
Shine-Dalgarno	CC	O
(SD)	NNP	O
sequence.	)	O
Furthermore,	.	O
the	,	O
expression	DT	O
of	NN	O
the	IN	O
gene	DT	O
can	NN	O
also	MD	O
be	RB	O
reduced	VB	O
by	VBN	O
modifying	IN	O
a	VBG	O
non-translated	DT	O
region	JJ	O
other	NN	O
than	JJ	O
the	IN	O
expression	DT	O
control	NN	O
sequence.	NN	O
Furthermore,	.	O
the	,	O
entire	DT	O
gene	JJ	O
as	NN	O
well	RB	O
as	RB	O
the	IN	O
sequences	DT	O
on	NNS	O
both	IN	O
sides	DT	O
of	NNS	O
the	IN	O
gene	DT	O
on	NN	O
the	IN	O
chromosome	DT	O
can	NN	O
be	MD	O
deleted.	VB	O
Furthermore,	.	O
a	,	O
mutations	DT	O
which	NNS	O
cause	WDT	O
an	VBP	O
amino	DT	O
acid	NN	O
substitution	NN	O
(missense	NN	O
mutation),	JJ	O
a	,	O
stop	DT	O
codon	NN	O
(nonsense	NN	O
mutation),	JJ	O
or	,	O
a	CC	O
frame	DT	O
shift	JJ	O
mutation	NN	O
which	NN	O
adds	WDT	O
or	VBZ	O
deletes	CC	O
one	VBZ	O
or	CD	O
two	CC	O
nucleotides	CD	O
into	NNS	O
the	IN	O
coding	DT	O
region	VBG	O
of	NN	O
the	IN	O
target	DT	O
gene	NN	O
on	NN	O
the	IN	O
chromosome	DT	O
can	NN	O
be	MD	O
introduced	VB	O
Journal	VBN	B
of	NNP	I
Biological	IN	I
Chemistry,	NNP	I
272:8611-8617	,	I
(1997);	CD	I
Proceedings	:	B
of	NNS	I
the	IN	I
National	DT	I
Academy	NNP	I
of	NNP	I
Sciences,	IN	I
USA,	,	I
95	,	I
5511-5515	CD	I
(1998);	JJ	I
Journal	:	B
of	NNP	I
Biological	IN	I
Chemistry,	NNP	I
266,	,	I
20833-20839	,	I
(1991)).(	CD	O
Furthermore,	.	O
modification	,	O
can	NN	O
be	MD	O
caused	VB	O
by	VBN	O
a	IN	O
conventional	DT	O
mutagenesis	JJ	O
based	NN	O
on	VBN	O
X-ray	IN	O
or	NN	O
ultraviolet	CC	O
irradiation	JJ	O
or	NN	O
the	CC	O
use	DT	O
of	NN	O
a	IN	O
mutagen	DT	O
such	NN	O
as	JJ	O
N-methyl-N′-nitro-N-nitrosoguanidine,	IN	O
as	,	O
long	RB	O
as	RB	O
the	IN	O
activity	DT	O
of	NN	O
the	IN	O
target	DT	O
protein	NN	O
is	NN	O
decreased.	VBZ	O
An	.	O
expression	DT	O
control	NN	O
sequence	NN	O
can	NN	O
be	MD	O
modified	VB	O
by	VBN	O
mutating	IN	O
one	VBG	O
or	CD	O
more	CC	O
nucleotides,	JJR	O
two	,	O
or	CD	O
more	CC	O
nucleotides,	JJR	O
or	,	O
three	CC	O
or	CD	O
more	CC	O
nucleotides.	JJR	O
Deletions	.	O
can	NNS	O
occur	MD	O
in	VB	O
the	IN	O
N-terminus	DT	O
region,	NNP	O
an	,	O
internal	DT	O
region,	JJ	O
or	,	O
the	CC	O
C-terminus	DT	O
region,	JJ	O
or	,	O
even	CC	O
the	RB	O
entire	DT	O
coding	JJ	O
region,	NN	O
so	,	O
long	RB	O
as	RB	O
the	IN	O
function	DT	O
of	NN	O
the	IN	O
target	DT	O
protein	NN	O
is	NN	O
decreased	VBZ	O
or	VBN	O
deleted.	CC	O
The	.	O
longer	DT	O
the	JJR	O
region	DT	O
which	NN	O
is	WDT	O
deleted,	VBZ	O
the	,	O
greater	DT	O
the	JJR	O
likelihood	DT	O
of	NN	O
inactivating	IN	O
the	VBG	O
gene.	DT	O
Furthermore,	.	O
the	,	O
deleted	DT	O
reading	JJ	O
frames	NN	O
upstream	NNS	O
and	RB	O
downstream	CC	O
of	NN	O
the	IN	O
region	DT	O
can	NN	O
be	MD	O
the	VB	O
same	DT	O
or	JJ	O
different.	CC	O
To	.	O
inactivate	TO	O
a	VB	O
gene	DT	O
by	NN	O
inserting	IN	O
a	VBG	O
sequence	DT	O
into	NN	O
the	IN	O
coding	DT	O
region	VBG	O
of	NN	O
the	IN	O
gene,	DT	O
the	,	O
sequence	DT	O
can	NN	O
be	MD	O
inserted	VB	O
into	VBN	O
any	IN	O
part	DT	O
of	NN	O
the	IN	O
coding	DT	O
region	VBG	O
of	NN	O
the	IN	O
gene.	DT	O
The	.	O
longer	DT	O
the	JJR	O
inserted	DT	O
sequence,	JJ	O
the	,	O
greater	DT	O
the	JJR	O
likelihood	DT	O
of	NN	O
inactivating	IN	O
the	VBG	O
gene.	DT	O
The	.	O
reading	DT	O
frames	NN	O
upstream	VBZ	O
and	JJ	O
downstream	CC	O
of	NN	O
the	IN	O
insertion	DT	O
site	NN	O
can	NN	O
be	MD	O
the	VB	O
same	DT	O
or	JJ	O
different.	CC	O
The	.	O
sequence	DT	O
to	NN	O
be	TO	O
inserted	VB	O
is	VBN	O
not	VBZ	O
particularly	RB	O
limited	RB	O
so	VBN	O
long	RB	O
as	RB	O
the	IN	O
insertion	DT	O
decreases	NN	O
or	VBZ	O
deletes	CC	O
the	VBZ	O
function	DT	O
of	NN	O
the	IN	O
encoded	DT	O
protein,	JJ	O
and	,	O
examples	CC	O
include	NNS	O
a	VBP	O
transposon	DT	O
carrying	NN	O
an	VBG	O
antibiotic	DT	O
resistance	JJ	O
gene,	NN	O
a	,	O
gene	DT	O
useful	NN	O
for	JJ	O
L-cysteine	IN	O
production	JJ	O
and	NN	O
so	CC	O
forth.	RB	O
A	.	O
target	DT	O
gene	NN	O
on	NN	O
the	IN	O
chromosome	DT	O
can	NN	O
be	MD	O
modified	VB	O
as	VBN	O
described	IN	O
above	VBN	O
by,	IN	O
for	,	O
example,	IN	O
preparing	,	O
a	VBG	O
deletion-type	DT	O
version	JJ	O
of	NN	O
the	IN	O
gene	DT	O
in	NN	O
which	IN	O
a	WDT	O
partial	DT	O
sequence	JJ	O
of	NN	O
the	IN	O
gene	DT	O
is	NN	O
deleted	VBZ	O
so	VBN	O
that	RB	O
the	IN	O
deletion-type	DT	O
gene	JJ	O
does	NN	O
not	VBZ	O
produce	RB	O
a	VB	O
normally-functioning	DT	O
proteins.	JJ	O
Then,	.	O
a	,	O
bacterium	DT	O
can	NN	O
be	MD	O
transformed	VB	O
with	VBN	O
a	IN	O
DNA	DT	O
containing	NN	O
the	VBG	O
deletion-type	DT	O
gene	JJ	O
to	NN	O
cause	TO	O
homologous	VB	O
recombination	JJ	O
between	NN	O
the	IN	O
deletion-type	DT	O
gene	JJ	O
and	NN	O
the	CC	O
native	DT	O
gene	JJ	O
on	NN	O
the	IN	O
chromosome,	DT	O
which	,	O
results	WDT	O
in	NNS	O
the	IN	O
substitution	DT	O
of	NN	O
the	IN	O
deletion-type	DT	O
gene	JJ	O
for	NN	O
the	IN	O
gene	DT	O
on	NN	O
the	IN	O
genome.	DT	O
The	.	O
protein	DT	O
encoded	NN	O
by	VBN	O
the	IN	O
deletion-type	DT	O
gene	JJ	O
has	NN	O
a	VBZ	O
conformation	DT	O
different	NN	O
from	JJ	O
that	IN	O
of	DT	O
the	IN	O
wild-type	DT	O
enzyme	JJ	O
protein,	NN	O
if	,	O
it	IN	O
is	PRP	O
even	VBZ	O
produced,	RB	O
and	,	O
thus	CC	O
the	RB	O
function	DT	O
is	NN	O
reduced	VBZ	O
or	VBN	O
deleted.	CC	O
Such	.	O
gene	JJ	O
disruption	NN	O
based	NN	O
on	VBN	O
gene	IN	O
substitution	NN	O
utilizing	NN	O
homologous	VBG	O
recombination	JJ	O
is	NN	O
known,	VBZ	O
and	,	O
examples	CC	O
include	NNS	O
Red-driven	VBP	O
integration	JJ	O
Datsenko,	NN	B
K.	,	I
A.,	NNP	I
and	,	I
Wanner,	CC	I
B.	,	I
L.,	NNP	I
Proc.	,	I
Natl.	.	I
Acad.	.	I
Sci.	.	I
USA,	.	I
97:6640-6645	,	I
(2000)),(	CD	O
using	,	O
a	VBG	O
linear	DT	O
DNA	JJ	O
utilizing	NN	O
in	NN	O
Red	IN	O
driven	NNP	O
integration	JJ	O
in	NN	O
combination	IN	O
with	NN	O
an	IN	O
excision	DT	O
system	NN	O
derived	NN	O
from	VBN	O
λ	IN	O
phage	JJ	O
(Cho,	NN	O
E.	,	O
H.,	NNP	O
Gumport,	,	O
R.	,	O
I.,	NNP	O
Gardner,	,	O
J.	,	O
F.,	NNP	O
J.	,	O
Bacteriol.,	.	O
184:5200-5203	,	O
(2002))	CD	O
(refer	)	O
to	VBP	O
WO2005/010175),	TO	O
using	,	O
a	VBG	O
plasmid	DT	O
containing	NN	O
a	VBG	O
temperature	DT	O
sensitive	NN	O
replication	JJ	O
origin	NN	O
or	NN	O
a	CC	O
plasmid	DT	O
capable	JJ	O
of	JJ	O
conjugative	IN	O
transfer,	JJ	O
utilizing	,	O
a	VBG	O
suicide	DT	O
vector	JJ	O
without	NN	O
a	IN	O
replication	DT	O
origin	NN	O
in	NN	O
a	IN	O
host	DT	O
(U.S.	NN	O
Pat.	NNP	O
No.	.	O
6,303,383,	.	O
Japanese	,	O
Patent	JJ	O
Laid-open	NNP	O
No.	NNP	O
05-007491),	.	O
and	,	O
so	CC	O
forth.	RB	O
Decrease	.	O
of	NN	O
the	IN	O
expression	DT	O
of	NN	O
a	IN	O
target	DT	O
gene	NN	O
can	NN	O
be	MD	O
confirmed	VB	O
by	VBN	O
comparing	IN	O
the	VBG	O
amount	DT	O
of	NN	O
mRNA	IN	O
transcribed	NN	O
from	VBN	O
the	IN	O
gene	DT	O
with	NN	O
that	IN	O
in	DT	O
a	IN	O
wild-type	DT	O
strain	JJ	O
or	NN	O
non-modified	CC	O
strain.	JJ	O
The	.	O
expression	DT	O
amount	NN	O
can	NN	O
be	MD	O
confirmed	VB	O
by	VBN	O
Northern	IN	O
hybridization,	NNP	O
RT-PCR	,	O
(Molecular	NNP	O
Cloning	JJ	O
(Cold	NNP	O
Spring	NNP	O
Harbor	NNP	O
Laboratory	NNP	O
Press,	NNP	O
Cold	,	O
Spring	NNP	O
Harbor	NNP	O
(USA),	NNP	O
2001)),	,	O
and	,	O
the	CC	O
like.	DT	O
A	.	O
decrease	DT	O
of	NN	O
the	IN	O
amount	DT	O
of	NN	O
a	IN	O
target	DT	O
protein	NN	O
can	NN	O
be	MD	O
confirmed	VB	O
by	VBN	O
Western	IN	O
blotting	JJ	O
using	VBG	O
antibodies	VBG	O
(Molecular	NNS	O
Cloning	JJ	O
(Cold	NNP	O
Spring	NNP	O
Harbor	NNP	O
Laboratory	NNP	O
Press,	NNP	O
Cold	,	O
Spring	NNP	O
Harbor	NNP	O
(USA),	NNP	O
2001)).	,	O
The	.	O
L-cysteine-producing	DT	O
bacterium	JJ	O
can	NN	O
have	MD	O
a	VB	O
SAT	DT	O
which	NNP	O
has	WDT	O
been	VBZ	O
mutated	VBN	O
to	VBN	O
be	TO	O
resistant	VB	O
to	JJ	O
feedback	TO	O
inhibition.	VB	O
The	.	O
following	DT	O
mutations	JJ	O
in	NNS	O
SAT	IN	O
are	NNP	O
known	VBP	O
to	VBN	O
induce	TO	O
resistance	VB	O
to	NN	O
feedback	TO	O
inhibition	VB	O
and	NN	O
are	CC	O
derived	VBP	O
from	VBN	O
Escherichia	IN	O
coli:	NNP	O
when	:	O
the	WRB	O
methionine	DT	O
residue	NN	O
at	NN	O
position	IN	O
256	NN	O
is	CD	O
replaced	VBZ	O
with	VBN	O
a	IN	O
glutamate	DT	O
residue	NN	O
(Japanese	NN	O
Patent	JJ	O
Laid-open	NNP	O
No.	NNP	O
11-155571),	.	O
when	,	O
the	WRB	O
methionine	DT	O
residue	NN	O
at	NN	O
position	IN	O
256	NN	O
is	CD	O
replaced	VBZ	O
with	VBN	O
an	IN	O
isoleucine	DT	O
residue	NN	O
Denk,	NN	B
D.	,	I
and	NNP	I
Boeck,	CC	I
A.,	,	I
J.	,	I
General	.	I
Microbiol.,	NNP	I
133,	,	I
515-525	,	I
(1987)),(	CD	O
a	,	O
mutation	DT	O
in	NN	O
the	IN	O
region	DT	O
from	NN	O
the	IN	O
amino	DT	O
acid	NN	O
residue	NN	O
at	NN	O
position	IN	O
97	NN	O
to	CD	O
the	TO	O
amino	DT	O
acid	NN	O
residue	NN	O
at	NN	O
position	IN	O
273	NN	O
or	CD	O
a	CC	O
deletion	DT	O
of	NN	O
the	IN	O
C-terminus	DT	O
region	JJ	O
from	NN	O
the	IN	O
amino	DT	O
acid	NN	O
residue	NN	O
at	NN	O
position	IN	O
227	NN	O
(International	CD	O
Patent	NNP	O
Publication	NNP	O
WO97/15673,	NNP	O
U.S.	,	O
Pat.	NNP	O
No.	.	O
6,218,168),	.	O
when	,	O
the	WRB	O
amino	DT	O
acid	NN	O
sequence	JJ	O
corresponding	NN	O
to	VBG	O
positions	TO	O
89	NNS	O
to	CD	O
96	TO	O
of	CD	O
the	IN	O
wild-type	DT	O
SAT	JJ	O
contains	NNP	O
one	VBZ	O
or	CD	O
more	CC	O
mutations	JJR	O
(U.S.	NNS	O
Patent	NNP	O
Published	NNP	O
Application	NNP	O
No.	NNP	O
20050112731(A1)),	.	O
and	,	O
so	CC	O
forth.	RB	O
In	.	O
the	IN	O
cysE5	DT	O
gene	NN	O
which	NN	O
encodes	WDT	O
the	VBZ	O
mutant	DT	O
SAT	JJ	O
described	NNP	O
in	NN	O
the	IN	O
examples,	DT	O
the	,	O
Val	DT	O
residue	NNP	O
and	NN	O
the	CC	O
Asp	DT	O
residue	NNP	O
at	NN	O
positions	IN	O
95	NNS	O
and	CD	O
96	CC	O
of	CD	O
the	IN	O
wild-type	DT	O
SAT	JJ	O
are	NNP	O
replaced	VBP	O
with	VBN	O
an	IN	O
Arg	DT	O
residue	NNP	O
and	NN	O
Pro	CC	O
residue,	NNP	O
respectively.	,	O
The	.	O
SAT	DT	O
gene	NNP	O
is	NN	O
not	VBZ	O
limited	RB	O
to	VBN	O
the	TO	O
gene	DT	O
of	NN	O
Escherichia	IN	O
coli,	NNP	O
but	,	O
can	CC	O
be	MD	O
any	VB	O
gene	DT	O
encoring	NN	O
a	VBG	O
protein	DT	O
having	NN	O
the	VBG	O
SAT	DT	O
activity.	NNP	O
An	.	O
SAT	DT	O
isozyme	NNP	O
of	NN	O
Arabidopsis	IN	O
thaliana	NNP	O
desensitized	NNP	O
to	VBD	O
feedback	TO	O
inhibition	VB	O
by	NN	O
L-cysteine	IN	O
is	NNP	O
known,	VBZ	O
and	,	O
the	CC	O
gene	DT	O
encoding	NN	O
this	VBG	O
SAT	DT	O
can	NNP	O
also	MD	O
be	RB	O
used	VB	O
FEMS	VBN	B
Microbiol.	NNP	I
Lett.,	.	I
179	,	I
(1999)	CD	I
453-459).(	)	O
If	.	O
a	IN	O
gene	DT	O
encoding	NN	O
a	VBG	O
mutant	DT	O
SAT	JJ	O
is	NNP	O
introduced	VBZ	O
into	VBN	O
a	IN	O
bacterium,	DT	O
L-cysteine-producing	,	O
ability	JJ	O
is	NN	O
imparted	VBZ	O
to	VBN	O
the	TO	O
bacterium.	DT	O
To	.	O
introduce	TO	O
a	VB	O
mutant	DT	O
SAT	JJ	O
gene	NNP	O
into	NN	O
a	IN	O
bacterium,	DT	O
various	,	O
vectors	JJ	O
which	NNS	O
are	WDT	O
typically	VBP	O
used	RB	O
for	VBN	O
protein	IN	O
expression	JJ	O
can	NN	O
be	MD	O
used.	VB	O
Examples	.	O
of	NNS	O
such	IN	O
vectors	JJ	O
include	NNS	O
pUC19,	VBP	O
pUC18,	,	O
pHSG299,	,	O
pHSG399,	,	O
pHSG398,	,	O
RSF1010,	,	O
pBR322,	,	O
pACYC184,	,	O
pMW219	,	O
and	NN	O
so	CC	O
forth.	RB	O
In	.	O
order	IN	O
to	NN	O
introduce	TO	O
a	VB	O
recombinant	DT	O
vector	JJ	O
containing	NN	O
a	VBG	O
SAT	DT	O
gene	NNP	O
into	NN	O
a	IN	O
bacterium,	DT	O
methods	,	O
which	NNS	O
are	WDT	O
typically	VBP	O
used	RB	O
to	VBN	O
transform	TO	O
bacteria	VB	O
can	NNS	O
be	MD	O
used,	VB	O
such	,	O
as	JJ	O
the	IN	O
method	DT	O
of	NN	O
D.	IN	B
A.	NNP	I
Morrison	NNP	I
(Methods	NNP	I
in	NNP	I
Enzymology,	IN	I
68,	,	I
326	,	I
(1979)),treating	CD	O
recipient	,	O
cells	VBG	O
with	NN	O
calcium	NNS	O
chloride	IN	O
to	NN	O
increase	NN	O
permeability	TO	O
of	VB	O
the	NN	O
cells	IN	O
for	DT	O
DNA	NNS	O
Mandel,	IN	B
M.	NNP	I
and	,	I
Higa,	NNP	I
A.,	CC	I
J.	,	I
Mol.	,	I
Biol.,	NNP	I
53,	.	I
159	,	I
(1970)),(	,	O
and	CD	O
a	,	O
method	CC	O
based	DT	O
on	NN	O
electroporation.	VBN	O
Furthermore,	IN	O
the	.	O
SAT	,	O
activity	DT	O
can	NNP	O
also	NN	O
be	MD	O
enhanced	RB	O
by	VB	O
increasing	VBN	O
the	IN	O
copy	VBG	O
number	DT	O
of	NN	O
the	NN	O
SAT	IN	O
gene.	DT	O
The	NNP	O
copy	.	O
number	DT	O
of	NN	O
the	NN	O
SAT	IN	O
gene	DT	O
can	NNP	O
be	NN	O
increased	MD	O
by	VB	O
introducing	VBN	O
the	IN	O
SAT	VBG	O
gene	DT	O
into	NNP	O
a	NN	O
bacterium	IN	O
by	DT	O
using	NN	O
a	IN	O
vector	VBG	O
such	DT	O
as	NN	O
those	JJ	O
described	IN	O
above,	DT	O
or	VBN	O
by	,	O
introducing	CC	O
multiple	IN	O
copies	VBG	O
of	JJ	O
the	NNS	O
SAT	IN	O
gene	DT	O
onto	NNP	O
the	NN	O
chromosomal	IN	O
DNA	DT	O
of	JJ	O
a	NNP	O
bacterium.	IN	O
Multiple	DT	O
copies	.	O
of	JJ	O
the	NNS	O
SAT	IN	O
gene	DT	O
are	NNP	O
introduced	NN	O
by	VBP	O
homologous	VBN	O
recombination	IN	O
which	JJ	O
targets	NN	O
a	WDT	O
sequence	VBZ	O
present	DT	O
on	NN	O
the	NN	O
chromosomal	IN	O
DNA	DT	O
in	JJ	O
multiple	NNP	O
copies.	IN	O
A	JJ	O
repetitive	.	O
DNA	DT	O
or	JJ	O
inverted	NN	O
repeat	CC	O
present	JJ	O
at	NN	O
the	NN	O
end	IN	O
of	DT	O
a	NN	O
transposable	IN	O
element	DT	O
can	JJ	O
be	NN	O
used	MD	O
as	VB	O
a	VBN	O
sequence	IN	O
which	DT	O
is	NN	O
present	WDT	O
on	VBZ	O
the	JJ	O
chromosomal	IN	O
DNA	DT	O
in	JJ	O
multiple	NNP	O
copies.	IN	O
Alternatively,	JJ	O
as	.	O
disclosed	,	O
in	IN	O
Japanese	VBN	O
Patent	IN	O
Laid-open	JJ	O
No.	NNP	O
2-109985,	NNP	O
multiple	.	O
copies	,	O
of	JJ	O
the	NNS	O
SAT	IN	O
gene	DT	O
can	NNP	O
be	NN	O
introduced	MD	O
into	VB	O
the	VBN	O
chromosomal	IN	O
DNA	DT	O
by	JJ	O
incorporating	NN	O
them	IN	O
into	VBG	O
a	PRP	O
transposon	IN	O
and	DT	O
transferring	NN	O
it.	CC	O
Furthermore,	VBG	O
it	.	O
is	,	O
known	PRP	O
that	VBZ	O
the	VBN	O
ydeD	IN	O
gene	DT	O
coding	JJ	O
for	NN	O
the	VBG	O
YdeD	IN	O
protein	DT	O
participates	NNP	O
in	NN	O
secretion	VBZ	O
of	IN	O
metabolic	NN	O
products	IN	O
of	JJ	O
the	NNS	O
cysteine	IN	O
pathway,	DT	O
and	NN	O
L-cysteine-producing	,	O
ability	CC	O
can	JJ	O
also	NN	O
be	MD	O
improved	RB	O
by	VB	O
enhancing	VBN	O
the	IN	O
activity	VBG	O
of	DT	O
the	NN	O
YdeD	IN	O
protein	DT	O
(Japanese	NNP	O
Patent	NN	O
Laid-open	JJ	O
No.	NNP	O
2002-233384).	NNP	O
The	.	O
activity	.	O
of	DT	O
the	NN	O
YdeD	IN	O
protein	DT	O
can	NNP	O
be	NN	O
increased	MD	O
by,	VB	O
for	VBN	O
example,	,	O
improving	IN	O
expression	,	O
of	VBG	O
the	NN	O
ydeD	IN	O
gene.	DT	O
Expression	JJ	O
of	.	O
the	NN	O
ydeD	IN	O
gene	DT	O
can	JJ	O
be	NN	O
improved	MD	O
in	VB	O
the	VBN	O
same	IN	O
manner	DT	O
as	JJ	O
that	NN	O
of	IN	O
the	DT	O
modification	IN	O
for	DT	O
improving	NN	O
expression	IN	O
of	VBG	O
the	NN	O
dsbA	IN	O
gene	DT	O
described	JJ	O
later.	NN	O
The	VBD	O
ydeD	.	O
gene	DT	O
of	JJ	O
Escherichia	NN	O
coli	IN	O
can	NNP	O
be	NNS	O
obtained	MD	O
from	VB	O
Escherichia	VBN	O
coli	IN	O
chromosomal	NNP	O
DNA	NNS	O
by	JJ	O
PCR	NNP	O
using,	IN	O
for	NNP	O
example,	,	O
the	IN	O
primers	,	O
having	DT	O
the	NNS	O
nucleotide	VBG	O
sequences	DT	O
of	JJ	O
SEQ	NNS	O
ID	IN	O
NOS:	NNP	O
13	NNP	O
and	:	O
14.	CD	O
Furthermore,	CC	O
by	.	O
incorporating	,	O
3-phosphoglycerate	IN	O
dehydrogenase	VBG	O
(PGD)	JJ	O
desensitized	NN	O
to	)	O
the	VBD	O
feedback	TO	O
inhibition	DT	O
by	NN	O
serine,	NN	O
L-cysteine-producing	IN	O
ability	,	O
can	JJ	O
also	NN	O
be	MD	O
improved.	RB	O
As	VB	O
a	.	O
gene	IN	O
coding	DT	O
for	NN	O
such	VBG	O
a	IN	O
mutant	PDT	O
PGD,	DT	O
the	JJ	O
serA5	,	O
gene	DT	O
is	JJ	O
known	NN	O
(described	VBZ	O
in	VBN	O
U.S.	VBN	O
Pat.	IN	O
No.	NNP	O
6,180,373).	.	O
Furthermore,	.	O
an	.	O
L-cysteine-producing	,	O
Escherichia	DT	O
bacterium	JJ	O
which	NNP	O
has	NN	O
been	WDT	O
modified	VBZ	O
to	VBN	O
enhance	VBN	O
expression	TO	O
of	VB	O
the	NN	O
cysPTWAM	IN	O
cluster	DT	O
genes	NN	O
coding	NN	O
for	NNS	O
the	VBG	O
sulfate/thio	IN	O
sulfate	DT	O
transport	NN	O
system	NN	O
proteins	NN	O
(Japanese	NN	O
Patent	NNS	O
Laid-open	JJ	O
No.	NNP	O
2005-137369,	NNP	O
EP	.	O
1528108)	,	O
can	NNP	O
also	)	O
be	MD	O
used.	RB	O
Furthermore,	VB	O
an	.	O
Escherichia	,	O
bacterium	DT	O
which	NNP	O
has	NN	O
L-cysteine	WDT	O
producing-ability	VBZ	O
and	JJ	O
has	NN	O
been	CC	O
modified	VBZ	O
to	VBN	O
increase	VBN	O
expression	TO	O
of	VB	O
the	NN	O
emrAB,	IN	O
emrKY,	DT	O
yojIH,	,	O
acrEF,	,	O
bcr	,	O
or	,	O
cusA	NN	O
gene	CC	O
(Japanese	NN	O
Patent	NN	O
Laid-open	JJ	O
No.	NNP	O
2005-287333)	NNP	O
can	.	O
also	)	O
be	MD	O
used.	RB	O
Particular	VB	O
examples	.	O
of	JJ	O
the	NNS	O
bacteria	IN	O
having	DT	O
L-cysteine-producing	NNS	O
ability	VBG	O
include,	JJ	O
a	NN	O
bacterium	,	O
containing	DT	O
a	NN	O
mutant	VBG	O
SAT	DT	O
resistant	JJ	O
to	NNP	O
feedback	NN	O
inhibition,	TO	O
a	VB	O
bacterium	,	O
having	DT	O
enhanced	NN	O
activity	VBG	O
of	VBN	O
the	NN	O
YdeD	IN	O
protein,	DT	O
and	NNP	O
a	,	O
bacterium	CC	O
containing	DT	O
a	NN	O
PGD	VBG	O
protein	DT	O
desensitized	NNP	O
to	NN	O
feedback	VBD	O
inhibition	TO	O
by	VB	O
serine,	NN	O
a	IN	O
bacterium	,	O
containing	DT	O
a	NN	O
mutant	VBG	O
SAT	DT	O
resistant	JJ	O
to	NNP	O
feedback	NN	O
inhibition	TO	O
and	VB	O
having	NN	O
enhanced	CC	O
activity	VBG	O
of	VBN	O
the	NN	O
YdeD	IN	O
protein,	DT	O
a	NNP	O
bacterium	,	O
containing	DT	O
a	NN	O
mutant	VBG	O
SAT	DT	O
resistant	JJ	O
to	NNP	O
feedback	NN	O
inhibition	TO	O
and	VB	O
a	NN	O
PGD	CC	O
protein	DT	O
desensitized	NNP	O
to	NN	O
the	VBD	O
feedback	TO	O
inhibition	DT	O
by	NN	O
serine,	NN	O
a	IN	O
bacterium	,	O
having	DT	O
enhanced	NN	O
activity	VBG	O
of	VBN	O
the	NN	O
YdeD	IN	O
protein	DT	O
and	NNP	O
containing	NN	O
a	CC	O
PGD	VBG	O
protein	DT	O
desensitized	NNP	O
to	NN	O
feedback	VBD	O
inhibition	TO	O
by	VB	O
serine,	NN	O
and	IN	O
a	,	O
bacterium	CC	O
containing	DT	O
a	NN	O
mutant	VBG	O
SAT	DT	O
resistant	JJ	O
to	NNP	O
feedback	NN	O
inhibition	TO	O
and	VB	O
a	NN	O
PGD	CC	O
protein	DT	O
desensitized	NNP	O
to	NN	O
feedback	VBD	O
inhibition	TO	O
by	VB	O
serine,	NN	O
and	IN	O
having	,	O
enhanced	CC	O
activity	VBG	O
of	VBN	O
the	NN	O
YdeD	IN	O
protein.	DT	O
The	NNP	O
bacterium	.	O
can	DT	O
be	NN	O
obtained	MD	O
by	VB	O
modifying	VBN	O
a	IN	O
bacterium	VBG	O
belonging	DT	O
to	NN	O
the	NN	O
family	TO	O
Enterobacteriaceae	DT	O
which	NN	O
has	NNP	O
L-cysteine-producing	WDT	O
ability	VBZ	O
such	JJ	O
as	NN	O
those	JJ	O
described	IN	O
above	DT	O
so	VBN	O
that	IN	O
the	RB	O
activity	IN	O
of	DT	O
the	NN	O
protein	IN	O
encoded	DT	O
by	NN	O
dsbA	VBN	O
(henceforth	IN	O
also	NN	O
referred	NN	O
to	RB	O
as	VBD	O
“DsbA”)	TO	O
is	IN	O
increased.	)	O
Alternatively,	VBZ	O
after	.	O
such	,	O
modification	IN	O
that	JJ	O
the	NN	O
activity	IN	O
of	DT	O
the	NN	O
DsbA	IN	O
protein	DT	O
is	NNP	O
increased	NN	O
is	VBZ	O
performed,	VBN	O
L-cysteine-producing	VBZ	O
ability	,	O
can	JJ	O
be	NN	O
imparted.	MD	O
The	VB	O
dsbA	.	O
gene	DT	O
is	NN	O
the	NN	O
same	VBZ	O
as	DT	O
ECK3852,	JJ	O
b3860,	IN	O
dsf,	,	O
iarA	,	O
and	,	O
ppfA	NN	O
genes.	CC	O
The	NN	O
phrase	.	O
“the	DT	O
activity	NN	O
of	NNP	O
the	NN	O
protein	IN	O
encoded	DT	O
by	NN	O
the	VBN	O
dsbA	IN	O
gene	DT	O
is	NN	O
increased”	NN	O
means	VBZ	O
that	JJ	O
the	NNS	O
activity	IN	O
of	DT	O
the	NN	O
DsbA	IN	O
protein	DT	O
encoded	NNP	O
by	NN	O
the	VBN	O
dsbA	IN	O
gene	DT	O
is	NN	O
increased	NN	O
as	VBZ	O
compared	VBN	O
with	IN	O
a	VBN	O
non-modified	IN	O
strain	DT	O
such	JJ	O
as	NN	O
a	JJ	O
wild-type	IN	O
or	DT	O
parent	NN	O
strain.	CC	O
The	NN	O
activity	.	O
of	DT	O
the	NN	O
DsbA	IN	O
protein	DT	O
is	NNP	O
essentially	NN	O
an	VBZ	O
activity	RB	O
of	DT	O
oxidizing	NN	O
a	IN	O
substrate	VBG	O
protein	DT	O
(AmpC,	NN	O
DsbB,	NN	O
LivK,	,	O
OstA,	,	O
RcsF)	,	O
in	,	O
the	)	O
periplasm,	IN	O
and	DT	O
by	,	O
increasing	CC	O
the	IN	O
activity	VBG	O
of	DT	O
this	NN	O
DsbA	IN	O
protein,	DT	O
L-cysteine-producing	NNP	O
ability	,	O
can	JJ	O
be	NN	O
improved.	MD	O
Therefore,	VB	O
according	.	O
to	,	O
another	VBG	O
definition,	TO	O
the	DT	O
activity	,	O
of	DT	O
the	NN	O
DsbA	IN	O
protein	DT	O
means	NNP	O
an	NN	O
activity	VBZ	O
of	DT	O
improving	NN	O
L-cysteine-producing	IN	O
ability,	VBG	O
when	NNP	O
the	,	O
activity	WRB	O
is	DT	O
increased	NN	O
in	VBZ	O
bacteria.	VBN	O
Furthermore,	IN	O
it	.	O
was	,	O
revealed	PRP	O
that	VBD	O
when	VBN	O
the	IN	O
dsbA	WRB	O
gene	DT	O
was	NN	O
deleted,	NN	O
the	VBD	O
bacterium	,	O
became	DT	O
L-cysteine	NN	O
sensitive,	VBD	O
and	NNP	O
when	,	O
the	CC	O
dsbA	WRB	O
gene-deficient	DT	O
strain	NN	O
was	JJ	O
transformed	NN	O
with	VBD	O
the	VBN	O
dsbA	IN	O
gene,	DT	O
it	NN	O
was	,	O
recovered	PRP	O
from	VBD	O
the	VBN	O
cysteine	IN	O
sensitivity	DT	O
as	NN	O
described	NN	O
in	IN	O
the	VBN	O
examples.	IN	O
Therefore,	DT	O
according	.	O
to	,	O
another	VBG	O
definition,	TO	O
the	DT	O
activity	,	O
of	DT	O
the	NN	O
DsbA	IN	O
protein	DT	O
means	NNP	O
a	NN	O
property	VBZ	O
of	DT	O
being	NN	O
involved	IN	O
in	VBG	O
such	VBN	O
cysteine	IN	O
resistance	JJ	O
or	JJ	O
sensitivity.	NN	O
Such	CC	O
modification	.	O
that	JJ	O
the	NN	O
activity	IN	O
of	DT	O
the	NN	O
DsbA	IN	O
protein	DT	O
encoded	NNP	O
by	NN	O
the	VBN	O
dsbA	IN	O
gene	DT	O
is	NN	O
increased	NN	O
is	VBZ	O
attained	VBN	O
by,	VBZ	O
for	VBN	O
example,	,	O
increasing	IN	O
expression	,	O
of	VBG	O
the	NN	O
dsbA	IN	O
gene.	DT	O
Modification	JJ	O
for	.	O
enhancing	NN	O
expression	IN	O
of	VBG	O
the	NN	O
dsbA	IN	O
gene	DT	O
can	JJ	O
be	NN	O
attained	MD	O
by	VB	O
increasing	VBN	O
the	IN	O
copy	VBG	O
number	DT	O
of	NN	O
the	NN	O
dsbA	IN	O
gene	DT	O
by	NN	O
using,	NN	O
for	IN	O
example,	,	O
a	IN	O
gene	,	O
recombination	DT	O
technique.	NN	O
For	NN	O
example,	.	O
a	IN	O
recombinant	,	O
DNA	DT	O
can	JJ	O
be	NN	O
prepared	MD	O
by	VB	O
ligating	VBN	O
a	IN	O
gene	VBG	O
fragment	DT	O
containing	NN	O
the	NN	O
dsbA	VBG	O
gene	DT	O
with	JJ	O
a	NN	O
vector	IN	O
functioning	DT	O
in	NN	O
a	NN	O
host	IN	O
bacterium	DT	O
such	NN	O
as	NN	O
a	JJ	O
multi-copy	IN	O
type	DT	O
vector	JJ	O
and	NN	O
introduced	NN	O
into	CC	O
the	VBN	O
bacterium	IN	O
to	DT	O
transform	NN	O
it.	TO	O
Examples	VB	O
of	.	O
the	NNS	O
vector	IN	O
include	DT	O
vectors	NN	O
which	VBP	O
are	NNS	O
autonomously	WDT	O
replicable	VBP	O
in	RB	O
host	JJ	O
bacterium	IN	O
cells.	NN	O
Examples	NN	O
of	.	O
the	NNS	O
vector	IN	O
autonomously	DT	O
replicable	NN	O
in	RB	O
Escherichia	JJ	O
coli	IN	O
cells	NNP	O
include	NN	O
pUC19,	NNS	O
pUC18,	VBP	O
pHSG299,	,	O
pHSG399,	,	O
pHSG398,	,	O
pACYC184	,	O
(pHSG	,	O
and	NN	O
pACYC	NN	O
series	CC	O
vectors	JJ	O
are	NN	O
available	NNS	O
from	VBP	O
Takara	JJ	O
Bio),	IN	O
RSF1010,	NNP	O
pBR322,	,	O
pMW219	,	O
(pMW219	,	O
is	NN	O
available	NN	O
from	VBZ	O
NIPPON	JJ	O
GENE),	IN	O
pSTV29	NNP	O
(available	,	O
from	FW	O
Takara	JJ	O
Bio),	IN	O
and	NNP	O
so	,	O
forth.	CC	O
To	RB	O
introduce	.	O
such	TO	O
a	VB	O
recombinant	PDT	O
DNA	DT	O
into	JJ	O
a	NNP	O
bacterium,	IN	O
any	DT	O
known	,	O
transformation	DT	O
methods	JJ	O
that	NN	O
have	NNS	O
hitherto	WDT	O
been	VBP	O
reported	VBN	O
can	VBN	O
be	VBN	O
employed.	MD	O
For	VB	O
instance,	.	O
employable	IN	O
are	,	O
treating	JJ	O
recipient	VBP	O
cells	VBG	O
with	NN	O
calcium	NNS	O
chloride	IN	O
so	NN	O
as	NN	O
to	RB	O
increase	IN	O
permeability	TO	O
thereof	VB	O
for	NN	O
DNA,	NN	O
which	IN	O
has	,	O
been	WDT	O
reported	VBZ	O
for	VBN	O
Escherichia	VBN	O
coli	IN	O
K-12	NNP	O
Mandel,	JJ	B
M.	NNP	I
and	,	I
Higa,	NNP	I
A.,	CC	I
J.	,	I
Mol.	,	I
Biol.,	NNP	I
53,	.	I
159	,	I
(1970)),(	,	O
and	CD	O
preparing	,	O
competent	CC	O
cells	VBG	O
from	JJ	O
cells	NNS	O
which	IN	O
are	NNS	O
at	WDT	O
the	VBP	O
growth	IN	O
phase	DT	O
followed	NN	O
by	NN	O
introducing	VBN	O
the	IN	O
DNA	VBG	O
thereinto,	DT	O
which	NN	O
has	,	O
been	WDT	O
reported	VBZ	O
for	VBN	O
Bacillus	VBN	O
subtilis	IN	O
Duncan,	NN	B
C.	NNS	I
H.,	,	I
Wilson,	NNP	I
G.	,	I
A.	,	I
and	NNP	I
Young,	NN	I
F.	CC	I
E.,	,	I
Gene,	NNP	I
1,	,	I
153	,	I
(1977)).(	,	O
In	CD	O
addition	.	O
to	IN	O
these,	NN	O
also	TO	O
employable	,	O
is	RB	O
making	JJ	O
DNA-recipient	VBZ	O
cells	VBG	O
into	JJ	O
protoplasts	NNS	O
or	IN	O
spheroplasts,	NNS	O
which	CC	O
can	,	O
easily	WDT	O
take	MD	O
up	RB	O
recombinant	VB	O
DNA,	RP	O
followed	JJ	O
by	,	O
introducing	VBN	O
the	IN	O
recombinant	VBG	O
DNA	DT	O
into	JJ	O
the	NNP	O
cells,	IN	O
which	DT	O
is	,	O
known	WDT	O
to	VBZ	O
be	VBN	O
applicable	TO	O
to	VB	O
Bacillus	JJ	O
subtilis,	TO	O
actinomycetes	NNP	O
and	,	O
yeasts	NNS	O
Chang,	CC	B
S,	NNS	I
and	,	I
Choen,	,	I
S.	CC	I
N.,	,	I
Mol.	NNP	I
Gen.	,	I
Genet.,	.	I
168,	.	I
111	,	I
(1979);	,	I
Bibb,	CD	B
M.	:	I
J.,	,	I
Ward,	NNP	I
J.	,	I
M.	,	I
and	NNP	I
Hopwood,	NNP	I
O.	CC	I
A.,	,	I
Nature,	.	I
274,	,	I
398	,	I
(1978);	,	I
Hinnen,	CD	B
A.,	:	I
Hicks,	,	I
J.	,	I
B.	,	I
and	.	I
Fink,	NNP	I
G.	CC	I
R.,	,	I
Proc.	NNP	I
Natl.	,	I
Sci.	.	I
USA,	.	I
75,	.	I
1929	,	I
(1978)).(	,	O
Increase	CD	O
of	.	O
the	NN	O
copy	IN	O
number	DT	O
of	NN	O
the	NN	O
dsbA	IN	O
gene	DT	O
can	JJ	O
also	NN	O
be	MD	O
achieved	RB	O
by	VB	O
introducing	VBN	O
multiple	IN	O
copies	VBG	O
of	JJ	O
the	NNS	O
dsbA	IN	O
gene	DT	O
into	JJ	O
a	NN	O
genomic	IN	O
DNA	DT	O
of	JJ	O
a	NN	O
bacterium.	IN	O
In	DT	O
order	.	O
to	IN	O
introduce	NN	O
multiple	TO	O
copies	VB	O
of	JJ	O
the	NNS	O
dsbA	IN	O
gene	DT	O
into	JJ	O
a	NN	O
genomic	IN	O
DNA	DT	O
of	JJ	O
a	NN	O
bacterium,	IN	O
homologous	DT	O
recombination	,	O
is	JJ	O
carried	NN	O
out	VBZ	O
by	VBN	O
using	RP	O
a	IN	O
sequence	VBG	O
whose	DT	O
multiple	NN	O
copies	WP$	O
are	JJ	O
present	NNS	O
in	VBP	O
the	JJ	O
genomic	IN	O
DNA	DT	O
as	JJ	O
targets.	NNP	O
As	IN	O
sequences	.	O
whose	IN	O
multiple	NNS	O
copies	WP$	O
are	JJ	O
present	NNS	O
in	VBP	O
genomic	JJ	O
DNA,	IN	O
repetitive	JJ	O
DNA,	,	O
and	JJ	O
inverted	,	O
repeats	CC	O
existing	VBD	O
at	NNS	O
the	VBG	O
end	IN	O
of	DT	O
a	NN	O
transposable	IN	O
element	DT	O
can	JJ	O
be	NN	O
used.	MD	O
Another	VB	O
dsbA	.	O
gene	DT	O
can	JJ	O
be	NN	O
introduced	MD	O
aside	VB	O
the	VBN	O
dsbA	IN	O
gene	DT	O
existing	NN	O
on	NN	O
a	VBG	O
genome	IN	O
in	DT	O
tandem,	NN	O
or	IN	O
it	,	O
can	CC	O
be	PRP	O
introduced	MD	O
into	VB	O
an	VBN	O
unnecessary	IN	O
gene	DT	O
on	JJ	O
a	NN	O
genome	IN	O
in	DT	O
a	NN	O
plural	IN	O
number.	DT	O
Such	JJ	O
gene	.	O
transfer	JJ	O
can	NN	O
be	NN	O
attained	MD	O
by	VB	O
using	VBN	O
a	IN	O
temperature	VBG	O
sensitive	DT	O
vector	NN	O
or	JJ	O
an	NN	O
integration	CC	O
vector.	DT	O
Alternatively,	NN	O
as	.	O
disclosed	,	O
in	IN	O
Japanese	VBN	O
Patent	IN	O
Laid-open	JJ	O
No.	NNP	O
2-109985,	NNP	O
it	.	O
is	,	O
also	PRP	O
possible	VBZ	O
to	RB	O
incorporate	JJ	O
the	TO	O
dsbA	VB	O
gene	DT	O
into	NN	O
a	NN	O
transposon,	IN	O
and	DT	O
allow	,	O
it	CC	O
to	VB	O
transfer	PRP	O
to	TO	O
introduce	VB	O
multiple	TO	O
copies	VB	O
of	JJ	O
the	NNS	O
genes	IN	O
into	DT	O
a	NNS	O
genomic	IN	O
DNA.	DT	O
Transfer	JJ	O
of	.	O
the	NN	O
gene	IN	O
to	DT	O
the	NN	O
genome	TO	O
can	DT	O
be	NN	O
confirmed	MD	O
by	VB	O
performing	VBN	O
Southern	IN	O
hybridization	VBG	O
using	JJ	O
a	NN	O
part	VBG	O
of	DT	O
the	NN	O
dsbA	IN	O
gene	DT	O
as	JJ	O
a	NN	O
probe.	IN	O
Furthermore,	DT	O
in	.	O
addition	,	O
to	IN	O
the	NN	O
aforementioned	TO	O
increase	DT	O
of	JJ	O
the	NN	O
gene	IN	O
copy	DT	O
number,	NN	O
expression	NN	O
of	,	O
the	NN	O
dsbA	IN	O
gene	DT	O
can	JJ	O
be	NN	O
enhanced	MD	O
by	VB	O
replacing	VBN	O
an	IN	O
expression	VBG	O
control	DT	O
sequence	NN	O
such	NN	O
as	NN	O
a	JJ	O
promoter	IN	O
of	DT	O
the	NN	O
dsbA	IN	O
gene	DT	O
on	JJ	O
a	NN	O
genome	IN	O
DNA	DT	O
or	JJ	O
plasmid	NN	O
with	CC	O
a	NN	O
stronger	IN	O
one,	DT	O
by	JJR	O
making	,	O
the	IN	O
−35	VBG	O
and	DT	O
−10	NN	O
regions	CC	O
of	JJ	O
the	NNS	O
gene	IN	O
closer	DT	O
to	NN	O
the	NN	O
consensus	TO	O
sequence,	DT	O
by	NN	O
amplifying	,	O
a	IN	O
regulator	VBG	O
that	DT	O
increases	NN	O
expression	WDT	O
of	VBZ	O
the	NN	O
dsbA	IN	O
gene,	DT	O
or	NN	O
by	,	O
deleting	CC	O
or	IN	O
attenuating	VBG	O
a	CC	O
regulator	VBG	O
that	DT	O
decreases	NN	O
expression	WDT	O
of	VBZ	O
the	NN	O
dsbA	IN	O
gene	DT	O
according	NN	O
to	NN	O
the	VBG	O
methods	TO	O
described	DT	O
in	NNS	O
International	VBN	O
Patent	IN	O
Publication	NNP	O
WO00/18935.	NNP	O
For	NNP	O
example,	.	O
the	IN	O
lac	,	O
promoter,	DT	O
trp	NN	O
promoter,	,	O
trc	NN	O
promoter,	,	O
tac	NN	O
promoter,	,	O
araBA	NN	O
promoter,	,	O
lambda	JJ	O
phage	,	O
PR	JJ	O
promoter	NN	O
and	NNP	O
PL	NN	O
promoter,	CC	O
tet	NNP	O
promoter,	,	O
T7	NN	O
promoter,	,	O
Φ10	NNP	O
promoter,	,	O
and	NNP	O
so	,	O
forth	CC	O
are	RB	O
known	JJ	O
as	VBP	O
strong	VBN	O
promoters.	IN	O
Furthermore,	JJ	O
the	.	O
promoter	,	O
of	DT	O
the	NN	O
threonine	IN	O
operon	DT	O
of	NN	O
E.	NN	O
coli	IN	O
can	NNP	O
also	NNS	O
be	MD	O
used.	RB	O
A	VB	O
promoter	.	O
or	DT	O
SD	NN	O
region	CC	O
of	NNP	O
the	NN	O
dsbA	IN	O
gene	DT	O
can	JJ	O
also	NN	O
be	MD	O
modified	RB	O
so	VB	O
as	VBN	O
to	RB	O
become	IN	O
stronger	TO	O
by	VB	O
introducing	JJR	O
a	IN	O
nucleotide	VBG	O
substitution	DT	O
or	JJ	O
the	NN	O
like.	CC	O
Examples	DT	O
of	.	O
methods	NNS	O
for	IN	O
evaluating	NNS	O
strength	IN	O
of	VBG	O
a	NN	O
promoter	IN	O
and	DT	O
strong	NN	O
promoters	CC	O
are	JJ	O
described	NNS	O
in	VBP	O
the	VBN	O
paper	IN	O
of	DT	O
Goldstein	NN	B
et	IN	I
al.	NNP	I
(Prokaryotic	FW	I
promoters	.	I
in	JJ	I
biotechnology,	NNS	I
Biotechnol.	IN	I
Annu.	,	I
Rev.,	.	I
1,	.	I
105-128	,	I
(1995))	,	I
and	CD	O
so	)	O
forth.	CC	O
In	RB	O
addition,	.	O
it	IN	O
is	,	O
known	PRP	O
that	VBZ	O
substitution	VBN	O
of	IN	O
several	NN	O
nucleotides	IN	O
in	JJ	O
a	NNS	O
spacer	IN	O
between	DT	O
the	NN	O
ribosome	IN	O
binding	DT	O
site	NN	O
(RBS)	NN	O
and	NN	O
translation	)	O
initiation	CC	O
codon,	NN	O
especially	NN	O
a	,	O
sequence	RB	O
immediately	DT	O
upstream	NN	O
from	RB	O
the	JJ	O
initiation	IN	O
codon,	DT	O
greatly	NN	O
affects	,	O
mRNA	RB	O
translation	VBZ	O
efficiency,	JJ	O
and	NN	O
therefore	,	O
this	CC	O
sequence	RB	O
can	DT	O
be	NN	O
modified.	MD	O
Expression	VB	O
control	.	O
regions	NNP	O
such	NN	O
as	NNS	O
promoter	JJ	O
of	IN	O
the	NN	O
dsbA	IN	O
gene	DT	O
can	JJ	O
also	NN	O
be	MD	O
identified	RB	O
by	VB	O
using	VBN	O
a	IN	O
promoter	VBG	O
probe	DT	O
vector	NN	O
or	NN	O
gene	NN	O
analysis	CC	O
software	NN	O
such	NN	O
as	NN	O
GENETYX.	JJ	O
By	IN	O
such	.	O
substitution	IN	O
or	JJ	O
modification	NN	O
of	CC	O
promoter	NN	O
as	IN	O
described	NN	O
above,	IN	O
expression	VBN	O
of	,	O
the	NN	O
dsbA	IN	O
gene	DT	O
is	JJ	O
enhanced.	NN	O
Substitution	VBZ	O
of	.	O
an	NN	O
expression	IN	O
control	DT	O
sequence	NN	O
can	NN	O
also	NN	O
be	MD	O
attained	RB	O
by,	VB	O
for	VBN	O
example,	,	O
a	IN	O
method	,	O
using	DT	O
a	NN	O
temperature	VBG	O
sensitive	DT	O
plasmid	NN	O
or	JJ	O
Red-driven	NN	O
integration	CC	O
(WO2005/010175).	JJ	O
The	NN	O
nucleotide	.	O
sequence	DT	O
of	JJ	O
the	NN	O
dsbA	IN	O
gene	DT	O
of	JJ	O
Escherichia	NN	O
coli	IN	O
and	NNP	O
the	NN	O
amino	CC	O
acid	DT	O
sequence	NN	O
encoded	JJ	O
by	NN	O
this	VBN	O
gene	IN	O
are	DT	O
shown	NN	O
in	VBP	O
SEQ	VBN	O
ID	IN	O
NOS:	NNP	O
1	NNP	O
and	:	O
2,	CD	O
respectively.	CC	O
Since	,	O
the	.	O
nucleotide	IN	O
sequence	DT	O
of	JJ	O
the	NN	O
dsbA	IN	O
gene	DT	O
can	JJ	O
be	NN	O
different	MD	O
depending	VB	O
on	JJ	O
species	VBG	O
or	IN	O
strain	NNS	O
of	CC	O
the	NN	O
bacterium,	IN	O
the	DT	O
dsbA	,	O
gene	DT	O
to	NN	O
be	NN	O
modified	TO	O
can	VB	O
be	VBN	O
a	MD	O
variant	VB	O
of	DT	O
the	NN	O
nucleotide	IN	O
sequence	DT	O
of	JJ	O
SEQ	NN	O
ID	IN	O
NO:	NNP	O
1.	NNP	O
Homologues	:	O
of	.	O
DsbA	NNS	O
are	IN	O
known	NNP	O
for	VBP	O
many	VBN	O
bacteria,	IN	O
and	JJ	O
can	,	O
be	CC	O
found	MD	O
by	VB	O
search	VBN	O
of	IN	O
databases.	NN	O
When	IN	O
proteins	.	O
highly	WRB	O
homologous	VBZ	O
to	RB	O
the	JJ	O
DsbA	TO	O
protein	DT	O
of	NNP	O
the	NN	O
E.	IN	O
coli	DT	O
K-12	NNP	O
strain	NNS	O
are	NNP	O
searched	NN	O
for	VBP	O
on	VBN	O
the	IN	O
basis	IN	O
of	DT	O
sequence	NN	O
information,	IN	O
the	NN	O
search	,	O
can	DT	O
be	NN	O
performed	MD	O
as,	VB	O
for	VBN	O
example,	,	O
BLAST	IN	O
search	,	O
(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi).	NNP	O
Furthermore,	NN	O
when	.	O
homologues	,	O
are	WRB	O
searched	NNS	O
for	VBP	O
with	VBN	O
a	IN	O
keyword,	IN	O
if	DT	O
the	,	O
search	IN	O
engine	DT	O
of	NN	O
Entrez	NN	O
(http://www.ncbi.nlm.nih.gov/sites/gquery)	IN	O
is	NNP	O
used,	)	O
and	VBZ	O
a	,	O
term	CC	O
“dsbA”	DT	O
or	NN	O
“outer	NN	O
membrane	CC	O
channel	NN	O
protein”	NN	O
is	NN	O
inputted	NN	O
as	VBZ	O
a	VBN	O
keyword,	IN	O
for	DT	O
example,	,	O
candidate	IN	O
sequences	,	O
are	NN	O
retrieved	NNS	O
from	VBP	O
plural	VBN	O
databases.	IN	O
By	JJ	O
scrutinizing	.	O
these	IN	O
candidates,	VBG	O
objective	DT	O
homologue	,	O
sequences	JJ	O
can	NN	O
be	NNS	O
found.	MD	O
Among	VB	O
the	.	O
many	IN	O
DsbA	DT	O
homologues	JJ	O
found	NNP	O
by	NNS	O
such	VBN	O
a	IN	O
method,	JJ	O
nucleotide	DT	O
sequences	,	O
of	JJ	O
genes	NNS	O
and	IN	O
amino	NNS	O
acid	CC	O
sequences	NN	O
of	JJ	O
DsbA	NNS	O
homologues	IN	O
of	NNP	O
the	NNS	O
following	IN	O
bacteria	DT	O
are	JJ	O
shown	NNS	O
in	VBP	O
SEQ	VBN	O
ID	IN	O
NOS:	NNP	O
3	NNP	O
to	:	O
12.	CD	O
The	TO	O
accession	.	O
numbers	DT	O
in	NN	O
the	NNS	O
NCBI	IN	O
(National	DT	O
Center	NNP	O
for	NNP	O
Biotechnology	NNP	O
Information)	IN	O
database	NNP	O
and	)	O
identity	NN	O
(%)	CC	O
with	NN	O
respect	)	O
to	IN	O
the	NN	O
amino	TO	O
acid	DT	O
sequence	NN	O
of	JJ	O
SEQ	NN	O
ID	IN	O
NO:	NNP	O
2	NNP	O
are	:	O
shown	CD	O
in	VBP	O
the	VBN	O
parentheses.	IN	O
Shigella	DT	O
flexneri	.	O
301	NNP	O
(serotype	VBD	O
2a)	CD	O
(KEGG	JJ	O
Entry	)	O
Name:	NNP	O
SF3931,	NNP	O
99.5%)	:	O
Klebsiella	,	O
pneumoniae	)	O
subsp.	NNP	O
pneumoniae	NN	O
MGH	.	O
78578	NN	O
(KEGG	NNP	O
Entry	CD	O
Name:	NNP	O
KPN—04170,	NNP	O
81.2%)	:	O
Yersinia	,	O
enterocolitica	)	O
subsp.	NNP	O
enterocolitica	NN	O
8081	.	O
(KEGG	NN	O
Entry	CD	O
Name:	NNP	O
YE0020,	NNP	O
70.7%)	:	O
Photorhabdus	,	O
luminescens	)	O
subsp.	NNP	O
laumondii	VBZ	O
TTO1	.	O
(KEGG	NN	O
Entry	NNP	O
Name:	NNP	O
p1u0381,	NNP	O
60.1%)	:	O
Pasteurella	,	O
multocida	)	O
PM70	NNP	O
(KEGG	NN	O
Entry	NNP	O
Name:	NNP	O
PM1801,	NNP	O
48.1%)	:	O
The	,	O
dsbA	)	O
gene	DT	O
can	JJ	O
also	NN	O
encode	MD	O
a	RB	O
protein	VB	O
having	DT	O
a	NN	O
sequence	VBG	O
corresponding	DT	O
to	NN	O
the	VBG	O
amino	TO	O
acid	DT	O
sequence	NN	O
of	JJ	O
the	NN	O
aforementioned	IN	O
DsbA	DT	O
protein	JJ	O
or	NNP	O
DsbA	NN	O
homologue,	CC	O
such	NNP	O
as	,	O
the	JJ	O
amino	IN	O
acid	DT	O
sequences	NN	O
of	JJ	O
SEQ	NNS	O
ID	IN	O
NOS:	NNP	O
2,	NNP	O
4,	:	O
6,	,	O
8,	,	O
10	,	O
and	,	O
12,	CD	O
but	CC	O
which	,	O
include	CC	O
substitutions,	WDT	O
deletions,	VBP	O
insertions,	,	O
additions	,	O
or	,	O
the	NNS	O
like	CC	O
of	DT	O
one	IN	O
or	IN	O
several	CD	O
amino	CC	O
acid	JJ	O
residues	NN	O
at	NN	O
one	NNS	O
or	IN	O
several	CD	O
positions.	CC	O
Although	JJ	O
the	.	O
number	IN	O
of	DT	O
the	NN	O
“one	IN	O
or	DT	O
several”	NN	O
amino	CC	O
acid	NN	O
residues	NN	O
can	IN	O
differ	NNS	O
depending	MD	O
on	VB	O
their	VBG	O
position	IN	O
in	PRP$	O
the	NN	O
three-dimensional	IN	O
structure	DT	O
or	JJ	O
the	NN	O
types	CC	O
of	DT	O
amino	NNS	O
acid	IN	O
residues	NN	O
of	NN	O
the	NNS	O
proteins,	IN	O
it	DT	O
can	,	O
be	PRP	O
1	MD	O
to	VB	O
20,	CD	O
1	TO	O
to	,	O
10,	CD	O
or	TO	O
even	,	O
1	CC	O
to	RB	O
5.	CD	O
These	TO	O
substitutions,	.	O
deletions,	DT	O
insertions,	,	O
or	,	O
additions	,	O
of	CC	O
one	NNS	O
or	IN	O
several	CD	O
amino	CC	O
acid	JJ	O
residues	NN	O
can	IN	O
be	NNS	O
conservative	MD	O
mutations	VB	O
so	JJ	O
that	NNS	O
the	IN	O
function	IN	O
of	DT	O
the	NN	O
protein	IN	O
is	DT	O
maintained.	NN	O
A	VBZ	O
conservative	.	O
mutation	DT	O
is	JJ	O
a	NN	O
mutation	VBZ	O
wherein	DT	O
substitution	NN	O
takes	NN	O
place	NN	O
mutually	VBZ	O
among	NN	O
Phe,	RB	O
Trp	IN	O
and	,	O
Tyr,	NNP	O
if	CC	O
the	,	O
substitution	IN	O
site	DT	O
is	NN	O
an	NN	O
aromatic	VBZ	O
amino	DT	O
acid;	JJ	O
among	NN	O
Leu,	:	O
Ile	IN	O
and	,	O
Val,	NNP	O
if	CC	O
the	,	O
substitution	IN	O
site	DT	O
is	NN	O
a	NN	O
hydrophobic	VBZ	O
amino	DT	O
acid;	JJ	O
between	NN	O
Gln	:	O
and	IN	O
Asn,	NNP	O
if	CC	O
it	,	O
is	IN	O
a	PRP	O
polar	VBZ	O
amino	DT	O
acid;	JJ	O
among	NN	O
Lys,	:	O
Arg	IN	O
and	,	O
His,	NNP	O
if	CC	O
it	,	O
is	IN	O
a	PRP	O
basic	VBZ	O
amino	DT	O
acid;	JJ	O
between	NN	O
Asp	:	O
and	IN	O
Glu,	NNP	O
if	CC	O
it	,	O
is	IN	O
an	PRP	O
acidic	VBZ	O
amino	DT	O
acid;	JJ	O
and	NN	O
between	:	O
Ser	CC	O
and	IN	O
Thr,	NNP	O
if	CC	O
it	,	O
is	IN	O
an	PRP	O
amino	VBZ	O
acid	DT	O
having	NN	O
a	NN	O
hydroxyl	VBG	O
group.	DT	O
Typical	NN	O
examples	.	O
of	JJ	O
conservative	NNS	O
mutations	IN	O
are	JJ	O
conservative	NNS	O
substitutions.	VBP	O
Specific	JJ	O
examples	.	O
of	JJ	O
conservative	NNS	O
substitutions	IN	O
include:	JJ	O
substitution	NNS	O
of	:	O
Ser	NN	O
or	IN	O
Thr	NNP	O
for	CC	O
Ala;	NNP	O
substitution	IN	O
of	:	O
Gln,	NN	O
His	IN	O
or	,	O
Lys	PRP$	O
for	CC	O
Arg;	NNP	O
substitution	IN	O
of	:	O
Glu,	NN	O
Gln,	IN	O
Lys,	,	O
His	,	O
or	,	O
Asp	PRP$	O
for	CC	O
Asn;	NNP	O
substitution	IN	O
of	:	O
Asn,	NN	O
Glu	IN	O
or	,	O
Gln	NNP	O
for	CC	O
Asp;	NNP	O
substitution	IN	O
of	:	O
Ser	NN	O
or	IN	O
Ala	NNP	O
for	CC	O
Cys;	NNP	O
substitution	IN	O
of	:	O
Asn,	NN	O
Glu,	IN	O
Lys,	,	O
His,	,	O
Asp	,	O
or	,	O
Arg	NNP	O
for	CC	O
Gln;	NNP	O
substitution	IN	O
of	:	O
Gly,	NN	O
Asn,	IN	O
Gln,	,	O
Lys	,	O
or	,	O
Asp	NNP	O
for	CC	O
Glu;	NNP	O
substitution	IN	O
of	:	O
Pro	NN	O
for	IN	O
Gly;	NNP	O
substitution	IN	O
of	:	O
Asn,	NN	O
Lys,	IN	O
Gln,	,	O
Arg	,	O
or	,	O
Tyr	NNP	O
for	CC	O
His;	NNP	O
substitution	IN	O
of	:	O
Leu,	NN	O
Met,	IN	O
Val	,	O
or	,	O
Phe	NNP	O
for	CC	O
Ile;	NNP	O
substitution	IN	O
of	:	O
Ile,	NN	O
Met,	IN	O
Val	,	O
or	,	O
Phe	NNP	O
for	CC	O
Leu;	NNP	O
substitution	IN	O
of	:	O
Asn,	NN	O
Glu,	IN	O
Gln,	,	O
His	,	O
or	,	O
Arg	PRP$	O
for	CC	O
Lys;	NNP	O
substitution	IN	O
of	:	O
Ile,	NN	O
Leu,	IN	O
Val	,	O
or	,	O
Phe	NNP	O
for	CC	O
Met;	NNP	O
substitution	IN	O
of	:	O
Trp,	NN	O
Tyr,	IN	O
Met,	,	O
Ile	,	O
or	,	O
Leu	NNP	O
for	CC	O
Phe;	NNP	O
substitution	IN	O
of	:	O
Thr	NN	O
or	IN	O
Ala	NNP	O
for	CC	O
Ser;	NNP	O
substitution	IN	O
of	:	O
Ser	NN	O
or	IN	O
Ala	NNP	O
for	CC	O
Thr;	NNP	O
substitution	IN	O
of	:	O
Phe	NN	O
or	IN	O
Tyr	NNP	O
for	CC	O
Trp;	NNP	O
substitution	IN	O
of	:	O
His,	NN	O
Phe	IN	O
or	,	O
Trp	NNP	O
for	CC	O
Tyr;	NNP	O
and	IN	O
substitution	:	O
of	CC	O
Met,	NN	O
Ile	IN	O
or	,	O
Leu	NNP	O
for	CC	O
Val.	NNP	O
The	IN	O
above-mentioned	.	O
amino	DT	O
acid	JJ	O
substitution,	NN	O
deletion,	NN	O
insertion,	,	O
addition,	,	O
inversion	,	O
etc.	,	O
can	NN	O
be	.	O
a	MD	O
result	VB	O
of	DT	O
a	NN	O
naturally-occurring	IN	O
mutation	DT	O
or	JJ	O
variation	NN	O
due	CC	O
to	NN	O
an	JJ	O
individual	TO	O
difference	DT	O
or	JJ	O
a	NN	O
difference	CC	O
of	DT	O
species	NN	O
of	IN	O
a	NNS	O
microorganism	IN	O
as	DT	O
an	NN	O
origin	IN	O
of	DT	O
gene	NN	O
(mutant	IN	O
or	NN	O
variant).	JJ	O
Furthermore,	CC	O
the	.	O
gene	,	O
having	DT	O
such	NN	O
a	VBG	O
conservative	JJ	O
mutation	DT	O
as	JJ	O
mentioned	NN	O
above	IN	O
can	VBN	O
be	IN	O
a	MD	O
gene	VB	O
encoding	DT	O
a	NN	O
protein	VBG	O
which	DT	O
has	NN	O
a	WDT	O
homology	VBZ	O
of	DT	O
80%	NN	O
or	IN	O
more,	NN	O
90%	CC	O
or	,	O
more,	NN	O
95%	CC	O
or	,	O
more,	NN	O
97%	CC	O
or	,	O
more,	NN	O
98%	CC	O
or	,	O
more,	NN	O
or	CC	O
even	,	O
99%	CC	O
or	RB	O
more,	NN	O
to	CC	O
the	,	O
entire	TO	O
encoded	DT	O
amino	JJ	O
acid	VBD	O
sequence,	NN	O
and	NN	O
which	,	O
has	CC	O
a	WDT	O
function	VBZ	O
equivalent	DT	O
to	NN	O
that	NN	O
of	TO	O
a	DT	O
wild-type	IN	O
DsbA	DT	O
protein.	JJ	O
In	NNP	O
the	.	O
present	IN	O
specification,	DT	O
the	JJ	O
term	,	O
“homology”	DT	O
can	NN	O
mean	NN	O
“identity”.	MD	O
The	VB	O
dsbA	.	O
gene	DT	O
can	JJ	O
be	NN	O
a	MD	O
DNA	VB	O
which	DT	O
hybridizes	NN	O
with	WDT	O
a	VBZ	O
probe	IN	O
prepared	DT	O
from	NN	O
known	VBN	O
gene	IN	O
sequences,	VBN	O
for	NN	O
example,	,	O
the	IN	O
aforementioned	,	O
nucleotide	DT	O
sequence	JJ	O
of	JJ	O
the	NN	O
dsbA	IN	O
gene	DT	O
or	JJ	O
the	NN	O
dsbA	CC	O
gene	DT	O
homologues,	JJ	O
such	NN	O
as	,	O
the	JJ	O
sequence	IN	O
of	DT	O
SEQ	NN	O
ID	IN	O
NOS:	NNP	O
1,	NNP	O
5,	:	O
7,	,	O
9	,	O
or	,	O
11,	CD	O
or	CC	O
sequences	,	O
complementary	CC	O
to	NNS	O
the	JJ	O
sequences	TO	O
under	DT	O
stringent	NNS	O
conditions	IN	O
and	JJ	O
which	NNS	O
encodes	CC	O
a	WDT	O
protein	VBZ	O
which	DT	O
is	NN	O
a	WDT	O
functionally	VBZ	O
equivalent	DT	O
to	RB	O
the	JJ	O
DsbA	TO	O
protein.	DT	O
The	NNP	O
term	.	O
“stringent	DT	O
conditions”	NN	O
refers	NNP	O
to	NN	O
conditions	NNS	O
where	TO	O
a	NNS	O
so-called	WRB	O
specific	DT	O
hybrid	JJ	O
is	JJ	O
formed	NN	O
and	VBZ	O
a	VBN	O
non-specific	CC	O
hybrid	DT	O
is	JJ	O
not	NN	O
formed.	VBZ	O
Examples	RB	O
thereof	.	O
include	NNS	O
conditions	VBP	O
where	VBP	O
DNAs	NNS	O
having	WRB	O
high	NNP	O
homology,	VBG	O
for	JJ	O
example,	,	O
at	IN	O
least	,	O
80%,	IN	O
90%,	JJS	O
95%,	,	O
97%,	,	O
98%,	,	O
or	,	O
even	,	O
99%	CC	O
homology,	RB	O
hybridize	NN	O
with	,	O
each	VB	O
other	IN	O
and	DT	O
DNAs	JJ	O
having	CC	O
homology	NNP	O
less	VBG	O
than	NN	O
the	JJR	O
value	IN	O
do	DT	O
not	NN	O
hybridize	VBP	O
with	RB	O
each	VB	O
other;	IN	O
and	DT	O
specifically	:	O
include	CC	O
conditions	RB	O
corresponding	VBP	O
to	NNS	O
a	VBG	O
salt	TO	O
concentration	DT	O
and	NN	O
temperature	NN	O
of	CC	O
washing	NN	O
which	IN	O
are	VBG	O
typical	WDT	O
of	VBP	O
Southern	JJ	O
hybridization,	IN	O
that	JJ	O
is,	,	O
washing	WDT	O
once	,	O
or	VBG	O
2	RB	O
or	CC	O
3	CD	O
times,	CC	O
at	CD	O
a	,	O
salt	IN	O
concentration	DT	O
and	NN	O
temperature	NN	O
corresponding	CC	O
to	NN	O
1×SSC,	VBG	O
0.1%	TO	O
SDS	,	O
at	NN	O
60°	NNP	O
C.,	IN	O
0.1×SSC,	CD	O
0.1%	,	O
SDS	,	O
at	NN	O
60°	NNP	O
C.,	IN	O
or	CD	O
0.1×SSC,	,	O
0.1%	CC	O
SDS	,	O
at	NN	O
68°	NNP	O
C.	IN	O
The	CD	O
probe	NNP	O
can	DT	O
be	NN	O
a	MD	O
partial	VB	O
sequence	DT	O
of	JJ	O
a	NN	O
complementary	IN	O
sequence	DT	O
of	JJ	O
the	NN	O
gene.	IN	O
Such	DT	O
a	.	O
probe	JJ	O
can	DT	O
be	NN	O
prepared	MD	O
by	VB	O
PCR	VBN	O
using	IN	O
oligonucleotides	NNP	O
prepared	VBG	O
based	NNS	O
on	VBD	O
the	VBN	O
known	IN	O
nucleotide	DT	O
sequences	VBN	O
of	JJ	O
genes	NNS	O
as	IN	O
primers,	NNS	O
and	IN	O
a	,	O
DNA	CC	O
fragment	DT	O
containing	NNP	O
these	NN	O
sequences	VBG	O
as	DT	O
the	NNS	O
template.	IN	O
When	DT	O
a	.	O
DNA	WRB	O
fragment	DT	O
of	NNP	O
a	NN	O
length	IN	O
of	DT	O
about	NN	O
300	IN	O
by	IN	O
is	CD	O
used	IN	O
as	VBZ	O
the	VBN	O
probe,	IN	O
the	DT	O
conditions	,	O
of	DT	O
washing	NNS	O
after	IN	O
hybridization	VBG	O
can	IN	O
be,	NN	O
for	MD	O
example,	,	O
50°	IN	O
C.,	,	O
2×SSC,	CD	O
and	,	O
0.1%	,	O
SDS.	CC	O
The	NN	O
above	.	O
descriptions	DT	O
about	JJ	O
variants	NNS	O
of	IN	O
genes	NNS	O
and	IN	O
proteins	NNS	O
are	CC	O
similarly	NNS	O
applied	VBP	O
to	RB	O
enzymes	VBN	O
such	TO	O
as	NNS	O
serine	JJ	O
acetyltransferase	IN	O
and	JJ	O
cysteine	NN	O
desulfhydrase,	CC	O
the	NN	O
YdeD	,	O
protein,	DT	O
and	NNP	O
the	,	O
genes	CC	O
that	DT	O
code	NNS	O
for	WDT	O
them.	VBP	O
<2>	IN	O
Method	.	O
for	NNS	O
Producing	NNP	O
L-cysteine,	IN	O
L-cystine,	VBG	O
Derivatives	,	O
or	,	O
Precursors	VBZ	O
Thereof	CC	O
or	NNPS	O
Mixture	NNP	O
Thereof	CC	O
These	NNP	O
compounds	NNP	O
can	DT	O
be	NNS	O
produced	MD	O
by	VB	O
culturing	VBN	O
the	IN	O
bacterium	VBG	O
obtained	DT	O
as	NN	O
described	VBN	O
above	IN	O
in	VBN	O
a	IN	O
medium,	IN	O
and	DT	O
collecting	,	O
L-cysteine,	CC	O
L-cystine,	VBG	O
derivatives	,	O
or	,	O
precursors	VBZ	O
thereof	CC	O
or	NNS	O
a	VBP	O
mixture	CC	O
thereof	DT	O
from	NN	O
the	NN	O
medium.	IN	O
Examples	DT	O
of	.	O
a	NNS	O
derivative	IN	O
or	DT	O
precursor	JJ	O
of	CC	O
L-cysteine	NN	O
include	IN	O
S-sulfocysteine,	NNP	O
a	VBP	O
thiazolidine	,	O
derivative,	DT	O
a	NN	O
hemithioketal	,	O
corresponding	DT	O
the	JJ	O
thiazolidine	VBG	O
derivative	DT	O
mentioned	NN	O
above,	JJ	O
O-acetylserine,	VBN	O
N-acetylserine,	,	O
and	,	O
so	,	O
forth.	CC	O
Examples	RB	O
of	.	O
the	NNS	O
medium	IN	O
used	DT	O
for	NN	O
the	VBN	O
culture	IN	O
can	DT	O
include	NN	O
ordinary	MD	O
media	VB	O
containing	JJ	O
a	NNS	O
carbon	VBG	O
source,	DT	O
nitrogen	NN	O
source,	,	O
sulfur	NN	O
source,	,	O
inorganic	NN	O
ions,	,	O
and	JJ	O
other	,	O
organic	CC	O
components	JJ	O
as	JJ	O
required.	NNS	O
As	IN	O
the	.	O
carbon	IN	O
source,	DT	O
saccharides	NN	O
such	,	O
as	NNS	O
glucose,	JJ	O
fructose,	IN	O
sucrose,	,	O
molasses	,	O
and	,	O
starch	NNS	O
hydrolysate,	CC	O
and	NN	O
organic	,	O
acids	CC	O
such	JJ	O
as	NNS	O
fumaric	JJ	O
acid,	IN	O
citric	JJ	O
acid	,	O
and	JJ	O
succinic	NN	O
acid	CC	O
can	JJ	O
be	NN	O
used.	MD	O
As	VB	O
the	.	O
nitrogen	IN	O
source,	DT	O
inorganic	NN	O
ammonium	,	O
salts	JJ	O
such	NN	O
as	NNS	O
ammonium	JJ	O
sulfate,	IN	O
ammonium	NN	O
chloride	,	O
and	NN	O
ammonium	NN	O
phosphate,	CC	O
organic	NN	O
nitrogen	,	O
such	JJ	O
as	NN	O
soybean	JJ	O
hydrolysate,	IN	O
ammonia	JJ	O
gas,	,	O
aqueous	NN	O
ammonia	,	O
and	JJ	O
so	NN	O
forth	CC	O
can	RB	O
be	JJ	O
used.	MD	O
As	VB	O
the	.	O
sulfur	IN	O
source,	DT	O
inorganic	NN	O
sulfur	,	O
compounds,	JJ	O
such	NN	O
as	,	O
sulfates,	JJ	O
sulfites,	IN	O
sulfides,	,	O
hyposulfites	,	O
and	,	O
thiosulfates	NNS	O
can	CC	O
be	NNS	O
used.	MD	O
As	VB	O
organic	.	O
trace	IN	O
amount	JJ	O
nutrients,	NN	O
it	NN	O
is	,	O
desirable	PRP	O
to	VBZ	O
add	JJ	O
required	TO	O
substances	VB	O
such	JJ	O
as	NNS	O
vitamin	JJ	O
B1,	IN	O
yeast	NN	O
extract	,	O
and	NNP	O
so	NN	O
forth	CC	O
in	RB	O
appropriate	JJ	O
amounts.	IN	O
Other	JJ	O
than	.	O
these,	JJ	O
potassium	IN	O
phosphate,	,	O
magnesium	NN	O
sulfate,	,	O
iron	NN	O
ions,	,	O
manganese	NN	O
ions	,	O
and	JJ	O
so	NNS	O
forth	CC	O
are	RB	O
added	JJ	O
in	VBP	O
small	VBN	O
amounts.	IN	O
The	JJ	O
culture	.	O
can	DT	O
be	NN	O
performed	MD	O
under	VB	O
aerobic	VBN	O
conditions	IN	O
for	JJ	O
30	NNS	O
to	IN	O
90	CD	O
hours.	TO	O
The	CD	O
culture	.	O
temperature	DT	O
can	NN	O
be	NN	O
controlled	MD	O
to	VB	O
be	VBN	O
25°	TO	O
C.	VB	O
to	CD	O
37°	NNP	O
C.,	TO	O
and	CD	O
the	,	O
pH	CC	O
can	DT	O
be	NN	O
controlled	MD	O
to	VB	O
be	VBN	O
5	TO	O
to	VB	O
8	CD	O
during	TO	O
the	CD	O
culture.	IN	O
To	DT	O
adjust	.	O
the	TO	O
pH,	VB	O
inorganic	DT	O
or	,	O
organic	JJ	O
acidic	CC	O
or	JJ	O
alkaline	NN	O
substances,	CC	O
ammonia	NN	O
gas	,	O
and	NN	O
so	NN	O
forth	CC	O
can	RB	O
be	JJ	O
used.	MD	O
Collection	VB	O
of	.	O
L-cysteine	NN	O
from	IN	O
the	NNP	O
culture	IN	O
can	DT	O
be	NN	O
attained	MD	O
by,	VB	O
for	VBN	O
example,	,	O
any	IN	O
combination	,	O
of	DT	O
known	NN	O
ion	IN	O
exchange	VBN	O
resin	NN	O
methods,	NN	O
precipitation,	NN	O
and	,	O
other	,	O
known	CC	O
methods.	JJ	O
L-cysteine	VBN	O
obtained	.	O
as	JJ	O
described	VBN	O
above	IN	O
can	VBN	O
be	IN	O
used	MD	O
to	VB	O
produce	VBN	O
L-cysteine	TO	O
derivatives.	VB	O
The	JJ	O
cysteine	.	O
derivatives	DT	O
include	NN	O
methylcysteine,	NNS	O
ethylcysteine,	VBP	O
carbocysteine,	,	O
sulfocysteine,	,	O
acetylcysteine,	,	O
and	,	O
so	,	O
forth.	CC	O
Furthermore,	RB	O
when	.	O
a	,	O
thiazolidine	WRB	O
derivative	DT	O
of	JJ	O
L-cysteine	NN	O
is	IN	O
produced	NNP	O
in	VBZ	O
the	VBN	O
medium,	IN	O
L-cysteine	DT	O
can	,	O
be	NNP	O
produced	MD	O
by	VB	O
collecting	VBN	O
the	IN	O
thiazolidine	VBG	O
derivative	DT	O
from	NN	O
the	NN	O
medium	IN	O
to	DT	O
break	NN	O
the	TO	O
reaction	VB	O
equilibrium	DT	O
between	NN	O
the	NN	O
thiazolidine	IN	O
derivative	DT	O
and	NN	O
L-cysteine	JJ	O
so	CC	O
that	NNP	O
L-cysteine	IN	O
is	IN	O
excessively	NNP	O
produced.	VBZ	O
Furthermore,	RB	O
when	.	O
S-sulfocysteine	,	O
is	WRB	O
produced	NN	O
in	VBZ	O
the	VBN	O
medium,	IN	O
it	DT	O
can	,	O
be	PRP	O
converted	MD	O
into	VB	O
L-cysteine	VBN	O
by	IN	O
reduction	JJ	O
with	IN	O
a	NN	O
reducing	IN	O
agent	DT	O
such	VBG	O
as	NN	O
dithiothreitol.	JJ	O
EXAMPLES	IN	O
Hereinafter,	.	O
the	NNP	O
present	,	O
invention	DT	O
will	JJ	O
be	NN	O
explained	MD	O
more	VB	O
specifically	VBN	O
with	RBR	O
reference	RB	O
to	IN	O
the	NN	O
following	TO	O
non-limiting	DT	O
examples.	JJ	O
In	JJ	O
the	.	O
following	IN	O
descriptions,	DT	O
cysteine	JJ	O
means	,	O
L-cysteine.	NN	O
(1)	VBZ	O
Screening	.	O
of	)	O
Clones	NN	O
Showing	IN	O
Cysteine	NNP	O
Sensitivity	NNP	O
In	NNP	O
order	NNP	O
to	IN	O
comprehensively	NN	O
search	TO	O
for	RB	O
genes	VB	O
participating	IN	O
in	NNS	O
cysteine	VBG	O
resistance,	IN	O
the	NN	O
Keio	,	O
collection	DT	O
(single	NNP	O
gene-knock	NN	O
out	JJ	O
library	NN	O
except	IN	O
for	JJ	O
essential	IN	O
genes	IN	O
of	JJ	O
E.	NNS	O
coli	IN	O
BW25113,	NNP	O
Baba,	NNS	B
T,	,	I
et	,	I
al.,	,	I
2006,	FW	I
Mol.	,	I
Syst.	,	I
Biol.,	.	I
2:2006.0008)	.	I
was	,	O
screened	)	O
for	VBD	O
clones	VBN	O
showing	IN	O
sensitivity	NNS	O
to	VBG	O
cysteine.	NN	O
(1-1)	TO	O
Screening	.	O
of	)	O
Keio	NN	O
Collection	IN	O
for	NNP	O
Clones	NNP	O
Showing	IN	O
Cysteine	NNP	O
Sensitivity	NNP	O
The	NNP	O
3,985	NNP	O
clones	DT	O
of	CD	O
the	NNS	O
Keio	IN	O
collection	DT	O
were	NNP	O
cultured	NN	O
at	VBD	O
37°	VBN	O
C.	IN	O
for	CD	O
15	NNP	O
hours	IN	O
in	CD	O
0.5	NNS	O
ml	IN	O
of	CD	O
LB	NN	O
liquid	IN	O
medium.	NNP	O
This	JJ	O
culture	.	O
medium	DT	O
was	NN	O
stamped	NN	O
on	VBD	O
LB	VBN	O
agar	IN	O
media	NNP	O
containing	JJ	O
cysteine	NNS	O
at	VBG	O
different	NN	O
concentrations	IN	O
(0,	JJ	O
15,	NNS	O
20,	,	O
25	,	O
mM),	,	O
and	CD	O
culture	,	O
was	CC	O
performed	NN	O
overnight	VBD	O
at	VBN	O
37°	RB	O
C.	IN	O
Clones	CD	O
that	NNP	O
were	NNS	O
cysteine	WDT	O
sensitive	VBD	O
at	JJ	O
the	JJ	O
growth	IN	O
inhibition	DT	O
concentration	NN	O
of	NN	O
cysteine	NN	O
for	IN	O
wild-type	NN	O
strains	IN	O
(20	JJ	O
mM)	NNS	O
were	CD	O
visually	)	O
selected.	VBD	O
Specifically,	RB	O
clones	.	O
that	,	O
did	NNS	O
not	WDT	O
form	VBD	O
colonies	RB	O
on	VB	O
the	NNS	O
LB	IN	O
plate	DT	O
containing	NNP	O
15	NN	O
mM	VBG	O
cysteine	CD	O
were	JJ	O
selected	NN	O
as	VBD	O
candidates.	VBN	O
A	IN	O
dsbA	.	O
gene-deficient	DT	O
strain	JJ	O
was	JJ	O
obtained	NN	O
as	VBD	O
a	VBN	O
clone	IN	O
showing	DT	O
particularly	NN	O
strong	VBG	O
and	RB	O
distinctive	JJ	O
cysteine	CC	O
sensitivity	JJ	O
among	NN	O
the	NN	O
above	IN	O
candidates.	DT	O
DsbA	JJ	O
localizes	.	O
in	NNP	O
the	VBZ	O
periplasm,	IN	O
and	DT	O
forms	,	O
disulfide	CC	O
bond	NNS	O
(S—S	VBP	O
bond)	NN	O
in	NNP	O
a	)	O
substrate	IN	O
protein	DT	O
by	NN	O
utilizing	NN	O
the	IN	O
oxidized	VBG	O
state	DT	O
(—S—S—)	JJ	O
and	NN	O
the	)	O
reduced	CC	O
state	DT	O
(—SH/—SH)	JJ	O
of	NN	O
two	)	O
cysteine	IN	O
residues	CD	O
of	NN	O
DsbA	NNS	O
itself	IN	O
to	NNP	O
induce	PRP	O
folding	TO	O
of	VB	O
the	NN	O
substrate	IN	O
protein.	DT	O
At	NN	O
the	.	O
time	IN	O
of	DT	O
the	NN	O
S—S	IN	O
bond	DT	O
formation	NNP	O
of	NN	O
the	NN	O
substrate	IN	O
protein,	DT	O
the	NN	O
cysteine	,	O
residues	DT	O
of	NN	O
DsbA	NNS	O
changes	IN	O
from	NNP	O
those	NNS	O
of	IN	O
the	DT	O
oxidized	IN	O
type	DT	O
(—S—S—)	JJ	O
into	NN	O
the	)	O
reduced	IN	O
type	DT	O
(—SH/—SH).	VBN	O
As	NN	O
a	.	O
protein	IN	O
that	DT	O
recycles	NN	O
the	WDT	O
reduced	VBZ	O
type	DT	O
DsbA	JJ	O
produced	NN	O
as	NNP	O
described	VBD	O
above	IN	O
into	VBN	O
the	IN	O
oxidized	IN	O
type,	DT	O
DsbB	JJ	O
is	,	O
known.	NNP	O
It	VBZ	O
was	.	O
elucidated	PRP	O
that	VBD	O
the	VBN	O
electrons	IN	O
received	DT	O
by	NNS	O
DsbB	VBN	O
are	IN	O
transferred	NNP	O
to	VBP	O
ubiquinone	VBN	O
(UQ),	TO	O
which	VB	O
is	,	O
a	WDT	O
respiratory	VBZ	O
chain	DT	O
component,	NN	O
and	NN	O
oxygen	,	O
finally	CC	O
serves	NN	O
as	RB	O
an	VBZ	O
electron	IN	O
acceptor	DT	O
with	NN	O
the	NN	O
aid	IN	O
of	DT	O
cytochrome	NN	O
oxidase.	IN	O
Therefore,	JJ	O
a	.	O
series	,	O
of	DT	O
these	NN	O
DsbA,	IN	O
DsbB,	DT	O
and	,	O
the	,	O
respiratory	CC	O
chain	DT	O
system	NN	O
play	NN	O
a	NN	O
role	VB	O
of	DT	O
performing	NN	O
the	IN	O
oxidative	VBG	O
crosslinking	DT	O
reaction	JJ	O
of	NN	O
cysteine	NN	O
residues	IN	O
on	NN	O
a	NNS	O
substrate	IN	O
protein.	DT	O
Although	NN	O
it	.	O
was	IN	O
known	PRP	O
that	VBD	O
the	VBN	O
cysteine	IN	O
residues	DT	O
in	NN	O
a	VBZ	O
protein	IN	O
were	DT	O
used	NN	O
as	VBD	O
a	VBN	O
substrate	IN	O
as	DT	O
described	NN	O
above,	IN	O
it	VBN	O
was	,	O
unpredictable	PRP	O
that	VBD	O
the	JJ	O
addition	IN	O
of	DT	O
a	NN	O
low	IN	O
molecule	DT	O
cysteine	JJ	O
itself	NN	O
had	NN	O
a	PRP	O
certain	VBD	O
influence	DT	O
on	JJ	O
that	NN	O
system.	IN	O
(1-2)	DT	O
Cysteine	.	O
Sensitivity	)	O
Induced	NNP	O
by	NNP	O
dsbA	NNP	O
Gene	IN	O
Deficiency	JJ	O
Since	NNP	O
a	NNP	O
dsbA-deficient	IN	O
strain	DT	O
was	JJ	O
obtained	NN	O
by	VBD	O
the	VBN	O
screening	IN	O
of	DT	O
the	NN	O
Keio	IN	O
Collection,	DT	O
growth	NNP	O
of	,	O
the	NN	O
gene-deficient	IN	O
strain	DT	O
was	JJ	O
observed	NN	O
on	VBD	O
the	VBN	O
agar	IN	O
medium	DT	O
containing	NN	O
cysteine	NN	O
of	VBG	O
different	NN	O
concentrations	IN	O
in	JJ	O
order	NNS	O
to	IN	O
analyze	NN	O
the	TO	O
sensitivity	VB	O
of	DT	O
that	NN	O
strain	IN	O
to	DT	O
cysteine	NN	O
in	TO	O
more	VB	O
detail.	IN	O
Furthermore,	JJR	O
as	.	O
for	,	O
the	IN	O
to/C	IN	O
gene	DT	O
(Japanese	JJ	O
Patent	NN	O
Application	JJ	O
No.	NNP	O
2008-040167,	NNP	O
Wiriyathanawudhiwong,	.	O
N.	,	O
et	,	O
al.,	NNP	O
Appl.	FW	O
Microbiol.	,	O
Biotechnol.	.	O
(2009)	.	O
81:903-913),	.	O
which	)	O
was	,	O
previously	WDT	O
obtained	VBD	O
in	RB	O
a	VBN	O
similar	IN	O
manner,	DT	O
and	JJ	O
of	,	O
which	CC	O
deletion	IN	O
is	WDT	O
known	NN	O
to	VBZ	O
induce	VBN	O
cysteine	TO	O
sensitivity,	VB	O
a	JJ	O
similar	,	O
experiment	DT	O
was	JJ	O
performed	NN	O
by	VBD	O
using	VBN	O
a	IN	O
to/C-deficient	VBG	O
strain.	DT	O
The	JJ	O
dsbA-deficient	.	O
strain	DT	O
and	JJ	O
to/C-deficient	NN	O
strain	CC	O
used	NN	O
in	NN	O
this	VBN	O
experiment	IN	O
were	DT	O
JW3832	NN	O
strain	VBD	O
and	NNP	O
JW5503	NN	O
strain,	CC	O
respectively	NNP	O
(both	,	O
were	RB	O
included	DT	O
in	VBD	O
the	VBN	O
Keio	IN	O
collection),	DT	O
and	NNP	O
their	,	O
parent	CC	O
strain	PRP$	O
was	NN	O
the	NN	O
BW25113	VBD	O
strain	DT	O
Andreas	NNP	B
Haldimann,	NN	I
A.	NNP	I
and	,	I
Wanner,	NNP	I
B.	CC	I
L.,	,	I
J.	NNP	I
Bacteriol.,	,	I
2001	.	I
November,	,	I
183	CD	I
(21):6384-6393).(	,	O
The	CD	O
plasmids	.	O
carrying	DT	O
the	NNS	O
dsbA	VBG	O
gene	DT	O
and	NN	O
the	NN	O
to/C	CC	O
gene	DT	O
for	JJ	O
the	NN	O
complementation	IN	O
experiment	DT	O
were	NN	O
pDsbA	NN	O
and	VBD	O
pTo1C	JJ	O
(ASKA	CC	O
clone	NN	O
Kitagawa,	NNP	B
M.,	NN	I
et	,	I
al.,	,	I
2005,	FW	I
DNA	,	I
Res.,	,	I
12:291-299)),(	NNP	O
and	,	O
the	,	O
vector	CC	O
used	DT	O
as	NN	O
the	VBN	O
base	IN	O
of	DT	O
them	NN	O
was	IN	O
pCA24	PRP	O
(vector	VBD	O
for	NN	O
ASKA	NN	O
clone	IN	O
Kitagawa,	NNP	B
M.,	NN	I
et	,	I
al.,	,	I
2005,	FW	I
DNA	,	I
Res.,	,	I
12:291-299)).(	NNP	O
The	,	O
bacteria	.	O
containing	DT	O
each	NNS	O
of	VBG	O
the	DT	O
plasmids	IN	O
were	DT	O
each	NNS	O
inoculated	VBD	O
into	DT	O
5	VBN	O
ml	IN	O
of	CD	O
L	NN	O
medium	IN	O
(10	NNP	O
g/L	NN	O
of	CD	O
Bacto	NN	O
trypton,	IN	O
5	NNP	O
g/L	,	O
of	CD	O
Bacto	NN	O
yeast	IN	O
extract,	NNP	O
5	NNP	O
g/L	,	O
of	CD	O
NaCl),	NN	O
and	IN	O
cultured	,	O
overnight	CC	O
at	VBD	O
30°	VBN	O
C.	IN	O
The	CD	O
culture	NNP	O
was	DT	O
serially	NN	O
diluted	VBD	O
10	RB	O
times	VBN	O
for	CD	O
every	NNS	O
dilution	IN	O
with	DT	O
0.9%	NN	O
physiological	IN	O
saline	NN	O
to	JJ	O
prepare	NN	O
serially	TO	O
diluted	VB	O
cell	RB	O
suspensions	VBN	O
(10−2	NN	O
to	NNS	O
10−6),	CD	O
and	TO	O
the	,	O
cell	CC	O
suspensions	DT	O
were	NN	O
spotted	NNS	O
(5	VBD	O
μl)	VBN	O
onto	CD	O
L	)	O
agar	IN	O
medium	NNP	O
(10	NN	O
g/L	NN	O
of	CD	O
Bacto	NN	O
trypton,	IN	O
5	NNP	O
g/L	,	O
of	CD	O
Bacto	NN	O
yeast	IN	O
extract,	NNP	O
5	NNP	O
g/L	,	O
of	CD	O
NaCl,	NN	O
15	IN	O
g/L	,	O
of	CD	O
agar)	NN	O
containing	IN	O
various	)	O
concentrations	VBG	O
(10,	JJ	O
15,	NNS	O
20	,	O
mM)	,	O
of	CD	O
cysteine.	)	O
Culture	IN	O
was	.	O
performed	NN	O
at	VBD	O
37°	VBN	O
C.	IN	O
overnight,	CD	O
and	NNP	O
growth	,	O
tests	CC	O
of	NN	O
the	NNS	O
dsbA-deficient	IN	O
strain	DT	O
and	JJ	O
the	NN	O
to/C-deficient	CC	O
strain	DT	O
in	JJ	O
the	NN	O
cysteine	IN	O
medium,	DT	O
and	NN	O
complementation	,	O
(recovery	CC	O
of	NN	O
growth)	NN	O
tests	IN	O
with	)	O
the	VBZ	O
dsbA	IN	O
plasmid	DT	O
and	NN	O
the	NN	O
to/C	CC	O
plasmid	DT	O
were	NN	O
performed.	NN	O
The	VBD	O
results	.	O
are	DT	O
shown	NNS	O
in	VBP	O
FIG.	VBN	O
1.	IN	O
The	.	O
dsbA-deficient	.	O
strain	DT	O
JW3832/pCA24	JJ	O
and	NN	O
the	NNP	O
to/C-deficient	CC	O
strain	DT	O
JW5503/pCA24	JJ	O
showed	NN	O
marked	NNP	O
cysteine	VBD	O
sensitivity	JJ	O
as	JJ	O
compared	NN	O
with	IN	O
the	VBN	O
control	IN	O
strain	DT	O
BW25113/pCA24,	NN	O
and	NN	O
when	,	O
the	CC	O
dsbA	WRB	O
and	DT	O
to/C	NN	O
gene	CC	O
were	JJ	O
introduced	NN	O
as	VBD	O
plasmids	VBN	O
(JW3832/pDsbA	IN	O
strain,	NNS	O
JW5503/pTolC	NNP	O
strain),	,	O
the	NNP	O
strains	,	O
recovered	DT	O
from	NNS	O
the	VBN	O
sensitivity.	IN	O
Therefore,	DT	O
it	.	O
was	,	O
found	PRP	O
that	VBD	O
DsbA	VBN	O
was	IN	O
involved	NNP	O
in	VBD	O
the	VBN	O
cysteine	IN	O
resistance,	DT	O
like	NN	O
to/C.	,	O
(2)	IN	O
Toxicity	.	O
of	)	O
Cysteine	NN	O
to	IN	O
Cell	NNP	O
and	TO	O
Relation	NNP	O
to	CC	O
DsbA	NNP	O
Since	TO	O
deficiency	NNP	O
of	IN	O
the	NN	O
dsbA	IN	O
gene	DT	O
induced	JJ	O
cysteine	NN	O
sensitivity,	VBD	O
experiments	JJ	O
were	,	O
performed	NNS	O
about	VBD	O
toxicity	VBN	O
of	IN	O
cysteine	NN	O
to	IN	O
cells	NN	O
and	TO	O
relation	NNS	O
thereof	CC	O
to	NN	O
DsbA.	NN	O
(2-1)	TO	O
Accumulation	.	O
of	)	O
Reduced	NN	O
Type	IN	O
DsbA	NNP	O
Induced	NNP	O
by	NNP	O
Cysteine	NNP	O
In	IN	O
order	NNP	O
to	IN	O
examine	NN	O
whether	TO	O
cysteine	VB	O
has	IN	O
any	NN	O
influence	VBZ	O
on	DT	O
the	NN	O
oxidized	IN	O
and	DT	O
reduced	VBN	O
states	CC	O
of	VBN	O
the	NNS	O
DsbA	IN	O
protein,	DT	O
the	NNP	O
oxidized	,	O
and	DT	O
reduced	JJ	O
states	CC	O
of	JJ	O
DsbA	NNS	O
were	IN	O
analyzed	NNP	O
when	VBD	O
cysteine	VBN	O
was	WRB	O
added,	NN	O
or	VBD	O
YdeD,	,	O
a	CC	O
cysteine	,	O
secretion	DT	O
factor,	JJ	O
was	NN	O
highly	,	O
expressed.	VBD	O
It	RB	O
is	.	O
known	PRP	O
that	VBZ	O
YdeD	VBN	O
is	IN	O
a	NNP	O
secretion	VBZ	O
protein	DT	O
localizing	NN	O
at	NN	O
cell	VBG	O
membranes,	IN	O
and	NN	O
participates	,	O
in	CC	O
transportation	NNS	O
from	IN	O
cytoplasm	NN	O
to	IN	O
periplasm	NN	O
Dasler,	TO	B
T.	VB	I
et	,	I
al.,	NNP	I
Mol.	FW	I
Microbiol.,	,	I
2000,	.	I
36:1101-1112).(	,	O
Therefore,	,	O
it	.	O
is	,	O
estimated	PRP	O
that	VBZ	O
if	VBN	O
YdeD	IN	O
is	IN	O
highly	NNP	O
expressed,	VBZ	O
the	RB	O
supply	,	O
of	DT	O
cysteine	NN	O
to	IN	O
the	NN	O
periplasm	TO	O
is	DT	O
increased.	NN	O
The	VBZ	O
strains	.	O
used	DT	O
in	NNS	O
this	VBN	O
experiment	IN	O
were	DT	O
the	NN	O
E.	VBD	O
coli	DT	O
BW25113	NNP	O
strain	NNS	O
Andreas	NNP	B
Haldimann	NN	I
and	NNP	I
Barry	NNP	I
L.	CC	I
Wanner,	NNP	I
J.	NNP	I
Bacteriol.,	,	I
2001	.	I
November,	,	I
183	CD	I
(21):6384-6393)	,	I
(as	CD	O
a	)	O
wild-type	IN	O
parent	DT	O
strain,	JJ	O
the	NN	O
dsbA-deficient	,	O
JW3832	DT	O
strain	JJ	O
and	NNP	O
dsbB-deficient	NN	O
JW5182	CC	O
strain	JJ	O
derived	NNP	O
from	NN	O
BW25113	VBD	O
strain	IN	O
Baba,	NNP	B
T,	NN	I
et	,	I
al.,	,	I
2006,	FW	I
Mol.	,	I
Syst.	,	I
Biol.,	.	I
2:2006.0008).(	.	O
As	,	O
a	.	O
plasmid	IN	O
carrying	DT	O
the	NN	O
dsbB	VBG	O
gene,	DT	O
pDsbB	NN	O
ASKA	,	B
clone,	NN	I
Kitagawa,	NNP	I
M.	,	I
et	,	I
al.,	NNP	I
2005,	FW	I
DNA	,	I
Res.,	,	I
12:291-9)	NNP	I
(was	,	O
used.	)	O
A	VBD	O
plasmid	.	O
pYdeD	DT	O
carrying	NN	O
the	NN	O
ydeD	VBG	O
gene	DT	O
for	NN	O
highly	NN	O
expressing	IN	O
YdeD	RB	O
was	VBG	O
constructed	NNP	O
as	VBD	O
follows.	VBN	O
PCR	IN	O
was	.	O
performed	NNP	O
by	VBD	O
using	VBN	O
the	IN	O
genomic	VBG	O
DNA	DT	O
of	JJ	O
the	NN	O
E.	IN	O
coli	DT	O
MG1655	NNP	O
strain	NNS	O
as	NNP	O
a	NN	O
template,	IN	O
P1	DT	O
(5′-CGCGGATCCAATGGTCATAAATGGCAGCGTAGCGC-3′:	,	O
SEQ	NNP	O
ID	:	O
NO:	NNP	O
13)	NNP	O
and	:	O
P2	)	O
(5′-CGCGGATCCGCAGGGCGTTGCGGAACAAAC-3′:	CC	O
SEQ	NNP	O
ID	:	O
NO:	NNP	O
14)	NNP	O
as	:	O
primers	)	O
according	IN	O
to	NNS	O
the	VBG	O
protocol	TO	O
attached	DT	O
to	NN	O
Pyrobest	VBD	O
DNA	TO	O
polymerase	NNP	O
(Takara)	NNP	O
to	NN	O
obtain	)	O
a	TO	O
ydeD	VB	O
gene	DT	O
fragment	JJ	O
of	NN	O
about	NN	O
1.5	IN	O
kb	IN	O
including	CD	O
a	NNS	O
region	VBG	O
of	DT	O
about	NN	O
300	IN	O
by	IN	O
upstream	CD	O
from	IN	O
the	NN	O
ydeD	IN	O
gene	DT	O
and	NN	O
a	NN	O
region	CC	O
of	DT	O
about	NN	O
200	IN	O
by	IN	O
downstream	CD	O
from	IN	O
the	NN	O
ydeD	IN	O
gene.	DT	O
The	NN	O
BamHI	.	O
site	DT	O
was	NNP	O
designed	NN	O
in	VBD	O
both	VBN	O
the	IN	O
primers.	DT	O
The	DT	O
PCR	.	O
fragment	DT	O
was	NNP	O
digested	NN	O
with	VBD	O
BamHI,	VBN	O
and	IN	O
then	,	O
inserted	CC	O
into	RB	O
pSTV29	VBN	O
(Takara)	IN	O
at	NN	O
the	)	O
BamHI	IN	O
site,	DT	O
and	NNP	O
the	,	O
obtained	CC	O
plasmid	DT	O
in	VBN	O
which	NN	O
the	IN	O
ydeD	WDT	O
gene	DT	O
fragment	NN	O
was	NN	O
inserted	NN	O
in	VBD	O
the	VBN	O
same	IN	O
direction	DT	O
as	JJ	O
the	NN	O
lacZ	IN	O
gene	DT	O
on	JJ	O
the	NN	O
pSTV29	IN	O
vector	DT	O
was	NN	O
designated	NN	O
plasmid	VBD	O
pYdeD.	VBN	O
The	NN	O
amplified	.	O
portion	DT	O
was	JJ	O
sequenced	NN	O
by	VBD	O
PCR	VBN	O
to	IN	O
confirm	NNP	O
that	TO	O
it	VB	O
did	IN	O
not	PRP	O
contain	VBD	O
a	RB	O
mutation.	VB	O
In	DT	O
order	.	O
to	IN	O
distinguish	NN	O
the	TO	O
oxidized	VB	O
state	DT	O
and	JJ	O
the	NN	O
reduced	CC	O
state	DT	O
of	JJ	O
the	NN	O
DsbA	IN	O
protein,	DT	O
the	NNP	O
protein	,	O
was	DT	O
modified	NN	O
with	VBD	O
AMS	VBN	O
(4-acetamido-4′-maleimidyl-stilbene-2,2′-disulfonate)	IN	O
Kadokura,	NNP	B
H.	)	I
et	,	I
al.,	NNP	I
2004,	FW	I
Science,	,	I
303,	,	I
534-537).(	,	O
Each	,	O
of	.	O
the	DT	O
wild-type	IN	O
strain,	DT	O
the	JJ	O
dsbA-deficient	,	O
strain,	DT	O
the	JJ	O
dsbB-deficient	,	O
strain,	DT	O
the	JJ	O
wild-type	,	O
strain	DT	O
+pYdeD	JJ	O
and	NN	O
the	NN	O
dsbB-deficient	CC	O
strain	DT	O
+pDsbB	JJ	O
was	NN	O
cultured	NN	O
overnight	VBD	O
at	VBN	O
30°	RB	O
C.	IN	O
in	CD	O
3	NNP	O
ml	IN	O
of	CD	O
LB	NN	O
medium,	IN	O
and	NNP	O
the	,	O
resulting	CC	O
culture	DT	O
was	JJ	O
used	NN	O
as	VBD	O
a	VBN	O
preculture	IN	O
medium.	DT	O
The	NN	O
preculture	.	O
medium	DT	O
was	NN	O
inoculated	NN	O
into	VBD	O
the	VBN	O
LB	IN	O
medium	DT	O
in	NNP	O
a	NN	O
1%	IN	O
amount,	DT	O
and	NN	O
culture	,	O
was	CC	O
performed	NN	O
at	VBD	O
30°	VBN	O
C.	IN	O
with	CD	O
shaking	NNP	O
until	IN	O
OD660	VBG	O
reached	IN	O
0.4	NNP	O
to	VBD	O
0.5.	CD	O
Then,	TO	O
cysteine	.	O
was	,	O
added	NN	O
at	VBD	O
5	VBN	O
mM	IN	O
as	CD	O
the	NN	O
final	IN	O
concentration	DT	O
to	JJ	O
expose	NN	O
the	TO	O
cells	VB	O
to	DT	O
cysteine	NNS	O
for	TO	O
20	VB	O
minutes.	IN	O
The	CD	O
oxidized	.	O
and	DT	O
reduced	JJ	O
states	CC	O
of	JJ	O
the	NNS	O
DsbA	IN	O
protein	DT	O
were	NNP	O
examined	NN	O
by	VBD	O
the	VBN	O
method	IN	O
of	DT	O
Ito	NN	B
et	IN	I
al.	NNP	I
(Kobayashi,	FW	I
T.,	.	I
Kishigami,	,	I
S.,	,	I
Sone,	,	I
M.,	,	I
Inokuchi,	,	I
H.,	,	I
Mogi,	,	I
T.	,	I
and	,	I
Ito	NNP	I
K.,	CC	I
Proc.	NNP	I
Natl.	,	I
Acad.	.	I
Sci.	.	I
USA,	.	I
94,	.	I
11857-11862).	,	I
That	,	O
is,	.	O
after	DT	O
giving	,	O
the	IN	O
stress,	VBG	O
100	DT	O
μl	,	O
of	CD	O
TCA	NN	O
(trichloroacetic	IN	O
acid,	NNP	O
final	JJ	O
concentration:	,	O
16.7%)	JJ	O
was	:	O
immediately	)	O
added	VBD	O
to	RB	O
0.5	VBN	O
ml	TO	O
of	CD	O
the	NN	O
culture	IN	O
medium	DT	O
(OD660	NN	O
was	NN	O
about	NNP	O
0.5),	VBD	O
and	IN	O
the	,	O
mixture	CC	O
was	DT	O
stirred,	NN	O
left	VBD	O
standing	,	O
on	VBD	O
ice	VBG	O
for	IN	O
20	NN	O
minutes	IN	O
to	CD	O
precipitate	NNS	O
the	TO	O
cells,	VB	O
and	DT	O
centrifuged	,	O
to	CC	O
collect	VBD	O
the	TO	O
cells.	VB	O
Then,	DT	O
700	.	O
μl	,	O
of	CD	O
acetone	NN	O
was	IN	O
added	NN	O
to	VBD	O
the	VBN	O
obtained	TO	O
precipitates,	DT	O
the	VBN	O
mixture	,	O
was	DT	O
stirred,	NN	O
then	VBD	O
left	,	O
standing	RB	O
on	VBD	O
ice	VBG	O
for	IN	O
20	NN	O
minutes,	IN	O
and	CD	O
recentrifuged	,	O
to	CC	O
collect	VBD	O
the	TO	O
cells.	VB	O
The	DT	O
precipitates	.	O
were	DT	O
dissolved	NNS	O
in	VBD	O
a	VBN	O
solution	IN	O
of	DT	O
1%	NN	O
SDS,	IN	O
50	NN	O
mM	,	O
Tris-HCl	CD	O
(pH	NN	O
6.8)	NNP	O
and	VB	O
10	)	O
mM	CC	O
4-acetamido-4′-maleimidyl-stilbene-2,2′-disulfonate	CD	O
(AMS,	NNS	O
Invitrogen)	JJ	O
prepared	,	O
immediately	)	O
before	VBD	O
use.	RB	O
The	IN	O
labeled	.	O
protein	DT	O
was	JJ	O
then	NN	O
separated	VBD	O
by	RB	O
non-reduced	VBN	O
SDS	IN	O
gel	JJ	O
electrophoresis	NNP	O
(12.5%),	NN	O
and	NN	O
then	,	O
detected	CC	O
by	RB	O
Western	VBN	O
blotting.	IN	O
The	JJ	O
nitrocellulose	.	O
membrane	DT	O
after	JJ	O
the	NN	O
blotting	IN	O
was	DT	O
shaken	NN	O
in	VBD	O
a	VBN	O
blocking	IN	O
solution	DT	O
(TTBS	JJ	O
containing	NN	O
3%	NNP	O
of	VBG	O
skim	NN	O
milk,	IN	O
0.05%	JJ	O
(wt/vol)	,	O
of	NN	O
Tween	)	O
20,	IN	O
200	NNP	O
mM	,	O
Tris-HCl	CD	O
(pH	NN	O
7.5),	NNP	O
500	VB	O
mM	,	O
NaCl)	CD	O
for	NN	O
1	)	O
hour.	IN	O
The	CD	O
membrane	.	O
was	DT	O
washed	NN	O
with	VBD	O
TTBS,	VBN	O
and	IN	O
then	,	O
shaken	CC	O
in	RB	O
a	VBN	O
primary	IN	O
antibody	DT	O
solution	JJ	O
(anti-DsbA	NN	O
blood	NN	O
serum	JJ	O
(rabbit),	NN	O
Kadokura,	NN	O
H.	,	O
et	,	O
al.,	NNP	O
2004,	FW	O
Science,	,	O
303,	,	O
534-537)	,	O
for	,	O
1	)	O
hour.	IN	O
The	CD	O
membrane	.	O
was	DT	O
washed	NN	O
with	VBD	O
TTBS,	VBN	O
and	IN	O
then	,	O
shaken	CC	O
in	RB	O
a	VBN	O
secondary	IN	O
antibody	DT	O
solution	JJ	O
(TTBS	NN	O
containing	NN	O
0.2%	NNP	O
of	VBG	O
peroxidase-labeled	NN	O
anti-rabbit	IN	O
IgG	JJ	O
(GE	JJ	O
Healthcare)	NNP	O
and	NNP	O
3%	)	O
of	CC	O
albumin).	NN	O
The	IN	O
label	.	O
was	DT	O
detected	NN	O
by	VBD	O
using	VBN	O
ECL	IN	O
Plus	VBG	O
Western	NNP	O
Blotting	NNP	O
Detection	NNP	O
Reagents	NNP	O
(Amersham).	NNP	O
The	NNP	O
results	.	O
are	DT	O
shown	NNS	O
in	VBP	O
FIG.	VBN	O
2.	IN	O
From	.	O
the	.	O
fact	IN	O
that	DT	O
no	NN	O
band	IN	O
was	DT	O
detected	NN	O
for	VBD	O
the	VBN	O
dsbA-deficient	IN	O
strain,	DT	O
and	JJ	O
the	,	O
appearance	CC	O
of	DT	O
the	NN	O
bands	IN	O
for	DT	O
the	NNS	O
dsbB-deficient	IN	O
strain	DT	O
and	JJ	O
dsbB-deficient	NN	O
strain	CC	O
+pDsbB,	JJ	O
it	NN	O
was	,	O
confirmed	PRP	O
that	VBD	O
the	VBN	O
oxidized	IN	O
type	DT	O
and	JJ	O
reduced	NN	O
type	CC	O
of	JJ	O
DsbA	NN	O
were	IN	O
correctly	NNP	O
detected.	VBD	O
When	RB	O
cysteine	.	O
was	WRB	O
not	NN	O
added,	VBD	O
only	RB	O
the	,	O
oxidized	RB	O
type	DT	O
DsbA	JJ	O
was	NN	O
observed	NNP	O
for	VBD	O
the	VBN	O
wild-type	IN	O
strain.	DT	O
However,	JJ	O
the	.	O
reduced	,	O
type	DT	O
DsbA	JJ	O
accumulated	NN	O
after	NNP	O
exposure	VBD	O
to	IN	O
cysteine	NN	O
(reduction	TO	O
stress),	VB	O
and	NN	O
the	,	O
DsbA-DsbB	CC	O
complex	DT	O
also	NNP	O
markedly	NN	O
accumulated.	RB	O
Moreover,	RB	O
it	.	O
was	,	O
found	PRP	O
that	VBD	O
the	VBN	O
reduced	IN	O
type	DT	O
DsbA	JJ	O
also	NN	O
accumulated	NNP	O
in	RB	O
the	VBD	O
wild-type	IN	O
strain	DT	O
when	JJ	O
YdeD	NN	O
was	WRB	O
highly	NNP	O
expressed	VBD	O
in	RB	O
that	VBN	O
strain.	IN	O
The	DT	O
DsbA-DsbB-UQ	.	O
oxidation	DT	O
system	NNP	O
is	NN	O
originally	NN	O
a	VBZ	O
system	RB	O
for	DT	O
disulfide	NN	O
bond	IN	O
formation	JJ	O
in	NN	O
proteins.	NN	O
However,	IN	O
it	.	O
was	,	O
found	PRP	O
that	VBD	O
when	VBN	O
cysteine	IN	O
excessively	WRB	O
existed,	NN	O
it	RB	O
worked	,	O
to	PRP	O
oxidize	VBD	O
it	TO	O
into	VB	O
cystine,	PRP	O
and	IN	O
thus	,	O
the	CC	O
reduced	RB	O
type	DT	O
DsbA	JJ	O
accumulated.	NN	O
(2-2)	NNP	O
Accumulation	.	O
of	)	O
Reduced	NN	O
Type	IN	O
OstA	NNP	O
Protein	NNP	O
Induced	NNP	O
by	NNP	O
Cysteine	NNP	O
Since	IN	O
it	NNP	O
was	IN	O
elucidated	PRP	O
that	VBD	O
the	VBN	O
reduced	IN	O
type	DT	O
DsbA	JJ	O
was	NN	O
accumulated	NNP	O
by	VBD	O
cysteine	VBN	O
(reduction	IN	O
stress),	NN	O
it	NN	O
was	,	O
decided	PRP	O
to	VBD	O
investigate	VBN	O
toxicity	TO	O
of	VB	O
cysteine	NN	O
and	IN	O
oxidized	NN	O
and	CC	O
reduced	VBN	O
states	CC	O
of	VBN	O
a	NNS	O
protein	IN	O
in	DT	O
the	NN	O
periplasm.	IN	O
The	DT	O
OstA	.	O
is	DT	O
a	NNP	O
protein	VBZ	O
in	DT	O
the	NN	O
periplasm	IN	O
indispensable	DT	O
to	NN	O
growth,	JJ	O
and	TO	O
requires	,	O
disulfide	CC	O
bond	VBZ	O
formed	JJ	O
by	NN	O
DsbA.	VBN	O
In	IN	O
order	.	O
to	IN	O
investigate	NN	O
the	TO	O
oxidized	VB	O
and	DT	O
reduced	JJ	O
states	CC	O
of	JJ	O
the	NNS	O
OstA	IN	O
protein,	DT	O
the	NNP	O
E.	,	O
coli	DT	O
BW25113	NNP	O
strain	NNS	O
as	NNP	O
the	NN	O
wild-type	IN	O
parent	DT	O
strain	JJ	O
and	NN	O
the	NN	O
dsbA-deficient	CC	O
JW3832	DT	O
strain	JJ	O
derived	NNP	O
from	NN	O
the	VBD	O
BW25113	IN	O
strain	DT	O
were	NNP	O
used,	NN	O
and	VBD	O
the	,	O
plasmid	CC	O
pmyc-OstA	DT	O
for	JJ	O
expressing	NN	O
OstA	IN	O
fused	VBG	O
with	NNP	O
an	VBD	O
Myc	IN	O
tag	DT	O
Kadokura,	NNP	B
H.	NN	I
et	,	I
al.,	NNP	I
2004,	FW	I
Science,	,	I
303,	,	I
534-537)	,	I
(was	,	O
introduced	)	O
into	VBD	O
them.	VBN	O
Under	IN	O
the	.	O
same	IN	O
culture	DT	O
conditions	JJ	O
as	NN	O
those	NNS	O
of	IN	O
the	DT	O
aforementioned	IN	O
experiment	DT	O
for	JJ	O
investigating	NN	O
the	IN	O
oxidized	VBG	O
and	DT	O
reduced	VBN	O
states	CC	O
of	VBN	O
DsbA,	NNS	O
addition	IN	O
of	,	O
L-cysteine	NN	O
(final	IN	O
concentration:	NNP	O
5	JJ	O
mM)	:	O
and	CD	O
modification	)	O
of	CC	O
the	NN	O
protein	IN	O
with	DT	O
AMS	NN	O
(4-acetamido-4′-maleimidyl-stilbene-2,2′-disulfonate)	IN	O
were	NNP	O
performed,	)	O
and	VBD	O
the	,	O
OstA	CC	O
protein	DT	O
was	NNP	O
detected	NN	O
by	VBD	O
Western	VBN	O
blotting.	IN	O
As	JJ	O
the	.	O
antibody,	IN	O
anti-Myc	DT	O
(mouse)	,	O
was	JJ	O
used	)	O
in	VBD	O
this	VBN	O
experiment.	IN	O
The	DT	O
results	.	O
are	DT	O
shown	NNS	O
in	VBP	O
FIG.	VBN	O
3.	IN	O
It	.	O
was	.	O
found	PRP	O
that,	VBD	O
in	VBN	O
the	,	O
DsbA-deficient	IN	O
strain,	DT	O
all	NNP	O
of	,	O
the	DT	O
OstA	IN	O
proteins	DT	O
are	NNP	O
the	NNS	O
reduced	VBP	O
type,	DT	O
irrespective	JJ	O
of	,	O
addition	NN	O
or	IN	O
no	NN	O
addition	CC	O
of	DT	O
cysteine.	NN	O
In	IN	O
the	.	O
wild-type	IN	O
strain,	DT	O
when	JJ	O
there	,	O
was	WRB	O
no	EX	O
cysteine,	VBD	O
the	DT	O
OstA	,	O
protein	DT	O
was	NNP	O
the	NN	O
oxidized	VBD	O
type	DT	O
with	JJ	O
correctly	NN	O
formed	IN	O
disulfide	RB	O
bond,	VBN	O
but	JJ	O
the	,	O
reduced	CC	O
type	DT	O
accumulated	JJ	O
after	NN	O
the	VBN	O
addition	IN	O
of	DT	O
cysteine.	NN	O
It	IN	O
was	.	O
elucidated	PRP	O
that	VBD	O
the	VBN	O
reduced	IN	O
type	DT	O
DsbA	JJ	O
accumulated	NN	O
due	NNP	O
to	VBD	O
cysteine	JJ	O
(reduction	TO	O
stress),	VB	O
accordingly	NN	O
the	,	O
OstA	RB	O
protein	DT	O
which	NNP	O
is	NN	O
as	WDT	O
an	VBZ	O
essential	IN	O
protein	DT	O
was	JJ	O
not	NN	O
correctly	VBD	O
oxidized,	RB	O
and	RB	O
this	,	O
constituted	CC	O
one	DT	O
of	VBD	O
toxicities	CD	O
of	IN	O
cysteine	NNS	O
for	IN	O
growth.	NN	O
On	IN	O
the	.	O
basis	IN	O
of	DT	O
the	NN	O
above	IN	O
consideration,	DT	O
it	JJ	O
was	,	O
considered	PRP	O
that	VBD	O
enhancement	VBN	O
of	IN	O
DsbA	NN	O
was	IN	O
effective	NNP	O
in	VBD	O
an	JJ	O
environment	IN	O
where	DT	O
cysteine	NN	O
abundantly	WRB	O
existed	NN	O
such	RB	O
as	VBD	O
that	JJ	O
of	IN	O
cysteine	DT	O
production	IN	O
by	NN	O
fermentation.	NN	O
(3)	IN	O
Construction	.	O
of	)	O
Cysteine-producing	NN	O
Bacterium	IN	O
A	NNP	O
cysteine-producing	NNP	O
bacterium	NNP	O
was	JJ	O
constructed	NN	O
by	VBD	O
introducing	VBN	O
pACYC-DES	IN	O
carrying	VBG	O
a	JJ	O
mutant	VBG	O
cysE	DT	O
coding	JJ	O
for	NN	O
a	VBG	O
mutant	IN	O
serine	DT	O
acetyltransferase	JJ	O
in	NN	O
which	NN	O
feedback	IN	O
inhibition	WDT	O
by	NN	O
L-cysteine	NN	O
was	IN	O
reduced,	NNP	O
the	VBD	O
ydeD	,	O
gene,	DT	O
and	NN	O
a	,	O
mutant	CC	O
serA	DT	O
gene	JJ	O
coding	NN	O
for	NN	O
a	VBG	O
3-phosphoglycerate	IN	O
dehydrogenase	DT	O
in	JJ	O
which	NN	O
feedback	IN	O
inhibition	WDT	O
by	NN	O
L-serine	NN	O
was	IN	O
reduced	NNP	O
on	VBD	O
one	VBN	O
plasmid	IN	O
into	CD	O
E.	NN	O
coli	IN	O
BW25113.	NNP	O
The	NNS	O
construction	.	O
of	DT	O
pACYC-DES	NN	O
is	IN	O
described	NN	O
in	VBZ	O
EP	VBN	O
1528108	IN	O
B1.	NNP	O
Furthermore,	CD	O
in	.	O
order	,	O
to	IN	O
investigate	NN	O
the	TO	O
effect	VB	O
of	DT	O
overexpression	NN	O
of	IN	O
DsbA	NN	O
on	IN	O
cysteine	NNP	O
production,	IN	O
cysteine-producing	NN	O
bacteria	,	O
introduced	JJ	O
with	NNS	O
pDsbA	VBN	O
or	IN	O
an	NN	O
empty	CC	O
vector	DT	O
pCA24N	JJ	O
serving	NN	O
as	NN	O
a	VBG	O
control	IN	O
were	DT	O
constructed.	NN	O
E.	VBD	O
coli	.	O
BW25113	NNP	O
can	NNS	O
be	NNP	O
obtained	MD	O
from	VB	O
the	VBN	O
Escherichia	IN	O
coli	DT	O
Genetic	NNP	O
Stock	VBZ	O
Center	NNP	O
(830	NNP	O
Kline	NNP	O
Biology	CD	O
Tower,	NNP	O
Dept.	NNP	O
of	,	O
Molecular,	.	O
Cellular,	IN	O
and	,	O
Developmental	,	O
Biology,	CC	O
266	NNP	O
Whitney	,	O
Ave.,	CD	O
PO	NNP	O
box	,	O
208103,	NNP	O
Yale	NN	O
University,	,	O
New	NNP	O
Haven,	,	O
Conn.	NNP	O
06520-8103)	,	O
by	NNP	O
referring	)	O
to	IN	O
the	VBG	O
number	TO	O
of	DT	O
CGSC#7636.	NN	O
An	IN	O
L-cysteine-producing	.	O
bacterium	DT	O
can	JJ	O
also	NN	O
be	MD	O
similarly	RB	O
constructed	VB	O
by	RB	O
using	VBN	O
the	IN	O
E.	VBG	O
coli	DT	O
W3110	NNP	O
strain	NNS	O
or	NNP	O
the	NN	O
like	CC	O
instead	DT	O
of	JJ	O
the	RB	O
above	IN	O
strain.	DT	O
E.	JJ	O
coli	.	O
K12	NNP	O
W3110	NNS	O
can	NNP	O
be	NNP	O
obtained	MD	O
from	VB	O
ATCC	VBN	O
as	IN	O
ATCC	NNP	O
27325.	IN	O
(4)	NNP	O
L-Cysteine	.	O
Production	)	O
by	JJ	O
DsbA-Enhanced	NN	O
Cysteine-Producing	IN	O
Bacterium	NNP	O
A	NNP	O
DsbA-enhanced	NNP	O
cysteine-producing	NNP	O
bacterium	JJ	O
(E.	JJ	O
coli	NN	O
BW25113/pACYC-DES/pDsbA	NNP	O
strain),	VBZ	O
and	NNP	O
a	,	O
DsbA-non-enhanced	CC	O
control	DT	O
strain	NNP	O
(E.	NN	O
coli	NN	O
BW25113/pACYC-DES/pCA24N	NNP	O
strain)	VBZ	O
were	NNP	O
each	)	O
inoculated	VBD	O
into	DT	O
5	VBN	O
ml	IN	O
of	CD	O
L	NN	O
medium	IN	O
(10	NNP	O
g/L	NN	O
of	CD	O
Bacto	NN	O
trypton,	IN	O
5	NNP	O
g/L	,	O
of	CD	O
Bacto	NN	O
yeast	IN	O
extract,	NNP	O
5	NNP	O
g/L	,	O
of	CD	O
NaCl,	NN	O
tetracycline	IN	O
(10	,	O
μg/mL),	NN	O
chloramphenicol	CD	O
(30	,	O
μg/mL)),	NN	O
and	CD	O
cultured	,	O
at	CC	O
30°	VBD	O
C.	IN	O
overnight	CD	O
(preculture).	NNP	O
The	MD	O
cell	.	O
suspension	DT	O
after	NN	O
an	NN	O
overnight	IN	O
culture	DT	O
was	JJ	O
taken	NN	O
in	VBD	O
a	VBN	O
volume	IN	O
of	DT	O
250	NN	O
μl,	IN	O
and	CD	O
added	,	O
to	CC	O
25	VBD	O
ml	TO	O
of	CD	O
the	NN	O
fresh	IN	O
medium	DT	O
(SM1+10%	JJ	O
L	NN	O
medium),	NN	O
and	NNP	O
culture	,	O
was	CC	O
performed	NN	O
at	VBD	O
30°	VBN	O
C.	IN	O
with	CD	O
shaking	NNP	O
at	IN	O
140	VBG	O
rpm.	IN	O
In	CD	O
this	.	O
culture,	IN	O
tetracycline	DT	O
(10	,	O
mg/mL)	NN	O
and	CD	O
chloramphenicol	)	O
(30	CC	O
μg/mL)	NN	O
were	CD	O
added	)	O
to	VBD	O
the	VBN	O
medium	TO	O
in	DT	O
order	NN	O
to	IN	O
maintain	NN	O
the	TO	O
plasmids	VB	O
in	DT	O
the	NNS	O
cells.	IN	O
The	DT	O
medium	.	O
was	DT	O
temporally	NN	O
sampled,	VBD	O
and	RB	O
production	,	O
of	CC	O
cysteine,	NN	O
cystine,	IN	O
and	,	O
cysteine-related	,	O
compounds	CC	O
were	JJ	O
analyzed	NNS	O
after	VBD	O
various	VBN	O
periods.	IN	O
The	JJ	O
composition	.	O
of	DT	O
the	NN	O
SM1	IN	O
medium	DT	O
used	NNP	O
for	NN	O
the	VBN	O
culture	IN	O
was	DT	O
as	NN	O
follows:	VBD	O
0.1	IN	O
M	:	O
KH2PO4—K2HPO4	CD	O
buffer	NNP	O
(pH	NNP	O
7.0),	NN	O
30	JJ	O
g/L	,	O
of	CD	O
glucose,	NN	O
10	IN	O
g/L	,	O
of	CD	O
(NH4)2SO4,	NN	O
0.1	IN	O
g/L	,	O
of	CD	O
NaCl,	NN	O
7.2	IN	O
μM	,	O
FeSO4.7H2O,	CD	O
0.6	NN	O
μM	,	O
Na2MoO4,	CD	O
40.4	NN	O
μM	,	O
H3BO3,	CD	O
2.9	NN	O
μM	,	O
CoCl2,	CD	O
1	NN	O
μMl	,	O
CuSO4,	CD	O
8.1	NN	O
μM	,	O
MnCl2,	CD	O
1	NN	O
mM	,	O
MgSO4,	CD	O
0.1	NN	O
mM	,	O
CaCl2	CD	O
Dassler,	NN	B
T.	NNP	I
et	,	I
al.,	NNP	I
2000,	FW	I
Mol.	,	I
Microbiol.,	,	I
36,	.	I
1101-1112).(	,	O
Cysteine,	,	O
cystine,	.	O
and	,	O
cysteine-related	,	O
compounds	CC	O
were	JJ	O
quantified	NNS	O
as	VBD	O
follows	VBN	O
according	IN	O
to	VBZ	O
the	VBG	O
method	TO	O
of	DT	O
Gaitonde	NN	O
Gaitonde,	IN	B
M.	NNP	I
K.,	,	I
1967,	NNP	I
Biochem.	,	I
J.,	,	I
104,	.	I
627-633).